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Abstract 
Deracemisation is a process in which one enantiomer of a racemic mixture is 
converted to its optical isomer through a stereoinversion reaction. The aim of this 
project was to identify a novel enantioselective amine oxidase that would be suitable 
for application in deracemisation reactions of chiral amines. 
The application of the technique of "directed evolution" allows changing certain 
amino acids in the enzyme so those new enzymes can be generated with altered 
properties. The real key to success in this area is the development of high-throughput 
assays that can be used to select the variant enzymes of interest. 
Prior to these studies there were no reports in the literature concerning the 
application of amine oxidases for the deracemisation of chiral amines. In our initial 
studies we demonstrated that the amine oxidase from Aspergillus niger (MAO-N) 
possessed very low activity towards L-alpha-methylbenzylamine (L-AMBA) with 
even slower oxidation of the D-enantiomer (D-AM1BA). The gene encoding for 
MAO-N was subjected to random mutagenesis using a E. co/i mutator strain XL1-
Red (Stratagene). This strain is deficient in the DNA repair system and permits the 
introduction of mutations randomly not only in the mutator genome, but also in 
foreign DNA, which has been transformed into the mutator strain. Using this 
approach it was possible to select a variant of MAO-N with activity towards L-
AMIBA 50 times higher and selectivity towards L-AMBA 6 times higher then the 
wild type. 
The amine oxidase mutant was used for the deracemisation of racemic alpha-
methylbenzylamine giving a 77% yield of the L-enantiomer with 93% e.e. These 
results show that new procedures of mutagenesis using a mutator strain can be 
simpler compared to more popular techniques such as error-prone PCR and DNA 
recombination. The efficiency of mutagenesis was achieved in conjunction with a 
novel high throughput screen. 
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Optically active amines are highly desired intermediates as starting materials for the 
production of enantiomericaly pure drugs. They are often used in asymmetric 
synthesis as chiral auxilliaries or catalysts, and also as building blocks for 
therapeutically important pharmaceutical and agrochemical compounds.W For 
example (S)1methoxy-2-amiflOprOPane, which is produced by BASF AG in a 
multi-tonne scale, is used as the starting material for optically active corn-herbicides 
(FRONTIER X2®  and OUTLOOK) production.' 
In the case of pharmaceutical or agrochemical compounds, generally only one 
enantiomer of a target molecule is active with the other showing no, or even 
detrimental, biological activity. Therefore the need to prepare compounds in an 
enantiopure form arises from both commercial and safety issues. 
1.1. BiocatalysiS 
Traditional chemical catalysis generally refers to processes in which chemical 
reactions are catalysed by transition metals or organometallic compounds, sometimes 
under extreme pressure and temperature conditions and in the presence of toxic 
organic chemicals.47  
An alternative approach to the conventional chemical synthesis of enantiomerically 
pure compounds lies in the area of biocatalysis. Enzymes are remarkable catalysts 
that perform their tasks under mild conditions and with a high degree of regio- 
selectivity and enantio-selectivity. 
A large number of enzymes have become commercially available for organic 
synthesis. Of about 2500 identified so far, some 300 are available in a partially 
purified form. Because of advances in molecular biology, fermentation and 
Introduction 
purification techniques, the fine chemical production costs are being reduced to 
industrially attractive levels.8  
1.1.1. 	Kinetic resolutions 
The process wherein one enantiomer of a racemate is more readily transformed into 
the product compare to its mirror image is known as a kinetic resolution (Figure l). 
kR  
(R)-A 	 30. 	 (R)..P 
fast 
ks 	
kR  =1= ks  
(S)-A 	 (S)-P 
slow 
A = substrate 
P = product 
Figure 1: kinetic resolution. 
The first kinetic resolution was documented by Pasteur in 1858, when he discovered 
that ammonium tartarate, fermented in the presence of Penicillium glaucam, resulted 
in faster metabolism of the D-enantiomer compare to the L-enantiomer.9 Today either 
chemo- or biocatalysis can be used to bring about such resolutions, with reports of 
biocatalytic resolutions greatly outnumbering the chemocatalytic methods. The 
hydrolase enzymes, such as lipases and acylases, are the most popular class of 





ROH 	 0 Enz-Ser-OH o 
Enz-Ser-OH + RAOR 	
Jr 	Enz-Ser-0R 	 RnucIeophiIe 
nucleophile: H20, ROH, RNH2 
Figure 2: mechanism of lipase-catalysed acyl transfer to an alcohol or amine 
acceptor. 
Lipases belong to a large class of enzymes that hydrolyse the ester bond between the 
fatty-acyl side chains and the lipid backbone. The lipase active side is composed of 
three different residues: serine, histidine and aspartate or glutamate. The hydrolysis 
of an ester involves formation of an acyl enzyme complex. The catalytic cycle is 
initiated by nucleophilic attack of the hydroxyl group of the serine side chain onto 
the carbonyl carbon atom of the ester bond followed by release of the alcohol. 
Thereafter nucleophilic attack by water liberates the carboxylic acid and the enzyme 
is regenerated (Figure 2). 
As lipases are active in organic solvents, water can be replaced by other nucleophiles 
such as alcohols. The result of this reaction is a transesterification. This reaction is 
commonly used for kinetic resolution of amino acids.10  Amines can also be used as 
nucleophiles. Racemic amines are efficiently resolved using ethylmethoxyacetate 
1,11a (Figure 3A) or ethyl acetate as the acylating agent."'Due to the simplicity of 
lipase-catalysed reactions, a number of kinetic resolutions are now carried out on an 
industrial scale. 1,12  Nevertheless, it would seem that performing the enantioselective 
acylation of amines catalyzed by penicillin acylase from Alcaligenesfaecalis in 
aqueous medium could be more efficient and practical (Figure 3B).13 
One such process is the resolution of racemic primary amines using Candida 
antarctica lipase and ethyl acetate as the acyl donor.Hb This method is used to 
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Figure 3: (A) lipase-catalysed synthesis of enantiomerically pure 1 -phenylethylamine 
(BASF); (B) A icaligenesfaecaiis penicillin acylase—catalysed acylation of amines, 
with phenylacetamide as an acyl donor. 
Chiral amines e.g. c-methylbenzy1amine (AIVIIBA) have also been kinetically 
resolved using an (o-transaminase (Figure 4). 
14  It was found that the enzyme was 
inhibited by the acetophenone product, which resulted in a decrease in the yield of 
the reaction. The problem was overcome by using a bi-phasic system, which offered 
two advantages: i) the inhibitory product acetophenone could be extracted from the 
aqueous phase and ii) AMBA formed an imine with cyclohexanone and resided 
primarily in the organic phase, thereby allowing the organic phase to act as a 
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Figure 4: kinetic resolution of AMBA using o-transaminase." 
However, no matter how efficient the resolution, classical kinetic resolutions suffer 
from three major disadvantages: (i) the maximum yield that can be obtained is only 
50%, (ii) separation of the product from the unreacted starting material can be 
problematic and (iii) for kinetic reasons, the enantiomeric purity becomes depleted 
beyond 50% conversion.15 
1.1.2. 	Asymmetric biosynthesis 
Transaminases (aminotransferases) use the cofactor PLP (pyridoxal-5'-phosphate) to 
transfer an amine group by deamination from a donor amine, via PMP 
(pyridoxamine-5'-phosphate), to an acceptor a-keto acid. In the second stage of the 
reaction the amino group of PMP is transferred to a.-keto acid to yield a new amine 
and regenerated PLP. The rate of both reactions is about equal (Keq = 1), so that the 
substrate/product mixture is difficult to separate. This problem can be overcome by 
coupling the reaction with oxidative deamination of inexpensive (5)-amino acids 
5 
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such as (1S)-aspartate to oxaloacetate which decarboxylates spontaneously to 
pyruvate16'17 (Figure 5). 
PLP 	 NH 
+ 	transaminase 
I transaminase 0 	
2 
NH2  
PLP______ NH 	, + 
RCO0H R COOH 
R COOH 	 R 
Pyridoxamine 
phosphate(PMP) 
Figure 5: reaction of transamination catalysed by PLP-dependent transaminase. 
The transaminase technology has been successfully developed by Celgene 
Corporation for the production of chiral amines by direct asymmetric synthesis from 
the corresponding prochiral ketone and amino donor (e.g. isopropylamine, 2-amino 
butane)18  (Figure 6). In this way, pilot production of chiral amines to multi- lOOkg 
scale has been carried out at Celgene. 
(R)-transaminase 
01'2 NH 
 isopropyl 	acetone 
amine 
Figure 6: asymmetric synthesis of a chiral amine using an (R)-transaminase. 
The main advantages of transaminase catalysed processes are the high turnover 
numbers of the enzymes and no requirement for external cofactor recycling. A 
number of compounds including L-2-aminobutyric acid and L—tertiary leucine have 
now been produced using transaminase-based biotransformations.19'20  
Enantiomerically pure L-2-aminobutyric acid was produced from L-threonine and L-
aspartic acid in a whole cell biotransformation using recombinant E. co/i cells 
threorne 
deaminase 
i/vA 	 COOH 
H2N COOH 





H2  COOH 
L-threonine 





expressing cloned genes encoding threonine deaminase, tyrosine aminotransferase, 
and acetolactate synthase. The reversible nature of the reaction leads to the presence 
of a keto acid by-product, which limits the overall yield, and purity of product. To 
enhance the biosynthesis of L-2-aminobutyric acid, the keto acid was eliminated by 
incorporation of acetolactate synthase into the synthetic biochemical pathway of L-2- 











Figure 7: engineered biosynthetic pathway for production of L-2-aminobutyric acid 
(NSC Technologies). 
The presence of acetolactate synthase increased the overall yield of the product from 
68% to 92%. In the absence of threonine deaminase, the yield and purity are 
comparable to the three gene system but the commercial feasibility of the process is 
significantly diminished by the high cost and unavailability of 2-ketobutyrate. 
In addition, a-keto acids can be reductively aminated to ct-amino acids in a reaction 
with the equilibrium on the side of aminated products (Keq = 9 




Following conversion of the keto acid to the intermediate imine, the enzyme leucine 
dehydrogenase (LeuDH)'7  catalyses attack of hydride from NADH to give the 
optically pure amino acid as the product. Analogues of L-tert-leucine can also be 
prepared, which serve as chiral intermediates for the synthesis of antitumor, anti-
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Figure 8: scheme for NADH recycling via synthesis of L-tert-leucine by reductive 
amination (Degussa-Hills AG). 
Enzymatic reductive amination with NADH as cofactor can only be operated on a 
large scale if the cofactor is regenerated (Figure 8).1724  The oxidised form of the 
cofactor NAD is regenerated to NADH by employing formate dehydrogenase 
(FDH) and ammonium formate. The formate is oxidised irreversibly to CO2. which 
can be easily removed. 
1.1.3. 	Deracemisation 
Deracemisation can be defined as a process that leads to the formation of a single 





1.1.3.1. 	Dynamic kinetic resolution 
The non-static process in which the substrate can be racemised in situ is called 
'dynamic kinetic resolution' (Figure 9). 
kR 




(S)-A 	 (S)-P 
slow 
A = substrate 
P product 
Figure 9: dynamic kinetic resolution. 
If the rate of racemisation (krac) is much greater than the rate of product formation 
(kR), then a theoretical yield of 100% is possible. For the maximum efficiency, 
product formation should be irreversible, the enantiomeric ratio (E) should be 20 
(where E= kIks) and 	should be approximately ten times faster than kR, 
26 
A number of examples of dynamic kinetic resolutions have been published since 
1980. 26-30 This process very often requires conditions for racemisation that are 
incompatible with the enzyme used for resolution. A relatively new area in dynamic 
kinetic resolution uses enzymes and transition metal complexes in tandem,31 where 
the transition metals that bring about racemisation are more compatible with 
biological systems. 
Benzylic a-substituted primary amines can be racemised by palladium on charcoal at 
elevated temperatures, allowing for the preparation of enantiopure chiral amides in 
>60% yield.32  Palladium is inserted into the N-H bond, followed by 13-elimination of 
PdH to give a palladium-complexed imine. This is then non-selectively reduced by 
Introduction 
palladium-catalysed hydrogenation to give the racemic starting material 
(Figure 10) ...... 
NH 	Novozym SP 	435 2 
IN 
PhMe 	ethyl acetate 
Et3N, 50-55°C 







Ph Me 	Ph Me 
64% yield 
99% e.e 
Figure 10: palladium-catalysed racemisatiopn of benzylic amines. 
This process has been scaled-up by BASF Technologies with a capacity of 1000 
tonnes per annum.' 
Another approach for accessing optically pure amines was reported by Celgene via 
direct asymmetric synthesis from the corresponding prochiral ketone, or via 
resolution of the racemic amine, wherein the undesired enantiomer is converted back 
to the ketone (Figure 11). 18 
10 
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NH 	 0 	 NH 
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(yield 100%) 	 (100%) 	 (50%) 	(50%) 
racemic 
amine 	 single enantiomer 
chiral amine 
Figure 11: Celgene chiral amine production. 
The selective ring opening of D-hydantoins by the enzyme D-hydantoinase is the 
basis for a successful industrial scale preparation of D-amino acids (Figure 12)24 The 
spontaneous racemisation of hydantoins at pH 8.0 or above allows a dynamic kinetic 











pH > 8 	 D-carbamoylase 
H20 
R 0 
RCO2H + CO2 + NH3 
HNNH 1 	
NH2 
L-hydantoin 	 D-amino acid 




A number of amino acid racemases have been employed for the dynamic kinetic 
resolution of chiral amino acids34 (Figure 13). 
H 
RCOOH Racemizaon 












R...f. COO H 
NH  
L-amino acid 
Figurel3: production of optically active D-and L-amino acids from N-acyl-DL-
amino acids by D- or L- aminoacylase and N-acylamino acid racemase. 
Ideally the rate of racemization should be equal to or greater than the rate of 
hydrolysis and the racemase must be active only towards N-acylamino acids but not 
towards the free amino acids. 
1.1.3.2 	Deracemisation by stereoinversion 
Deracemisation by stereoinversion is a cyclical process where only one enantiomer 
of a racemic mixture is oxidised to form an achiral intermediate which can be 
reduced by an enzyme with the opposite stereochemical preference M' The net redox-
balance of the system is zero and the necessary redox cofactors, e.g. nicotinamide 
adenine dinucleotide, may be recycled internally.351  The success of such systems 
relies on at least one of the redox reactions being irreversible. Biocatalytic 
12 
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stereoinversions have been successfully used in the preparation of optically pure a-
amino acids.3  The preparation of natural and unnatural a-amino acids via such a 
two-enzyme system is exemplified in Figure 14.3& D-Amino acid oxidase from 
porcine kidney (DAAO) selectively deaminates the D-amino acid from the racemic 
mixture. The a-keto acid produced from the reaction is then converted to the 
corresponding L-amino acid using an aminotransferase from Escherichia coil, with 
L-glutamate as the amine donor. Although excellent yields and enantioselectivities 
are observed, the system suffers from a few disadvantages: 
ion-exchange chromatography is required to separate L-glutamate from the 
desired amino acid and 
the first step is a kinetic resolution and therefore the rate of oxidation of the 







D-amino acid 	 amino- 	 + 
NH oxidase 	0 	 transferase 	NH3 
A111, 
RC0.,- 	 R CO2- 	
R CO2- 
yield = 61-96% 
e.e. >98% 
R = -CH(CH3)2, -CH2CH(CH3)21  -C(CH3)CH(CH3)2 1 -CH7SCH31  -CH2Ph, -CH2CH=CH2
, -CH2CH3 
Figure 14: stereoinversion of a-amino acids. 
1.1.3.3. 	Deracemisalion by a cyclic oxidation-reduction sequence 
In 1971, Hafner and Wellner demonstrated the stereoinversion of D- to L- alanine by 
a cyclic oxidation-reduction sequence.36a In this approach, the starting racemic 
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mixture was subjected to enantioselective oxidation using a D-amino acid oxidase 
which selectively converted one enantiomer to the corresponding achiral imine. 
Addition of a reducing agent to the reaction resulted in conversion of the imine back 
to a 1:1 mixture of amino acids (Figure 15&16). 
H202 




NH 	+H70 	0 
RC0OH -H2O R,,ACOOH 
+ NH3  
non-selective reduction (chemical) 
Figure 15: stereoinversion of a-amino acids by an oxidation-reduction cycle. 
The first step of this method is a kinetic resolution with the limitation of 50% yield, 
and the second step bears no chiral induction at all. 










0 	1 	2 	3 	4 
CYCLE No 
kR > k' 
= 2 x kR 
Figure 16: cyclic oxidation-reduction sequence.36b 
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However, a combination of the two reactions is potentially a very effective and 
economic technique. If this process undergoes a sufficient number of cycles then 
eventually the amino acid becomes enantiomerically pure (Figure 16), provided that 
the oxidation is highly enantioselective and the intermediate imino acid is efficiently 
reduced before it undergoes hydrolysis to the ketone. 
Soda et al. 37' 38  extended this concept to the deracemisation of the cyclic a-amino 
acids proline and pipecolic acid in high yield and e.e. High chemical and optical 
yields were obtained due to the stability of the corresponding cyclic imine under 
aqueous conditions and their susceptibility to chemical reduction. 
	
X — CO
2H 	 CO2  H 
= CH2 - proline 	 imine 
x = CH9CH - pipecolic acid 
The major limitation of the reaction reported by Soda is the requirement for a large 
excess of NaBH4  used for the reduction step (500 equivalents) because of 
competitive reaction with water at pH 7.0. Turner et al.39 subsequently demonstrated 
only 6 equivalents of sodium cyanoborohydride (NaCNBH3) were required for the 
complete deracemisation of DL-proline, due to the greater aqueous stability of 
NaCNBH3 than NaBH4 at pH < 8.0. 0  The method has since been further developed 
to produce optically pure acyclic cc-amino acids in high yield (75-90%), using 
amine:boranes41 as reducing agents. 
The cyclic oxidation-reduction deracemisation protocol has also been investigated by 
the groups of Carnell42 and Faber43  and both groups have published examples of this 
type of reaction with reasonable success. However, in both cases separation of the 
achiral intermediate is required, before "reduction" can take place. 
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Deracemisation via repeated cycles of oxidation-reduction has been successfully 
applied to a range of D- and L-amino acids. However, to date there has been no 
report of using this method for the deracemisation of chiral amines. In principal 
deracemisation should be applicable to amines provided that suitable enantioselective 
amine oxidases can be identified. 
1.2 	Amine oxidases 
Amine oxidases (AOs) are a heterogeneous family of enzymes, which metabolise 
various monoamines, diamines and polyamines that are either produced 
endogeneously, or absorbed as dietary or xenobiotic substances. These enzymes are 
widely distributed in nature and found in microorganisms (bacteria, yeast, and fungi) 
and in higher organisms such as mammals including humans. Amine oxidases 
catalyse the oxidative deamination of amines to yield the corresponding aldehyde, 
hydrogen peroxide and ammonia (Figure 17). 
NH.. 












Figure 17: mechanism of oxidation of amines by amine oxidase. 
AOs are subdivided into two main classes based on the nature of their cofactors. The 
first class of amine oxidases are represented mainly by monoamine oxidases but also 
by DAO, PAO and LO (lysyl amine oxidase). The members of this first class [amine: 
oxygen oxidoreductase (deaminating), (copper-containing), EC 1.4.3.611 contain a 
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cofactor (TOPA) possessing a carbonyl group and also copper and are known to be 
inhibited by carbonyl reagents such as semicarbazide.4' The second class of amine 
oxidases [amine: oxygen oxidoreductase (deaminating), (flavin containing), EC 
1.4.3.4] consists of monoamine oxidase (MAO), diamine oxidase (DAO) and 
polyamine oxidase (PAO) and contain flavin adenine dinucleotide (FAD) as their 
cofactor. 44,45 
1.2.1. 	Physiological importance and substrate specificity of AOs 
1.2.1.1. 	Flavin AOs: MAO-A and MA 0-B 
A large amount of research was undertaken on flavin MAOs in the late 50's because 
of the potential of MAO inhibitors to act as antidepressants (MAO controls the levels 
of serotonin and noradrenalin (norepinephrine) in the brain). 
HO 	
X 
HO — j—dH_-CH2—NH —R 	 HO1(.j
CHCHf —NH 2 
H 
X=OH, R=CH3 - epinephrine (adrenalin) 	Serotonin (5-hydroxytryptamifle) 
X =OH, R=H 	- norepinephrine (noradrenalin) 
X=H, R=H - dopamine 
Figure 18: physiologically active amines. 
Monoamine oxidases have been studied during 60 years. Since then, the enzyme was 
purified from a number of sources, providing evidence for the presence of two 
distinct forms, MAO-A and MAO-B.47  Mammalian MAOs were found in the outer 
mitochondrial membrane within most cell types. Since both forms are important for 
neurotransmitter regulation, different MAO activities may be associated with 
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neurological disorders such as depression, Parkinson's disease and perhaps 
Alzheimer's disease.49 
MAO-A preferentially oxidises primary amines such as neurotransmitters 
noradrenaline (norepinephrine), 5-hydroxytryptamine (serotonin), secondary amines-
such as adrenaline (epinephrine) (Figure 18), and is inactivated irreversibly by low 
concentrations of clorgyline.50  MAO-B preferentially oxidises other primary amines 
e.g. benzylamine, 3-phenylethylamine and is inhibited by low concentrations of L-
deprenil.51  Tyramine, tryptamine, and dopamine are common substrates for both 
enzymes (Figure 18a). MAO-B also has the ability to metabolise some tertiary 
amines such as xenobiotic 	 (MPTP). 
The neurotoxic oxidation product of the latter compound induces Parkinsonism in 
humans and subhuman primates. 
52 MAO-A inhibitors are used clinically in the 
treatment of depression 53  and inhibition of MAO-B is used to treat Parkinson's 
disease. 54 
1.2.1.2. 	Flavin enzyme: MA 0-N 
In 1995 Schilling et al.55 reported that Aspergillus niger expressed two different 
amine oxidases when grown on a range of amines. Purification by DEAE-
Sepharose resulted in two fractions. The first, pink fraction was identical to the 
copper/TOPA enzyme previously described. The protein in the second pool 
(yellow), termed MAO-N, was a flavin containing enzyme which catalysed the 
oxidative deamination of aliphatic and aromatic monoamines, but not diamines 
(putrescine, cadaverine) or polyamines (spermine, spermidine, N-acetylspermidine). 
The flavin containing MAO-N was a soluble, tetrameric enzyme localized in the 
peroxysome, with a molecular mass of 55kDa. Upon extensive dialysis of the 
enzyme against 0.2M formic acid, FAD was irreversibly lost, which suggested that 
FAD was not covalently bound to MAO-N. By contrast, the FAD of mammalian 
MAOs is covalently bound to the active site cysteine residue. 
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The observations of MAO-N substrate specificity reported by different researchers 
were not the same. Thus, the data reported by Schilling et al.-55 was not in 
agreement with the results published by Sablin et.al.57 The latter authors suggested 
that their data were more accurate because they obtained it by analysis of a purer 
enzyme. Schilling et al. reported that the rate of oxidation of aliphatic amines 
increased with the number of methylene groups, but Sablin etal. found that medium 
chain-length aliphatic amines were the best substrates for MAO-N. On comparing 
the substrate specificity of MAO-N with MAO-A and MAO-B, Sablin et al. 
reported that MAO-N, in common with MAO-A, exhibited the same properties 
towards MPTP and many of its analogues, but differed from MAO-A in not 
oxidising biogenic amines. Schilling et al. reported that noradrenalin, serotonin and 
dopamine were good substrates for MAO-N. However, both authors reported that 
substrates such as benzylamine and 2-phenethylamine were oxidised by both MAO-
N and MAO-B. 
MAO-N is not inhibited by the copper inhibitor semicarbazide. It was found that 
MAO-N is affected by low concentrations of clorgylin (best inhibitor for MAO-A), 
and (-)-deprenyl (specific inhibitor for MAO-B), but the fungal enzyme has the 
highest sensitivity to pargyline, which inhibits equally both MAO-A and MAO-B. 
55 However, Sablin eLal.57  reported that inactivation of MAO-N by the MAO-A 
specific inhibitor clorgyline was found to occur about five times faster than with (-)-
deprenyl. Thus, in this regard, MAO-N behaves more like mammalian MAO-A 
than MAO-B. 
Schilling et al.55  compared the substrate specificities of flavin and copper 
containing AOs from Aspergillus niger and found them similar. However, copper 
AO had lower KM values compared to MAO-N. This could indicate that the copper 
AO is active at low concentrations of amines as nitrogen sources. On the other 
hand, if copper is limited, MAO-N which has no metal ions dependence could be 
important as a source of nitrogen.55  
Despite the fact that several flavin-containing amine oxidases had been described in 
bacteria, plants,59 and fungi 
40,61,62 MAO-N is the first non-vertebrate enzyme, 
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which is a true member of this class of MAO. MAO-N and the mammalian MAOs 
exhibit several structural and biochemical differences such as the cofactor 
attachment, the cellular localisation and lack of ability to distinguish between 
selective MAO-A and MAO-B substrates and inhibitors. Nevertheless, MAO-N can 
be proposed as an evolutionary prototype of MAO-A and B due to the many shared 
properties listed above. MAO-N can be used as a model to study both structural and 
catalytic properties. The lack of the FAD covalent attachment provides the 
possibility to acquire information on flavin-inhibitor adducts without proteolytic 
digestion, purification and interference of amino acids. 63  
1.2.1.3. 	Copper-containing amine oxidases 
Copper containing monoamine oxidases were first described in 1928.64 The copper 
amine oxidases are homodimers of subunit size approximately 70-95 kDa depending 
on the source. Each subunit contains one Cu(II) atom and a quinone cofactor which 
has been identified as 2,4,5-trihydroxyphenylalanine quinone (TPQ or TOPA 
quinone) in the bovine serum enzyme. 66,67 Subsequently TPQ has been identified 
biochemically,67  or its presence inferred from amino acid sequence homology in 
other copper-containing amine oxidases from Hansenulapolymorpha, 69 Kiebsiella 
aerogenes, 70Escherichia coli K 12,7172  lentil '73,74 pea ,75 Arthrobacter strain 
Pi, 76Arthrobacter globformis,77 human kidney 
'78 rat kidney 
'79 and A. globformis 
histaminase.80 
To differentiate mammalial copper containing monoamine oxidases from flavin 
MAO, the former was referred to as SSAO due to its sensitivity to semicarbazide. 
SSAO is also called "benzylamine oxidase"81  because of the relatively high activity 









Tissue-bound SSAO is only active towards mono amines such as tyramine, 
tryptamine, dopamine and 3phenylethylamine, whereas plasma SSAO is also very 
active against polyamines such as spermidine and spermine.82  The polyamine activity 
of plasma SSAO could be associated with polyamine metabolism in some animal 
species (e.g. ruminants). 83 
The fact that the substrate specificity of SSAO varies between species 
84 and that 
benzylamine is the best substrate for SSAO, makes it difficult to propose a 
hypothesis about the physiological role of SSAO in amine metabolism in vivo. The 
copper monoamine oxidases isolated from different micro-organisms also display 
differences in substrate specificity.85  So far, copper/TOPA amine oxidases are 
considered to be widely distributed in animal tissue. Low amounts of SSAO mRNA 
were detected in brain, heart, intestine, and kidney. An intermediate level of 
expression was seen in lung and skeletal muscle. SSAO is essentially present in 
smooth muscle cells in the blood vessel wall, but preferential SSAO gene expression 
was observed in adipose tissue and aorta. Amine oxidase is expressed in high 
endothelial venuls from peripheral lymphatic tissue and appears to play an important 
role in lymphocyte trafficking.87  The fact that SSAO from blood plasma plays an 
immunoregulatory role, is due to inhibition of lymphocyte transformation. All of 
these findings underline the multiple physiological roles of SSAO according to the 
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Figure 1 8a: chemical structures of endogenous and xenobiotic amines metabolized as 
substrates in vitro by amine oxidases. 
1.2.1.4. 	Polyamine oxidases and dianune oxidases 
It is worth noting that there are three other groups of AOs, namely diamineoxidases 
(DAOs), polyamineoxidases (PAOs) and lysyl oxidases(LOs). 
Several flavin-containing polyamine oxidases have been described in mammals, 89 
bacteria, plants,59 and fungi ."'61'62 The intracellular concentration of polyamines is 
regulated by polyamine oxidases. Inhibition of polyamine biosynthesis is 
associated with a decrease in cell proliferation, opening up the possibility of 
designing new antineoplastic 	 In fact, several polyamine analogues, 
such as those with an ethyl or benzyl substituent on the terminal amino groups, are 
currently employed as antitumour agents .92'93 Furthermore, it has been reported that 
accumulation of the products of polyamine catabolism resulting from the uptake of 
polyamine analogues leads to programmed cell death. 94,95,96 
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Flavin-containing PAOs catalyses the oxidation of the secondary amino group of 
spermine, spermidine and their acetyl derivatives. In contrast to copper containing 
PAOs, which act only on the primary amine groups at the ends of the molecule, 
83 the 
site of the enzymatic attack varies depending on the source of the enzyme. Thus, 
animal PAOs transforms spermidine and spermine into putrescine (1,4-
diaminobutane) and spermidine, respectively, plus propionaldehyde and H202. 
Conversely, in plants and bacteria, the enzyme acts on the other side of the secondary 
amino group, so that the products resulting from oxidation of spermidine and 
spermine are 4-aminobutyraldehyde and 3 aminopropyl-4-aminobutyraldehyde, 
	
respectively97'58' 	(Figure 19). 
A B 	 A 
NH2(CH2)2CHO + NH2(CH2)4NH2 + H2O 
NH2(CH2)3 NH (CH)4NH2 08 + H20 
Spermidine 





A 	NH2(CH2)2CHO + NH8(CH2)4NH(0H2)3NH2 +H20 
H 
NH2(CH2)3 NH (CH2)4NH(CH43NH2 +02 + H,0 
Spermin 	 B 
NH2(CH2)3 NH (CH2)3CHO + NH2 (CH2)3NH2 + H20 
1~ 
Co 
Figure 19: catalytic reaction and substrate specificity of PAO. A and B indicate the 
site of the enzymatic attack in the animal and plant enzyme, respectively. The plant 
enzyme oxidizes spermidine and spermine into 4-aminobutyraldehyde and 3- 
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aminopropyl-4-aminobutyraldehyde, which spontaneously cyclize to A'-pyrroline 
and 1 ,5-diaza-bicyclononane, respectively. 
Despite these differences, the plant, bacterial and animal proteins have essentially 
identical molecular properties. PAO is a monomeric soluble enzyme with a 
molecular weight of about 53 kDa. The prosthetic group is FAD, which is non-
covalently bound to the protein. 9' °°  
Diaminooxidases (DAOs) metabolise the diamines putrescine and cadaverine, but 
also deaminate histamine, hence sometimes they are called histaminases. 
84 Flavin 
containing DAOs have been found in microorganisms e.g. Micrococcus rubens.6° 
The highest level of DAO was found in swine kidney,101  but also in small intestine 
and maternal placenta. It has been shown that the plasma of pregnant women consist 
of copper containing DAO, thought to be released from the placenta,102 and which 
oxidatively deaminates histamine and short chain aliphatic diamines (e.g. putrescine 
and cadaverine). Flavin PAO activities were also found to be increased in the blood 
of pregnant women.103  Copper DAO and flavin PAO activities have also been shown 
to appear in the blood plasma of pregnant rats.104  By contrast, the level of SSAO in 
human plasma is not affected by pregnancy. 
105 Blood plasma of pregnant women 
inhibits lymphocyte transformation when it is added to in vitro assays in the presence 
of spermine or spermidine. This is thought to be due to the PAOs and DAOs 
immunoregulatory role in preventing rejection of the fetus by the mother.'06 
The final group of amine oxidases is the lysyl oxidases (LOs), which are a 
heterogeneous family of copper containing enzymes. LO was traditionally known as 
the extracellular catalyst of lysine-derived cross-links in fibrillar collagens and 
elastin. 107a,b More recently it was shown that LO covers a spectrum of physiological 
functions such as development regulations, tumor suppression, cell motility, and 
cellular senescence. The LO has an intracellular, extracellular and intranuclear origin 
and its potential role in cell adhesion and cell growth has been suggested.108 
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1.2.2. Enantio-and stereo-selective properties of amine oxidases 
Copper / TOPA amine oxidases display broad substrate specificity, exhibiting 
stereochemical heterogenity in the conversion of pro-chiral amines. 109 Amine 
oxidase from pea seed has been shown to catalyze the abstraction of the pro-S 
hydrogen from Clofbenzylamine, tyramine and dopamine. oa Porcine plasma 
amine oxidase, on the other hand, is pro-R specific for tyramine and dopamine. 
1101; 
 
Bovine plasma amine oxidase is pro-S specific for benzylamine, 
p-hydrohybenzylamine and 3 -methylbutylamine, but is non-stereo specific for 
tyramine and dopamine. 110b  It has also been reported that amine oxidases from 
E. co/i and the closely related enzyme isolated from Kiebsiella oxyloca, possessed 
stereospecificity towards the pro-S hydrogen in the oxidation of pro-chiral 
substrates.' 
The enantioselectivity of amine oxidases from E. co/i and K oxytoca with respect to 
chiral amines have been investigated by Hacisalihoglu and coworkers.iha It was 
found that both enzymes catalyze enantioselective oxidation of amphetamine with E-
values of 15. The preference for the (R)-enantiomer of amphetamine is in agreement 
with the pro-S specificity that has been observed for the conversion of 2-
phenylethylamine. This enantioselectivity might be related to the higher potency of 
(R)-(-)- amphetamine over the (S)-(+)-enantiomer during the release of biogenic 
amines in rat brain. 112 
1.2.3. 	Cloning, expression and X-ray structural studies 
1.2.3.1. 	Copper-containing amine oxidases 
A number of Cu/TOPA amine oxidases have been cloned and over expressed. SSAO 
from murine adipocyte is a membrane associated enzyme, which has been cloned 
86 
and shown to have 95% amino acid sequence identity with SSAO from rat 
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adipocyte 3  and with the human placental amine oxidase (83% identity). 
114 The level 
of identity is lower between murine SSAO and bovine serum amine oxidase (79% 
identity)67  and human kidney diamine oxidase (35% identity) 
'78 especially in the N-
terminal portion. This difference is because bovine serum amine oxidase and diamine 
oxidase are both secreted enzymes, while SSAO is membrane-associated. Cloned 
SSAO from adipocyte possesses activity against mono- poly- and diamines. 
The cDNA of copper amine oxidase from pea seeding has been cloned115 and 
expressed in Pichiapastoris, using the AOX1 promoter and the yeast a-factor 
secretion signal .116  The 313-structure of pea seeding amine oxidase has been solved 
and published. 117 The cDNA from human retina encoding copper amine oxidase was 
cloned and reveals the higest homology to bovine serum amine oxidase. 
118 The mao 
operon of Escherichia coil W3350, which comprises the genes mao-c and 
mao-a, was cloned and appeared to be similar to that of Kiebsiella aerogenes.7° E. 
coil W 3350 gene that encodes aromatic amine oxidase was isolated, sequenced, and 
expressed in E. coil TG2. The purified enzyme exhibited properties of a 
copper/TOPA amine oxidase. 119 The 3D structure of the AO from E. coil W 3350 has 
been solved and published. 120 
Another gene encoding for copper amine oxidase has been cloned from yeast 
Hansenuiapolymorpha69 and over expressed in Saccharomyces cerevisiae,121  
E. coil, '22 and the 3D structure solved. 
123  Two open reading frames, maoxl and 
maoxll, which are >99% homologous, were cloned from the chromosomal library of 
Arthrobacter P1 strain and expressed in E. coil. 76 The gene of Arthrobacter 
giobformis encoding a quinoprotein,, phenylethylamine oxidase, has also been 
cloned, sequenced and expressed in E. coil.77 The 3D structure of the copper 
containing amine oxidase from this strain has been solved. 
124 
All 3D structures reveal a high degree of structural similarity despite low sequence 
identity. An amino acid sequence alignment of 14 Cu-containing AOs identified only 
33 conserved residues. 125  All listed sequencing studies showed the presence of a 
tetrapeptide sequence, Asn-Tyr-Asp-Tyr, which has been found to be highly 
conserved in other copper amine oxidases. Mutation of the Tyr-382 from the 
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sequence of Asn3 81 -Tyr3 82-Asp3 83 -Tyr3 84 of the recombinant enzyme from 
Arthrobacter globformis into Phe resulted in the complete loss of catalytic activity 
and disappearance of the quinone compound that is specifically detected in the wild-
type enzyme, suggesting that Tyr-382 is the precursor of the covalently-bound 
cofactor ,77  which is produced by the enzyme in post-translational modification. 
Expression of copper-containing AO from Hansenulapolymorpha in S. cerevisiae 
has produced a functional recombinant enzyme. 121 Based on the fact, that S. 
cerevisiae is one of the few yeast species that does not have endogenous amine 
oxidase 126  it was concluded that the modification of the precursor tyrosine to TOPA 
cofactor happened in post-translational autoprocessing.12' 
1.2.3.2. 	Flavin-containing amine oxidases 
In spite of their pharmacological importance, structural and mechanistic studies of 
flavin containing amine oxidases have been hindered due to the high hydrophobic 
properties of these enzymes. Most of the recombinant MAOs are from mammalian 
sources, but they are naturally tightly bound to the outer mitochondrial membrane, 
requiring detergent solubilization. To understand the mechanism and structure of 
mammalian MAOs and to develop enzymes for the deracemisation of racemic 
amines as discussed in this thesis, it is important to search for enzyme expression 
systems that produce soluble protein in large quantities. 
A number of organisms have been reported to possess flavoprotein AOs, however 
almost all are either polyamine or diamine oxidases or have very narrow substrate 
specificities, e.g. tyramine oxidase. Amine oxidase activity was found in the mycelia 
of fungi belonging to Aspergillus, Penicillum, Monascus and Fusarium, grown on 
monoamines as the sole nitrogen source. '27 Frebort et al., when trying to induce 
copper/TOPA amine oxidases in filamentous fungi, noted that some species 
possessed amine oxidase activities that were more sensitive to pargyline (flavin AO 
specific) than phenylhydrazine (copper AO specific), suggesting the presence of a 
flavin dependent amine oxidase. Fusarium solani TG-2 showed only one active band 
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that did not stain against copper amine oxidase, which clearly indicated it possessed 
only the flavin enzyme. A. niger GRR, Penicillium chyrsogenum AKU 3401, 
Armilaria sp., Trichoderma reesei, Monascusfuliginosus - all of these species 
showed inhibition by both pargyline and phenylhydrazineine indicating that the 
species contained both the copper and flavin enzymes. 
128 However the fungus 
A. niger is the only reported source to date which has a flavin dependent mono-amine 
oxidase (MAO-N).55 
Schilling et al. 129 have cloned, sequence and expressed MAO-N from A. niger in 
E. coli. To generate a cDNA library, mRNA was isolated from culture of A. niger 
that had been induced with butylamine at concentration 0.1% (at 0.25% butylamine 
is toxic to the fungus).55  The deduced primary amino acid sequence of MAO-N was 
subjected to sequence alignment with MAO-B and MAO-A. All three N-termini 
have the 0—a-13 protein fold necessary for binding the ADP moiety of flavin 
dinucleotide.13°  However, unlike the mammalian enzymes, MAO-N does not contain 
the highly conserved C- terminus pentapeptide, Ser-Gly-Gly-Cys-Tyr, responsible 
for the covalent binding of FAD. 
131,132 
The MAO-A and MAO-B enzymes have an extended hydrophobic C-terminus 
compared to MAO-N, which is thought to be required for binding to the outer 
mitochondrial membrane. The lack of a membrane binding sequence in MAO-N 
should provide improved solubility, which may aid crystallisation studies. 
MAO-N and MAO-A shares 25.5% sequence identity (49.1% similarity) and MAO-
N and MAO-B have 23.7% identity (48.7% similarity) (Figure 20). 129 However, the 
highly conserved (95% identity) region proposed as an active site sequence in 
mammalian MAOs, is absent in MAO-N. MAO-N contains a C-terminal tripeptide 
Ala- Arg- Leu, which corresponds to the peroxisomal targeting signal found in many 
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Figure 20: comparision of monoamine oxidases from mammalian and fungal sources 
(areas of high sequence identity/similarity are shown in bold). 
Most of the studies have been carried out on MAO- A and B from human, rat and ox. 
The cDNA clones encoding for MAO-A and MAO-B were isolated from human 
liver. The molecular weight was determined as 59.7 kDa for MAO-A and 58.8 for 
MAO-B.134  Comparison of the deduced amino acid sequences show 70 % sequence 
identity. Both sequences contain the pentapeptide Ser-Gly-Gly-Cys-Tyr localized in 
the C-terminal region where the cofactor FAD covalently binds to cysteine.'34 
The primary sequences of bovine MAO-B and MAO-A have been determined by 
cDNA cloning.'35Both enzyme sequences possess an overall similarity of 41% and 
have >90% similarity for the flavin binding region of other enzymes. 
135  The next 
MAO cDNA cloned was from rat liver and was of type B136 and type A.'37 The latter 
report revealed further sequence similarity between different type of flavin 
monoamine oxidases from different sources. MAO-A from rat exhibited greater than 
85% sequence identity with bovine and human MAO-A and 70% identity with rat 
MAO-B 137 
Both mammalian MAO-A and MAO-B have some features in common. They are 
both homodimers and the molecular mass of both mammalian MAO-A and MAO-B 
is about 60 kDa. The prosthetic group of both enzymes from a variety of mammalian 
sources is 8a-S-cysteinyl FAD and the amino acid sequence around the flavin site is 
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Ser-Gly-Gly-cysteinyl FAD-Tyr. The flavin binding site is in the COOH-terminal 
region. There is a non-cleavable targeting signal in the 29 residue at the C-terminal 
end which directs the enzyme to the outer membrane, where it is anchored. 
138 
Several attempts have been made to express human liver MAO-B in mammalian cell 
lines139  but at very low yield. Shih and co-workers attempted expression in E. co/i 0 
but obtained far too low quantities of functional form. Both human MAO-A and 
MAO-B have been expressed in yeast 14' and mammalian cells,142 but again with a 
low yield of the protein. The heterologous high-level expression of human liver 
MAO-A in S. cerevisiae was reported by Weyler and co-workers."3 This 
recombinant system have been used in a number of mechanistic studies on 
recombinant human liver MAO-A.""45 
Attempts to over express human liver MAO-B in the same S. cerevisiae system have 
been unsuccessful despite the fact that both enzymes have 70% sequence identity. 
MAO-13 was successfully expressed in methylotrophic yeast Pichiapastoris using 
the AOX1 promoter and the yeast a-factor secretion signal."' Approximately 200 
mg of purified protein was obtained from a 2L fermentation culture. This enzyme 
exhibits many of the kinetic and structural properties of the well studied bovine 
enzyme 147  and was subjected to structural studies by X-ray crystallography. The 
crystal structure was solved to a resolution of 3.0A by Binda and co-workers. 148 A 
search of the Protein Data Bank'49  reveals that the closest structural matches of 
MAO-B are L-amino acid oxidase ° and polyamine oxidase.9 
MAO-A and MAO-B cDNAs were also obtained from some other sources. Chen et 
a/.'5' cloned a trout liver MAO by screening a cDNA library with a human MAO-A 
cDNA probe. The deduced amino acid sequence of trout MAO showed 70% identity 
to human MAO-A and 71% identity to human MAO-B. This enzyme contains FAD 
covalently bound to the pentapeptide Ser-Gly-Gly-Cys-Tyr as with other MAOs 
listed above. Trout MAO displays substrate and inhibitor selectivities that are not 
identical to those of either MAO-A or MAO-B, so it represents a novel type of 
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There was an attempt to clone MAO from carp liver and muscle, but MAO-related 
sequences were not detected by the PCR method using PCR primers designed for rat 
MAO-A, MAO-B and trout MAO cDNAs. This indicates low homology of amino 
acid sequences among rat, trout and carp MAOs.152 
Very recently, the gene for human PAO has been identified89  and the protein further 
studied. Human PAO shares the sensitivity to the specific mammalian PAO inhibitor 
MDL 72,527, but is not sensitive to pargyline (MAO inhibitor) or to semicarbazide 
(copper/TOPA AO inhibitor). 
Finally, the eDNA clone of maize polyamine oxidase was isolated from maize (Zea 
mays L. seeds) and characterised. The determination of the primary structure of 
maize PAO has revealed that the enzyme contains a Gly-X-Gly-X-X-Gly sequence 
characteristic of the residues forming the FAD binding site.59'132  The absence of a 
Cys residue required for covalent binding of FAD in vertebrate MAOs confirms a 
non-covalent binding of the flavin,1  reported also for MAO-N.129 
Maize PAO is clearly homologous (sequence identity of about 20-30%) to vertebrate 
monoamine oxidase. PAO and MAO differ in their substrate specificity, since PAO 
oxidizes secondary amines whereas monoamine oxidase acts on primary amino 
groups. However, the sequence similarity indicates that the two enzymes form a 
group of related flavin-dependent amine oxidases, which are likely to share a similar 
mechanism of catalysis. Maize PAO was produced and purified from the natural 
source in quantities of 10mg per kilogram of plant cells and subjected to X-ray 
crystallographic studies. The 3-D structure has been solved to 1.9A resolution9sa 
revealing structural similarity to L-amino acid oxidase from snake Calloselasma 
rhodostoma 	° and to human MAO-B. 148 
31 
Introduction 
1.2.4. 	Mechanism of catalysis by AOs 
1.2.4.1. 	Copper-containing A Os 
Copper amine oxidases are homodimeric enzymes that catalyze two reactions: firstly, 
a self-processing reaction to generate the 2,4,5-trihydroxyphenylalanine quinone 
(TPQ) cofactor from an active site tyrosine by a single turnover mechanism; 
secondly, the oxidative deamination of primary amine substrates with the production 
of the corresponding aldehyde, hydrogen peroxide, and ammonia catalyzed by the 
mature enzyme. The importance of active site residues in both of these processes has 
been investigated by structural studies and site-directed mutagenesis of enzymes 
from various organisms. 
117,120,123,124 
The TPQ is post-translationally synthesized by a single turnover, copper- and 
oxygen-dependent, processing event of an active site tyrosine residue. 155- The Cu(II) 
atom is coordinated by three histidine imidazole groups and two water molecules, the 
Cu(II) atom has a distorted square-pyramidal geometry, and the TPQ cofactor is 
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Figure 21: the formation of the cofactor TPQ.1  
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Kinetic and spectroscopic studies have revealed that the unmodified (tyrosine-
containing) apoprotein requires only copper and oxygen for stoichiometric TPQ 
formation. A preformed Cu(II) complex was shown to be competent for TPQ 
formation upon the addition of O21  (Figure 22). 
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Figure 22: oxidation of tyrosine residue to TPQ cofactor. 
124 
As a result of the availability of X-ray crystal structures, the catalytic mechanism of 
copper AO is well understood (Figure 23). 
The first step is formation of the enzyme bound imine (I) from the primary amine 
and the carbonyl group of TPQ. The second step is hydrogen abstraction from the 
methylene group to generate (II) followed by tautomerisation and subsequent 
hydrolysis to the aldehyde (III). Reoxidation of TPQ by molecular oxygen then takes 
place to yield (IV), which undergoes hydrolysis to TPQ liberating hydrogen peroxide 
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There is evidence in the literature that the copper/TOPA AO from E. co/i and K 
oxytoca carry out stereoselective and enantio selective transformations. 0 "' 
However, the copper AOs are not suitable enzymes for the deracemisation of amines, 
since the intermediate imine is not released from the active site. 
1.2.4.2. 	Flavin-containing AOs 
In 1995 the first direct evidence of an imine product from the reaction of an amine 
with MAO-B was reported. 157,158  Since then there has been much debate concerning 
the mechanism of imine intermediate production during the catalytic cycle. 
The first mechanism was proposed by Silverman 
159 and involves an initial single 
electron transfer (SET) from the nitrogen atom of amine (I) to N5 of the oxidized 




radical (IV). Subsequent deprotonation of (III) by an active side base residue would 
generate the iminium species (VI) and the reduced FAD (V) (Figure 24)160 
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Figure 24: single electron transfer (SET) mechanism. 160  
Although this mechanism is mechanisticaly attractive, to date there is no evidence for 
any flavin radical intermediate through stopped flow studies, nor a characteristic 
peak for a free radical in the electron paramagnetic resonance (epr) spectrum. 
A polar nucleophilic mechanism (also called the hydrogen abstraction mechanism: 
HAT) was originally suggested by Hamilton and co-workers. 161 Catalysis is proposed 
to occur initially via nucleophilic attack of the amine (I) onto the 4a position of flavin 
(II). Subsequent proton abstraction from the carbon atom of the an-tine-flavin adduct 
(Ill) is proposed to be facilitated by an active site base on the enzyme (polar 
nucleophilic mechanism) or directly by N5 of the flavin (concerted polar 
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Figure 25: concerted polar nucleophilic mechanism for MAO catalysis.145 
In this CPN mechanism, the formation of the 4a-alkylated isoalloxazine ring in a 
nucleophilic manner leads to a very strong base at N5 of the fiavin with a pKa of —30 
which is close to the pKa of benzyl protons. Thus, a concerted transfer of the benzyl 
proton to N5 of the 4a-alkyl flavin should be facilitated. Following this U'-C-H bond 
cleavage reaction, production of the protonated imine product will occur and the 
reduced fiavin cofactor is reoxidized by 02. Although the structural data 
148 do not 
provide evidence for a CPN (or HAT) mechanism, recent quantitative structure-
activity relationships (QSAR) data on MAO-A with a series ofpara-substituted 
benzylamine analogs145 provides definitive evidence that CC-C-H bond cleavage does 
occur by a proton abstraction mechanism. Current structural data on MAO-B148 and 
PAO' also show there to be no amino acid residue at the catalytic site that would be 
able to act as an active site base for any proposed H abstraction mechanisms. 
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Flavin AOs are potentially suitable enzymes for deracemisation since the imine 
intermediate is not covalently bound to the cofactor, thereby allowing reduction back 
to the amine. Furthermore, there is some evidence that MAO-B shows stereospecific 
removal of the pro-R hydrogen for certain substrates.159 
1.3. 	Enzyme directed evolution 
Directed evolution of enzymes in vitro, also called molecular evolution, works by 
mimicking the process of natural "irrational" evolution (random mutation, 
recombination and selection). Directed evolution starts from a parental enzyme and 
involves random mutagenesis and screening offering a fast and effective way to 
generate new "improved" enzymes under artificial evolutionary conditions. 
Conditions for random mutagenesis can be created in a thermocycler using 
polymerase chain reaction (PCR), by treatment with chemicals such as nitrous acid, 
hydroxylamine, formic acid, and hydrazine, or by transformation of the gene into a 
bacterial mutator strain. To isolate the mutated enzyme with desired properties, the 
library of variants must be subjected to a high through put screening assay to assess 
the desired activity. 
1.3.1 Construction of the libraries 
Random mutagenesis makes it possible to generate a large number of randomly 
distributed nucleotide substitution mutations in a cloned DNA fragment. Various 




1.3.1.1. 	Random point mutagenesis 
1) 	Random point mutagenesis in vitro using PCR. 
In PCR, a DNA sample is separated into single strands and incubated with a cocktail 
of DNA polymerase, reaction buffer, dNTP's and two nucleotide primers whose 
sequences flank the DNA segment of interest.162  The primers direct the DNA 
polymerase to convergentely synthesize complementary strands of the target DNA. 
Twenty cycles of PCR increases the number of copies of the target sequence by 
about a million fold with high fidelity (Figure 26). 
DNA polymerase 
oligonucleotide  
double-stranded DNA I 	single-stranded DNA 	 A-T-T-C-G-C-T- 
T-A-A-G-C-G-A- 
complementary chain generated 
by Watson-Crick base-pairing 
Figure 26: polymerase chain reaction (PCR) (I - denaturation, 95° C; ()-
oligonucleotide annealing, Ca. 50°C; ()- elongation by DNA polymerase; (4)- DNA 
amplification by multiple PCR cycles. 
Error prone PCR (epPCR) was developed by a modification of the standard 
procedure to decrease the fidelity of the PCR reaction by increasing the 
concentration of MgCl2, adding MnC12, or unbalancing the concentration of the four 
dNTPs.'164  By changing the reaction conditions it is possible to introduce 
mutations at the rate of up to seven base pairs per 1000 during 30 PCR cycles. A low 
error rate (23 base substitutions or 1 amino acid substitution per sequence per 
generation) accumulates beneficial mutations, whereas higher error rates tend to 
generate neutral and deleterious mutations, more frequently than beneficial ones. 
Beneficial mutations in multiple variants can be combined using recombination 
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methods such as Stemmer's DNA shuffling165  or StEP (staggered extension 
process).1  Recombination also removes neutral and deleterious mutations. The most 
common mutations are transitions (purine 	purine, pyrimidine pyrimidine) and 
the least common are transversions (purine -± pyrimidine). The method is not 
sufficient for small gene fragments (<1000 bp). epPCR can be optimised to 
introduce transitions (A G) and transversions (purine -* pyrimidine) at a similar 
level. 167 
Usually, optimal results are not obtained after one round of a mutagenesis cycle. 
169 
However, sequential error-prone PCR, where the output of one cycle is used as input 
for the next cycle, can accumulate greater level of mutation thereby increasing the 
opportunities to produce a beneficial mutant. 
ii) 	Site-directed random mutagenesis. 
Saturation mutagenesis. Saturation mutagenesis can be performed by overlap 
extension PCR.168  In this method, two DNA fragments having overlapping ends are 
synthesized by PCR and combined in a subsequent fusion PCR reaction in which the 
overlapping ends anneal. The 3' overlap of each strand serves as a primer for the 3' 
extension of the complementary strand. The resulting fusion product is amplified 
further by PCR with template forward/reverse external primers (Figure 27). Specific 
alterations in the nucleotide (nt) sequence can be introduced into the overlapping 
oligo primers. Screening of mutant clones revealed at least a 98% efficiency of 
mutagenesis .The number of variants (N) in which one amino acid per enzyme is 
replaced by one of the remaining 19 amino acids can be calculated by the equation: 
N= 19MX, /{(X—M)!M!] 
where X is the total number of amino acids per enzyme and M is the number of 
substituted amino acids. 169  The frequency of random nucleotide substitution has been 
estimated as approximately 1 in 4000 nt. This method resulted in a significant 
improvement over standard methods of site-directed mutagenesis because it is much 
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Figure 27: overlap extension PCR.' 
68 
Saturation mutagenesis has been applied to generate beneficial point mutations and 
also to explore active site "hot spot" sequences. 
iii) 	Random point mutagenesis in vivo. 
The alternative to in vitro PCR-based point mutagenesis is point mutagenesis in vivo. 
The latter method can be performed using the E. coli XL 1-Red mutator strain. 
170  The 
engineered genotype consists of mutations that inactivate three independent DNA 
repair pathways, namely in the loci mutS,171 mufF,172 and mutD.'73 
The mutS gene encodes for the MutS protein that recognises and binds to almost all 
base pair mismatches (exept C/C) despite their structural differences. MutS belongs 
to the methyl-directed MutHLS pathway in K coil which corrects mismatches arising 
during replication (Figure 28). MutS initiates repair by binding to the mismatch ( ) 
MutH endonuclease binds to hemimethylated dam sites (methylated adenines on 5'-
GATC-3' sequence). MutH endonuclease activity is stimulated by MutS and MutL in 
the presence of ATP () MutH incises the newly synthesised unmethylated strand. 
The nicked unmethylated strand is degraded by 5'3' and 3'5' exonucleases followed 
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by resynthesis performed by DNA polymerase III and the remaining nick is sealed by 
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Figure 28: methyl-directed mismatch correction system in E. coil. 174 
The muff gene encodes the MutT nucleoside triphosphatase, which hydrolyses 
8-oxodGTP, produced by active oxygen species (superoxide, hydrogen peroxide and 
hydroxyl radical) generated as by-products of normal aerobic metabolism. 8-
oxodGTP is hydrolysed to 8-oxodGMP in the nucleotide pool by MutT before it can 
be misincorporated opposite template adenines. A strain that lacks active MutT 
protein has elevated levels AT—GC transversions.175 
Mutation of the gene encoding MutD (dnaQ) causes a lack of the proofreading and 
self-editing function of DNA polymerase III. The dnaQ gene encodes a subunit of 
DNA polymerase III, which carries out a 3'—* 5' exonuclease (proofreading) 
function to remove incorrectly paired nucleotides during DNA replication. It was 
estimated that introduction of these three mutations into the wild type E. coil XL 1-
Red could increase the spontaneous mutation rate by approximately 5000 fold. 
170 
Greener et al.,176  evaluated the random mutation rate after 30 generations and found 
that the spontaneous mutation rate on a pBluescript plasmid was 1 mutation per 2kb 
of cloned DNA after 30 generations of growth. The advantage of using XL II -Red for 
random mutagenesis, compared with chemical mutagenesis or a PCR based protocol, 
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is that the mutation rate can be carefully controlled. However a major disadvantage 
of the XLI-Red mutator strain is its genetic instability. 
In contrast to XL 1-Red mutator strains, a genetically stable E. co/i mutator strain was 
engineered. 177  The target gene was propagated on a ColE 1-type plasmid which uses 
DNA polymerase I for the initiation of replication. After replication of the initial 1kb 
of the plasmid insertion, polymerase I is replaced by polymerase III which completes 
the replication. The E. coil mutator strain expressed a mutated polymerase I with 
negligible proofreading activity, and the MutHLS repair system was disabled. As 
polymerase I replicates only 1% of the host chromosome, the target gene was 
mutagenized with minimal effect upon the genotype and phenotype. This makes it 
possible to produce 150 cell generations such that only 10% of the cells in the 
culture become mutated. The limitation of this method is that the library diversity is 
limited by the low mutation rate and by the restriction that only 1 kb can be mutated. 
Both methods (error-prone PCR and using a mutator strain) have their pros and cons. 
By using the mutator strain, mutations are not only introduced within the gene of 
interest, but may also occur on the entire plasmid. Some clones may contain defect in 
the protein expression sequence and, as a consequence, not all clones may produce 
the enzyme of interest. On the other hand, this method is much more simple 
compared to error-prone PCR. Bornscheuer and co-worker 
178 reported serious 
problems in finding appropriate conditions for PCR itself as well as for the efficient 
ligation of PCR products. 
Finally, the outcome of random mutagenesis for directed evolution depends highly 
on the mutation rate. A low mutation rate requires the screening of large enzyme 
libraries (because only a few clones bear mutations), but too high a mutation rate 
might lead to an increasing number of inactive enzyme variants. Bornscheuer and co-
worker'78  have found with both methods that single mutations per gene is the 
optimum range of mutation rates to produce a beneficial mutation. 
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Here is a summary of the methods to produce point mutations in genes (Table 1). 
Point mutations Advantage/Disadvantage Nature of 
mutations 
Mutations rate 
E. co/i XLI -Red170 No special equipment The most 1 per 2kb per 30 
required, fast, minimum common cycles of growth 
optimisation required, no T— C; C— T; 
dependence on ligation- G—' A, 
transformation efficiency, Least common 
large gene size is A— G; T— G; 
applicable, easy to control G—' T; C— G; 
a mutation rate. The G— C 
presence of high 
population of wild type 
clones requires a very high 
throughput screening.  
Error-prone Mutation rate optimisation The most Up to 7 mutations 
required, ligation- common per 1kb per 30 
transformation conditions mutations are PCR cycles 
optimisation required, 1kb A— T, T—'A 
size is optimum. and the least 
common are 
G —'C, C—'G 
Table 1: the methods for producing point mutations in genes. 
1.3.1.2. 	In vitro methods for gene recombination 
i). 	Recombination of genes with high DNA homology 
DNA shuffling. This method was developed by Stemmer et al.165'179 as a random in 
vitro DNA recombination method, enabling molecular mixing of randomly mutated 
genes. It involves random fragmentation of several mutated DNAs followed by their 
reassembly by PCR into full length molecules and introduces additional point 
mutations at a very low rate. The randomly mutated gene is digested with DNasel to 
a pool of random DNA fragments followed by denaturation, self-priming and 
reassembly of the full-length gene by repeated PCR. The final library of full-length 
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recombinant DNA sequences is obtained by PCR amplification with forward and 
reverse oligonucleotides. The possible combination of the original mutations in the 
parental genes produces considerable molecular diversity and maximal combination 
of mutations to yield mutated enzymes. DNA shuffling allows the accumulation of 
beneficial point mutations by combining mutations resulting in two or more 
improved properties that have been evolved separately. 
180 
Hybrid enzyme technique. Diverse gene libraries for laboratory evolution can be 
created by recombination of related genes.181  This approach generates highly diverse 
sequences, but conserves function. Improved or altered enzymes can be identified by 
screening such hybrid protein libraries.18' Genes from multiple parents, and even 
from different species with sequence similarity, can be shuffled in a single step. 
The hybrid enzyme technique is similar to DNA shuffling and also has been termed 
molecular breeding by DNA shuffling or gene family shuffling (Figure 29). The 
method involves digesting target genes with DNasel to a pool of random DNA 
fragments (I) followed by denaturing, self-priming and reassembling full -length 
genes by repeated PCR (H.-1). The final library of full-lenh recombinant DNA 
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Figure 29: molecular breeding by DNA shuffling. 
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DNA shuffling is used widely to generate highly improved biocatalysts with features 
not present in the parent enzymes and not known in nature. 
Random-priming in vitro recombination (RPR).' This approach is an effective 
alternative to DNA shuffling. The principle of this technique is that a single-stranded 
DNA serves as a template for random priming DNA synthesis in PCR amplification. 
The primers used in the reaction are: (i) primers with random sequence and (ii) 
primers that are complementary to different sections of the template sequences. 
These primers are added to generate a large number of short DNA fragments. Due to 
base misincorporation and mispriming, these short DNA fragments also contain a 
low level of point mutations. The short DNA fragments can prime one another by 
homology, recombine and reassemble into full-length genes by a PCR-like 
technique. These sequences can be further amplified by PCR and cloned into an 
expression vector followed by screening or selection. RPR and screening or selection 
can be repeated using multiple cycles (Figure 30). 










-, 	> cloning and 	_F F''' 
expression 
Figure 30: random-priming in vitro recombination (RPR). ( ) random-priming 
synthesis-,() template removal (3) short fragments reassembly based on homology 
and amplification-, 4) PCR with forward and reverse primers, subcloiiing and 
expression in suitable host-,() screening for positive clones, (i') repeat cycle. 
184 
RPR may allow access to a greater range of amino acid substitutions than error-prone 
PCR. In comparison to DNA shuffling, the RPR technique has several advantages: 
reassembly and amplification 
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RPR can use single stranded polynucleotide templates without an 
intermediate step needed to synthesize the entire second strand. Potential 
mutations or crossovers can be introduced at the DNA level from single- or 
double-stranded DNA templates by using DNA polymerase, or directly from 
mRNA by using RNA-dependent DNA polymerase; 
DNA shuffling requires fragmentation of the double-stranded DNA template 
(generally with DNase I), followed by complete removal of DNAse before 
the fragments can be reassembled into full length sequences; 
Synthetic random primers have the same length and lack sequence bias. 
Every nucleotide of the template is copied or mutated at a similar frequency 
during extenuation; 
RPR DNA synthesis is independent on the length of the DNA template. 
Staggered extension process (StEP).1  This method is based on a PCR-like reaction 
with very short annealing and extension steps. StEP consists of priming the template 
sequences followed by very short repeated cycles of denaturation and extremely 
abbreviated annealing/polymerase-catalyzed extention (Figure 31). 
In each cycle the growing fragments can randomly anneal to different parental 
templates based on sequence complementarity and extend further to create 
recombinant sequences. Due to the template switching, the growing polynucleotides 
contain sequence information from different parental genes. StEP is continued until 
full-length genes are formed. It can be followed by a gene amplification step, if 
desired. The whole process can be performed with standard forward/reverse 
universal primers in a single tube. 
This method has an advantage over DNA shuffling. Separation of parent templates 
from recombined products is unnecessary and there is no need to fragment and 
reassemble the genes. StEP recombination method can be applied for directed 
evolution of genes, operons, pathways and even whole bacterial/viral genomes. 
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Figure 31: StEP recombination. Only one primer and single strands from two parent 
genes (templates) are shown. (I). Denatured templates are primed with one defined 
primer. (.) Short fragments are produced by brief polymerase-catalyzed primer 
extention. () Through another cycle of StEP, fragments randomly prime the 
templates (template switching) and extend further. (4) This process is repeated until 
full-length genes are produced. () Full-length genes are purified and (optionally) 
amplified in a PCR with external primers. 
In vitro exon shuffling. Since exons represent only 1% of the human genome and 
introns about 24%, most of the crossovers occur between exons, rather than inside of 
them. The natural process of creating new combinations of exons by intronic 
recombination is called exon shuffling. Exon shuffling in vitro, which is similar to 
DNA shuffling, is an important tool for mutagenising and recombining much longer 
DNA sequences, especially eukaryotic genes. Exon shuffling is a natural way to 
create novel proteins from combinations of exons by homologous recombination 
inside the introns. This differs from DNA shuffling, where the recombination 
happens within all of the gene fragments. Recombination within introns is able to 
assemble independent exons into genes for novel proteins.' In this method, exons 
that encode domains are amplified using mixtures of chimeric oligonucleotides, 
thereby determining which exons are spliced together. The mixture of these PCR 
fragments are used as primers and templates in self-priming overlap extension PCR 
into the full-length gene.' Recombination occurs when an exon from one gene is 
connected to an exon from a different gene. 
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New methodological developments. Over the past two years there have been several 
approaches to improve in vitro recombination efficiency. In vitro recombination by 
DNA shuffling'" creates libraries of chimeric genes with a strong tendency for 
reconstitution of parental structures by PCR-based reassembly methods. Priming 
among fragments of the same gene is favored and is known to decrease the number 
of crossovers and increase the proportion of non-chimeric parental structures in a 
recombinant library. 
To decrease the contamination by parental structures, combinatorial libraries 
enhanced by recombination in yeast (CLERY) was developed. 
187 This strategy for 
family shuffling in yeast expression vectors takes advantage of the unique properties 
of homologous recombination in yeast. 
The classical Stemmer DNA shuffling step is followed by secondary shuffling 
obtained by in vivo recombination in yeast. Overall, this shuffling strategy allows 
direct expression and functional selection in eukaryotic cells without the need for 
intermediate cloning steps in E. coil. This procedure is most suitable for shuffling 
eukaryotic genes that cannot be expressed in bacteria. The statistical analysis of 
randomly selected clones reveals a high proportion of chimeric genes (86%) and 
around 4.4 crossovers per gene. 
Random chimeragenesis on transient templates (RACHITT) has been developed by 
Coco et al. 188  The approach relies on the ordering, trimming, and joining of 
randomly cleaved parental DNA fragments annealed to a transient polynucleotide 
scaffold (Figure 32). 
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Figure 32: random chimeragenesis on transient templates (RACWTT).1  
The genes A and gene B have 89.9% identity (differing by 127 nucleotides). Gene B 
was made as a single-strand to serve as a transient scaffold template (black bar). This 
molecule mediates the ordering of gene A top-strand fragments (white bars) and 
serves as a template for the filling of gaps. After hybrydization of the DNase I 
digested top strand of gene A, unhybridized 5' termini or "flaps" were cleaved by the 
flap endonuclease activity of Taq DNA polymerase. Ligation continued in a reaction 
in which 3' flaps were digested by the 3'-5' exonuclease activity of Pfu DNA 
polymerase, which also serves to fill the gaps. 
RACHITT exploits a bottom-strand template from only one parent and only top-
strand fragments of other parents. This prevents parental fragments from reannealing 
to their own complementary strands. The authors generated chimeric libraries with 
an average of 14 crossovers per gene, several fold higher than observed for other 
methods. 29% of crossovers occurred in the region of 10 or fewer bases of sequence 
identity, which is similar to Stemmer's approach (32%).179 No unshuffled parental 
clones or duplicated "siblings" chimeras were detected. 
Family shuffling using single-stranded DNA (ssDNA).1  In order to improve the 
efficiency of hybrid formation in family shuffling, ssDNAs with 80% sequence 
identity have been used as templates. The only difference between the methods using 
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ssDNA and dsDNA was the template DNA for DNAse I fragmentation. The ssDNA 
preparation requires the genes to be cloned either in a phagemid vector or in a 
ssDNA phage such as M13, and ssDNA has to be prepared from filamentous phage 
particles. Although shuffling with ssDNAs requires one more step, it was worthwhile 
since chimeric genes were formed much more efficiently (chimerization rate 14%) 
than by shuffling with dsDNA (chimerisation rate <1%). 
ii) 	Recombination of genes with low DNA homology. 
All in vitro methods of gene recombination based on PCR are dependent on a 
stochastic process that reassembles homologous genes. All the available methods for 
DNA shuffling require high sequence similarity for recombination (>-60%). 
However, in shuffling parent sequences of lower identity or even with no sequence 
homology. When the level of similarity between the genes is too low for effective 
DNA shuffling by PCR, hybrid enzymes can be created by domain swapping in vitro. 
Recently Sieber et al.,' 90  introduced SHIPREC (sequence homology independent 
protein recombination). To maximize the abundance of functional hybrids in a 
library made by recombining two homologous genes of low sequence identity, the 
chimeras were selected by size to retain the length of the parent genes. SHTPREC 
therefore combines the N-terminal fragment of the parent protein with the 
appropriate C-terminal fragment and, in principle, makes all such possible 
combinations (Figure33). 
(I ) Two genes are connected to form a gene climer through a linker sequence 
containing multiple restriction sites. () Blunt ended fragments are generated from 
the dimer by random fragmentation and nuclease treatment. () Fragments of the 
correct size are selected from the pool. (4) Selected fragments are circularised by 
blunt end ligation. () Circular DNA pieces are linearized by restriction digestion in 
the linker region to create a library of chimeric genes. (o) The chimeric genes are 
subcloned and expressed in a suitable host. 
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Figure 33: SHIPREC (sequence homology independent protein recombination).'90 
Incremental truncation for the creation of hybrid libraries (ITCHY).191 In contrast to 
DNA shuffling and related methods, ITCHY does not rely on the parental genes 
containing regions of DNA sequence homology to create crossovers. The protein 
chimerization is driven by restriction enzyme fragmentation. A key step in the 
creation of these libraries is the digestion of the parental genes with 3' to 5' 
exonuclease (e.g., Exonuclease III, Exo III) under conditions (e.g., low temperature 
or in the presence of NaCl) which control the rate to 10 bases/min or less. During 
Exo III digestion, small aliquots are removed frequently and quenched by addition to 
a low pH, high salt buffer. Theoretically, every single base deletion of the two gene 
fragments can be collected. Blunt ends are prepared by treatment with single-strand 
nuclease. Fusion of the truncated gene fragments by blunt end ligation then 
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Figure 34: incremental truncation for the creation of hybrid enzymes (ITCHY ).'91  
( ) ExoIll random hydrolysis (2) NciI digest ( ) blunt end ligation. 
5' fragment of gene A and 3' fragment of gene B are cloned into the vector. NsiI 
restriction site is designed for creation of incremental truncation libraries from the 3' 
end of gene A and 5' end of gene B. 
This method was improved further to avoid extensive time for sampling. 
192 The 
modified method is known as THIO-ITCHY the and key change is the random, low 
frequency incorporation (spiking) of the target DNA segment with alpha-
phosphothioate nucleotides. These nucleotide analogues have been shown to protect 
the DNA from exonuclease digestion, thus leading to the desired variation in 
truncation length upon nuclease treatment. 
The generation of diversity is based on the random distribution of the a-
phosphothionate nucleotides and two targeted gene fragments can be combined into a 
single vector and processed for expression and screening. 
Two overlapping gene fragments are cloned in the same vector with a unique 
restriction site between them. The THIO-ITCHY libraries were constructed in two 
different ways. Firstly, one was obtained by incorporation of phosphothioates in a 
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(I) Linearization of the starting plasmid by restriction digestion at the unique site 
between two genes. (2) Treatment of the linearized plasmid with exonuclease III 
produces single-stranded overhangs, covering the entire length of the target region. 
(3) The single-stranded target region serves as the template for polymerase catalyzed 
synthesis of the complementary strand. The addition of small amounts of nucleotide 
analogues such as a-phosphothioate dNTPs to the reaction mixture results in 
random, low frequency incorporation of the analogue into the newly synthesised 
strand as indicated by stars. (4) A second incubation of the plasmid with exonuclease 
Ill results in hydrolysis of standard dNMPs while the dNMP analogues block 
enzymatic degradation. (5) The single-stranded portions of the plasmid s are removed 
by mung bean nuclease. (c) The blunt-ended constructs are recircularised by 
intramolecular ligation. 
The second library was produced by incorporation of phosphothioates in PCR 
amplification (Figure 36). (1) Linearization of the starting plasmid by restriction 
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digestion at the unique site between two genes. (2) PCR amplification of the entire 
linearized vector in the presence of a mixture of dNTPs and alpha-S-dNTPs. 
( 	Incubation of the plasmid with exonuclease III results in hydrolysis of standard 
dN'Ws while the alpha-S-dNTPs will block enzymatic degradation. (4) The single-
stranded overhangs of the plasmids are removed by mung bean nuclease. (2) The 
blunt-ended constructs are recircularized by intramolecular ligation. 
The most important advantage of TfflO-ITCHY is the possibility of combining 
incremental truncation with random mutagenesis, leading to further library diversity, 
which in turn can accelerate the identification of novel hybrid enzymes with 
improved function. 
One of the main limitations with the methods described above (Figure 35&36) is the 
ability to create only a single crossover between the two parental genes. To 
overcome this problem, Benkovic and co-workers193 developed a new non-
homologous recombination method named SCRATCHY, which combines ITCHY 
with DNA shuffling. A new non-homologous recombination method based on 
modelling framework eSCRATCHY provides insight into the effect of sequence 
identity and fragmentation length on crossover statistics. Sequence analysis of the 
naive shuffled library identified members with up to three crossovers per gene, and 
modelling predictions are in good agreement with the experimental findings. 
1.3.2. Library evaluation methodologies 
Libraries of mutated genes can be generated by a variety of methods as described 
above and the methodology is rapidly becoming routine. The outcome of directed 
evolution experiments, however, is critically dependent on how a library is evaluated 
and this is a challenge that largely remains unmet. 
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1.3.2.1. 	Selection methods 
Biological selection methods are based on complementation of auxotrophy or 
resistance to cytotoxic agents (e.g. antibiotics). Biological selection is a powerful 
method for screening large libraries and isolating variants of interest. In particular in 
vivo selection has been used very successfully to evolve microbiological pathways in 
situ and alter metabolic flux eg. Antibiotic or amino acid manufacture. However, in 
vivo methods can also be applied to specific enzymes. Oue and co-workers 
194  altered 
the substrate specificity of aspartate aminotransferase using amino acid auxotrophs 
for the selection of mutants with increased catalytic activity against 2-oxovaline 
(non-native valine) at a rate 6.7x 105 greater then the wild type enzyme. However, the 
utility of phenotypic biological selection has limitations. Microbal genomes have 
evolved adaptation mechanisms to cope with changes in environmental conditions. 
The application of selective pressure can result in mutations that do not affect the 
catalytic activity of the recovered mutant. For example, selections may yield 
mutations that increase the expression level of a catalytically slow enzyme. Also, 
mutations in unrelated genetic loci may induce a different pathway unrelated to the 
enzyme of interest, or a general stress response may affect the growth level of the 
microorganism. The selection must therefore be designed very carefully. 
The selection of large libraries is simplified by establishing a direct physical link 
between a gene, the protein that it encodes, and a desired function. This link can be 
established by in vivo and in vitro display technologies. For in vivo methods, the 
protein is displayed on the surface of the filamentous bacteriophag. In this method, 
a gene of interest is fused in-frame to phage genes encoding surface-exposed 
proteins, most commonly pIll. The gene fusions are translated into chimeric proteins 
in which the two domains fold independently. The phage displays a protein with 
binding affinity for the ligand immobilized on solid support. The selective adsorption 
of the ligand by the protein is known as "panning". The bound phage is desorbed 
from the surface, usually by acid elution, and amplified through infection of E. co/i. 
Usually, four to six rounds of panning and amplification are sufficient to select for 
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phage displaying specific polypeptides from very large libraries with diversities up to 
1011.195 
Nevertheles, this method has some limitations. Phage-display methods evolve 
the binding rather than catalytic capacity of the enzymes and provide information 
only for the clones that bind to a ligand. The method cannot be used for the 
quantitative analysis of an entire library. At the end of a phage panning experiment 
there is no data on the percentage of clones exhibiting a certain level of activity. 
An in vitro selection method, which establishs a link between the gene, the protein 
and the function, was reported by Tawfik and Griffiths196 and called 
compartmentalized self replication (CSR). In this method of in vitro protein 
translation, the protein activity does not interfere with cellular metabolism and can be 
distinguished from the background of all other cell reactions. The tiny aqueous 
droplets of water-in-oil emulsion serve as artificial compartments for in vitro protein 
synthesis and protein capture. Ribosomes, DNA, the corresponding protein and the 
reaction product are contained and kept physically separated within the droplet 
compartment (average one gene per compartment). The authors were able to extract 
the DNA encoding active enzyme again using product specific binders (Figure 37). 
lipids 









the desired activity 
Figure 37: compartmentalized self replication (CSP).' 97 
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A gene library is expressed in an in vitro transcription/translation reaction ( I ) and 
distributed to the water-in-oil emulsion (.). In the proposed selection, active enzyme 
variants modify the DNA template to which they are coupled through 
compartmentalization in the droplet (s). The emulsion is broken (4) and the modified 
DNA templates enrich the gene coding for active enzymes (s). The entire cycle can 
be repeated to achieve higher enrichment (fl ). 
One cycle was able to achieve an enrichment factor of at least 5000, and two cycles 
were enough to select the gene with the desired property (Hae III methyltransferase 
protected from digestion by Hae III) from a 107-fold excess of other DNA. The CSR 
method was also applied for directed evolution of Taq DNA polymerase.1 The 
authors increased the polymerase thermostability by 11 fold and resistance to heparin 
by 130 fold. 
1.3.2.2. 	Screening methods 
Enzyme activities in libraries can be screened by means of a direct assay performed 
in microtiter plates that detects the formation of a coloured or fluorescent reaction 
product or the temperature change of an exothermic reaction. Some examples of 
enantioselectivity evaluation by UV/Vis- based, fluorescence-based, IR-
thermographic systems and capillary array electrophoresis are described in a recent 
review.1  However, quantitative colorimetric or fluorimetnc assays performed 
directly in mictotiter plates are time consuming and expensive. 
Solid-phase screening of colonies on agar plates or on filters allows rapid screening 
of large libraries. Typically, variants are identified on the basis of cleavage of a 
substrate present in the solid phase and detection of product release by a local change 
in pH using a pH indicator,200a formation of a coloured or fluorescent product 
201 
development of a clearing zone or precipitation caused by the altered solubility of the 
released product in the solid phase202  or monitoring the growth rate depending on the 
cleavage of an insoluble substrate.203  
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Most solid-phase screening methods lack sensitive quantification of catalytic activity 
and are typically qualitative screens suitable for a first round of directed evolution. 
However, a sensitive fluorescent high throughput digital imaging screen has been 
developed for P450 monooxygenase expressed in E. coil. 204 
Kairos Scientific Inc. has developed high through put screening methods, based on a 
solid phase system that allows the screening of the colonies (500/cm2) that have been 
transferred onto an aporous assay disk. In this assay, each colony acts as a nanoliter 
reaction vessel and analysis is performed with a digital imaging spectrophotometer"' 
(Figure 38). 
Porous disk 
E3 --0. —* 	 -10.  
Incubate 011 	 Incubate on Nutrient 
Nutrient Medium 	 Medium+IPTG 
'Fastest' enzyme variants are 
automatically indicated by 4—( ) 4-
the kcat instrUmeflt 
Color develops in micro-colonies 	Enzyme reactions starts 
expressing active enzyme variants synchronously 	
Chloroform vapor 
permeabilizes cells 
Figure 38: steps in the solid phase enzyme evolution assay for use in the Kcat 
instrument.The porous assay disk was inoculated with a library of mutant plasmid 
transformants and left for incubated on the nutrient medium. The disk containing the 
microcolonies was lifted (I) and transferred to an inducer plate (2). The disk was 
lifted again (4) and placed into the chloroform lysis chamber (4). The disk was then 
subjected to solid phase assay directly in the 	instrument (4). The Kcat instrument 
begins recording spectra as function of time (c. When coloured colonies develop, 
the fastest enzyme variants are automatically indicated by the Kcat instrument 
(7)•20 
Cell-surface and phage-display methods have been limited mostly to the evolution of 
binding rather than catalysis. Olsen et al.,206 devised a strategy to screen large 
enzyme libraries displayed on bacterial cell surfaces by fluorescence-activated cell 
sorting (FACS). The E. coil cell-surface protease OmpT was evolved for novel 
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substrate specificity using a specially designed fluorescence resonance energy 
transfer substrate (FRET). The surface of a gramm-negative bacterium is highly 
negatively charged. The FRET substrate contained a fluorophore which consisted of 
a neutral FRET quenching partner released upon enzymatic conversion, and a 
positively charged fluorophore bound to the cell surface. Cleavage of the substrate by 
a surface-displayed enzyme disrupts intermolecular quenching, giving rise to a green 
fluorescent product that is surface retained via the polycationic tail. The amount of 
green fluorescence correlates with substrate turnover. 
Cells expressing high green fluorescence emission are physically sorted from the 
library mixture by flow cytometry. Enzyme mutants that bound to the substrate but 
did not turn over efficiently exhibit enhanced quencher fluorescence (red 
fluorescence), presumably because the quencher fluorophore is secluded within the 
active site of the protein. Because of these features, protein surface display coupled 
with FRET/FACS screening is unique in being able to distinguish enzyme clones 
either by kcat or KM. The capacity of this method permits screening of up to 109 cells 
per hour (Figure 39). 
. 	•j 
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Figure 39: FACS-based enzyme evolution system. F: fluorophore; Q:quencher.20' 
Another strategy based on FRET/FACS screening of periplasmically expressed 
proteins in E.coli was developed by Chen et al.207  This method allows the screening 
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of libraries of proteins that cannot be functional and stably displayed on a cell or 
phage surface. The authors found that under certain conditions, large ligands (up to 
1 OkDa) could diffuse into the periplasmic space, allowing the screening of a number 
of binding proteins, including nucleic acid binding proteins as well as the screening 
of enzyme libraries. 
For some activities, the reaction cannot be directly detected by light absorption or 
fluorescence. To overcome this problem, Firestine et al.208 have developed a strategy 
based on a three-hybrid system called QUEST (querying for enzymes using the 
three-hybrid system) where substrate turnover in vivo is coupled to a transcriptional 
event to generate a signal (Figure 40). 
I 	 <T'' C•> 	product 
transcription 
+ substrate 	 + enzvflle C 
o O0 	 transcription 
o o r> 
chemical inducer of dimerisation 	 clumeric transcriptional activator 
Figure 40: QEST system for enzyme evolution in 
Vivo.  208 
The chimeric fusion protein (green) binds to a chemical inducer of dimerisation 
(orange), resulting in activation of transcription ( I ). The substrate (yellow squares) 
inhibits dimerisation and switches the transcription off(). The target enzyme (red) 
converts the substrate into product (yellow circles) (3) and dimerisation again 
induces transcription (4). As the target activity is coupled to a transcriptional signal, 
the method is theoretically applicable to any enzymatic reaction. 
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1.3.3. 	Achievements by directed evolution in vivo 
The techniques of directed evolution have been used to achieve several goals: (i) to 
change enzyme specificity and stereoselectivity, (ii) to change the stability of 
enzymes (thermostability, organic solvents tolerance), and (iii) to engineer new 
activities. For the purpose of this thesis, only the application of directed evolution in 
the synthesis of chiral compounds will be considered. 
Control and optimisation of stereoselectivity in enzyme catalysed resolution and 
asymetric transformation has been a focus in recent years, because of the inefficiency 
of conventional methods for stereochemical control. Many highly stereoselective 
biocatalysts are already used in industry (Table 2). These biocatalysts, particulaly 
the group of hydrolases, have been further improved by laboratory evolution. 
Process Subs/rate Product Enzyme Scale Corn 
tonnes/ pany 
annum  
Resolution Racemic Enantiomeric Lipase iO3 BASF 
alcohols alcohols 
Resolution Racemic R- and 5- Lipase 102 BASF 
amines amide 
Kinetic Racemic L-amino acids Amidase 102 DSM 
resolution amino acid 
amides 
Amination Fumaric acid L-acpartic acid Aspartate 102 DSM 
ammonia 
lyase 
Table 2: stereoselective large-scale biocatalytic process.3'209 
The most popular members of the hydrolase group as stereoselective biocatalysts are 
esterases (carboxyl ester hydrolases) and lipases (triacyiglycerol hydrolases). The 
most valuable properties of esterases and lipases are their high regio- and 
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stereospecificity towards a wide range of different substrates. No cofactor is required 
and the enzymes are typically rather stable and even active in organic solvents. 
i). 	Esterases 
Although a considerable number of microbial carboxyl esterases have been 
overexpressed in suitable hosts, only a few of them have been used for the synthesis 
of optically pure compounds. The major reason for this is their limited commercial 
availability and their frequently observed moderate enantioselectivity. 
Bornscheuer et al. '200.  attempted to resolve the 3 -hydroxy esters(Figure 41, I&2), 
which show close structural similarity to a key building block in epothilones, a new 
class of anticancer drugs posessing cytotoxic activity at the stage of mitosis.210 
Previously, Bornscheuer et ai.2OObc have demonstrated the successful resolution of 
aliphatic and arylaliphatic 3-hydroxy esters using lipases or esterases. However, the 
sterically hindered 3 -hydroxy esters (Figure 41, I&2) were not accepted as substrates 
by 18 lipases and two esterases.200a The problem was overcome by evolving new 
enzymes by directed evolution. The substrate specificity of an esterase from 
Pseudomonasfluorescens (PFE) was altered by introduction of two point mutations 
by the mutator strain Epicurian coil XL1-Red.200  The key to the identification of 
improved variants was an agar plate assay system based on pH indicators, in which 
the colour changed upon hydrolysis of the ethylester. The best mutant showed a 
moderate improvement in enantioselectivity (E = 5,wild type E0)* although 
possessed only 50% of the activity of the wild type. 
* 
E value can be calculated from the VIKM value for each enantiomer, but also 
determined from % e.e. and conversion using the equations developed by Chen et 
al.2  11  
In the next step, the enantioselectivity of PFE was improved further. Mutant libraries 
were created by error-prone PCR and also by using the mutator strain. An extremely 
accurate determination of the enantioselectivity was achieved by using resorufin 
esters of (R)- or (5)-3-phenylbutyric acid (Figure 41, In), which allowed 
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measurement of fluorescence of resorufin in microtiter plates, avoiding problems 
with interfering compounds present in the culture medium. The measured 
enantioselectivity after a single round of error-prone PCR or passage in the mutator 
strain was approximately the same: E=5.2 - 6.6 (E3.5 for wild type). 
178 
A further increase in the enantioselectivity up to E=1 2 was obtained by saturation 
mutagenesis at all three positions identified for the first generation variant (E.Henke, 
U.T.Bornscheuer, unpublished).212  However, combination of the best variants by 
site-directed mutagenesis gave no further improvement. 













Figure 41: 3-hydroxy esters used as substrates for directed evolution of PFE. 
Preliminary homology modeling of PFE based on the known structure of 
haloperoxidase from Streptomyces aureofaciens (55% identity) showed that all 
mutations produced by error-prone PCR or the mutator strain were neither near nor 
in the active site of PFE, but at the periphery of the enzyme.200a 
Significantly higher increases in enantioselectivity were achieved for the resolution 
of methyl 3-bromo-2-methyl-propionate (U.T. Bornscheuer and R.J. Kazlauskas, 
unpublished )212 Using a homology model of PFE, Trp29 and Phe199 were 
subjected to random mutagenesis and the pH indicators were used for screening. 






3 -bromo-2-methyl -propionate 
To make the application of enantioselective enzymes in industrial processes more 
efficient, directed evolution was successfully used to improve the stability and 
activity of an esterase from B. subtilis, which selectively cleaves the p-nitrobenzyl 
ester of Loracarbef, a cephalosporin antibiotic.213  A combination of error-prone PCR 
and DNA shuffling led to the generation of a variant with 150 times higher activity 
compared to the wild type in 15% DMF. Moreover, directed evolution also resulted 
in an increase in the thermostability of this esterase by 14°C, thus making it more 
versatile in industrial application.214 
Lipases 
Lipases are widely used as catalysts for enantioselective reactions, but many 
substrates react with unacceptably low enantioselectivities for industrial application. 
Error-prone PCR was used for the random mutagenesis of a lipase from 
Pseudomonas aeruginosa, which catalyzes the hydrolytic kinetic resolution of 2-
methyl decanoate-p-nitrophenol ester, with a slight preference for the (5)-acid with a 
low frequency of mutation (1 per gene). Approximately 1000 mutants were screened 
by UV/Vis spectroscopy ( production of yellow hydrolysis product p-nitrophenol 
ester) in 96 well microtiter plates after each round of error-prone PCR. It was 
possible to improve the wild type enantioselectivity from e.e.2% to e.e . 81% at 25 




RyCO2H 	+ 	RCO2R' 
Oft 	 CH3 	 CH3 
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Figure 42: lipase catalysed hydrolysis of ester. R = n-C8H17; R' =p-NO2-C6H4. 
A combination of saturation mutagenesis and site-specific mutagenesis with a 
selected set of lipase variants produced by error-prone PCR increased the 
enantioselectivity further (ee = 90%, E = 26) for a mutant bearing five amino acid 
substitutions. 167 By modifying the combinatorial cassete mutagenesis215 the 
enantioselectivity reached E = 5 1.216ab It was recently shown that by screening 
approximately 45000 colonies, the direction of enantioselectivity could be reversed 
completely (from (5)- to (R)- with E=30) by several cycles of a combination of high 
error rate error-prone PCR and DNA shuffling. The best (R)-enantioselective mutant 
contained eleven amino acid substitutions.217 
iii) 	Other enzymes. 
Recently, Arnold and co-workeres218  reported the inversion of enantioselectivity of 
an hydantoinase from Arthrobacter sp. DSM 9771. for improved L-methionine 
production from D,L-5-(2-methylthioethyl) hydantoin in the presence of L-
carbamoylase and a racemase by recombinant E. coil. The D-selectivity (40% ee) 
was converted to moderate L-preference (20% ee at 30% conversion) by a 
combination of two rounds of error-prone PCR and saturated mutagenesis. Only one 
amino acid substitution was required to invert the enantioselectivity. The enzyme 
variant increased the productivity of the whole- cell process 5-fold to >90 % 
convertion. 
D-2-keto-3 -deoxy-6-phosphogluconate (KDPG) aldolase from E. coil catalyses 
asymmetric carbon-carbon bond formation via an aldol process. Fong et al.219 
evolved the aldolase to accept the nonphosphorylated analog of KDPG and L-
glyceraldehyde (D-glyceraldehyde-3-phosphate is a substrate for the wild type 
enzyme in the aldol reaction). Wymer et al 
.220  also performed directed evolution on 
KDPG aldolase, broadening its substrate range while retaining enantioselectivity. 
DNA shuffling and selection were used to create an E. coil aminotransferase22' that 
accepted 3-branched substrates, which were poorly accepted by the wild type 
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enzyme. This aminotransferase activity compensated for a defective host jivE gene 
(cells unable to make isoleucine, leucine and valine) and allowed cells to grow on 
minimal media in the absence of these amino acids. Four rounds of shuffling 
increased the activity of aspartate aminotransferase for valine and 2-oxo-valine (non-
natural valine) by five orders of magnitude, while decreasing by 30-fold the activity 
towards the natural substrate aspartate. 
1.4. 	General conclusions & Aims 
The extent of research into the synthesis of optically active amines over the last few 
decades has been extensive. However, there is still a need for more research and 
optimisation for the synthesis of enantiopure chiral amines, since a generic method 
for their production in high yields has not yet been found. 
The recent work by Soda et al. 37'38  on the deracemisation of cyclic amino acids is a 
promising route to both enantiopure a-amino acids and amines in high yield. In order 
to successfully employ this deracemisation as a general method, oxidase enzymes 
with high enantioselectivity and substrate specificity are required. The derace-
misation of racemic amines using a cyclic oxidation-reduction strategy is a potential-
ly cheap and efficient method for their production, assuming an enantioselective 
monoamine oxidase can be found. 
The aim of this work is to obtain variants of monoamine oxidases which possess 
activity and enantio selectivity towards substrates of interest by the methods of 
directed evolution. 
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2. 	Results & Discussion: Monoamine oxidase from 
Aspergillus niger. Cloning and expression 
Evidence in the literature suggested that copper dependent AOs, from porcine plasma 
and kidney, pea seeding, soy bean and chick pea, catalysed stereoselective oxidation 
of amines11° in addition to MAO-B.159 Enantioselective oxidation of the (R)-
enantiomer of amphetamine by copper-containing AO from E. co/i and Kiebsiella 
oryloca was shown by A. Hacisalihoglu et al.la  However, the mechanism of the 
copper AO's makes them unsuitable enzymes for the deracemisation of amines, since 
the intermediate imine is not released from the active site. Attention therefore turned 
to the FAD containing monoamine oxidase recently identified by Schilling et al. 
from the fungus A. niger (MAO-N).55  Although extensive characterization of the 
enzyme had been reported, the stereoselectivity of the enzyme towards chiral 
substrates had not been examined. -57  However, we reasoned that this enzyme had the 
potential to be a useful biocatalyst. It was soluble and did not require cofactor 
recycling. The hydrogen peroxide released in the oxidative reaction is easy to detect 
by colorimetric assay and this suggested that there was great potential for the 
directed evolution of MAO-N to alter the enantioselectivity. Shilling et al. 55 reported 
that MAO-N had high activity towards benzylamine (kcat 1400 min'). a-
methylbenzylamine a chiral analogue of the achiral substrate benzylamine, was 
chosen as a target substrate for evolving altered substrate specificity, in view of its 
value as a chiral molecule. It is currently produced on a multi-ton scale via an 
enzyme-catalyzed resolution process.' Moreover it is often used as a model substrate 
in the development of new processes for the synthesis of enantiomerically pure 
amines.'' 32, 223,224 
H 	 Me  
PhNH2 	 PhNH2 
1 
benzylamine 	 alpha-methylbenzyl amine 
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2.1. Cloning into pET system 
A construct containing the MAO-N gene cloned in the pET3a vector (pECME3) was 
kindly provided by Professor Schilling. 129  pET3a is one of a series of pET vectors 
supplied by Novagen. The pET vector is one of the most powerful systems for the 
cloning and expression of recombinant proteins in E.coli.225 The target gene is cloned 
into the pET plasmid downstream of strong bacteriophage T7 transcription and 
translation signals (Figure 43). 
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Figure 43: control of gene expression in the pET system. 
The expression host contains a chromosomal copy of the bacteriophage T7 RNA 
polymerase gene under lac UV5 promoter control. Transcription of T7 RNA 
polymerase is regulated by a protein called lac-repressor which is encoded by the 
gene lac I. An active repressor binds to the lac-operator (lacO) and blocks the 
transcription of mRNA. The expression of T7 RNA polymerase is induced by the 
addition of IPTG, which binds to the lac-repressor and rendering it unable to bind to 
DNA effectively. The expressed T7 RNA polymerase from the lac promoter then 
binds to the T7 promoter on the pET vector to enable transcription of the target gene 
in response to addition of IPTG. The IPTG is a useful expression inductor because 
the host cells do not metabolise it. E. coli BL21 (DE3) is used as an expression host 
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in pET system, because it carries a chromosomal copy of the gene for T7 RNA 
polymerase. This was accomplished using a lysogen of bacteriophage DE3, a lambda 
derivative that has the immunity region of phage 21 and carries a DNA fragment 
containing the lacI gene, the lacUV5 promoter, and the gene for T7 RNA 
polymerase.226 
The antibiotic ampicillin resistance is provided by the f3-lactamase gene (Ma) and the 
replication of the pET vector is controlled by CoIE1 origin of replication, and the 
vector can be selected in growing cells by addition of ampicillin to the culture, due to 
its 3-lactamase (Ma) gene. 
2.1.1. Cloning into the pET 16b vector 
The key starting point for directed evolution of an enzyme is the availability of active 
enzyme, in order that the screening/ selection part of the process can be carried out 
efficiently. Expression of MAO-N in the pECM1E3 vector was carried out using the 
previously described protocol.57 The authors reported that addition of IPTG in fact 
led to a decrease in MAO-N activity compared with uninduced conditions. Analysis 
of protein expression, in whole cell cultures, by SDS-PAGE showed that expression 
of MAO-N protein was poor. Therefore, in an attempt to improve expression of the 
protein, the gene encoding MAO-N was subcloned into the pET 16b vector, which is 
similar to pET3a, but benefits from the native lac operator for tighter control of 
expression. In addition, a 10 histidine peptide tag is attached to the N-terminus of the 
target protein, allowing efficient purification on a Ni chelating affinity column.22 
Mao-n gene amplification by PCR was performed with primers (7.2. 1.1) adapted 
from the native sequence to include codons more typical of highly expressed E. coli 
genes. This revision is shown in Table 3. 
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Amino acid DNA codon Occurrence in E. coli genes 
(%) 
Actual Revised Actual Optimal 
Arg4 CGA CGT 7 36 
Gly6 GGA GGT 13 34 
ThrlO ACA ACC 17 40 
Pro 11 CCC CCG 12 49 
Table 3: Primer revision according to codon preference in E.coli genes.227 
Restriction sites were introduced into the primers according to the pET1 6b cloning 
requirement (NdeI at N terminus and BamHI at C terminus). A "Stop" codon was 
introduced at the C terminus to terminate the transcription. Amplification of the gene 
was performed with taq DNA polymerase or with Hot start Herculase high fidelity 
(HF) DNA polymerase (7.2. 1.1). The PCR product was digested with Nde 11 Barn 
HI restriction endonucleases and ligated into NdeII Barn HI digested pET 16b 
(7.2.1.2). The final construct was used to transform E. coli Top 10 (7.2.1.2). E. coli 
Top 10 strain was chosen for mao-n gene cloning into the pET vector since it is recK 
(mutation in gene responsible for general recombination) and helps to prevent 
unwanted recombination in cloned DNA. This strain also gives high transformation 
efficiencies and good plasmid yields. In each case a positive transformant was 
identified by restriction analysis and used for MAO-N expression in E. coli BL2 1 
(DE3) (7.2.2; ii). These were designated as mao(taq)pETl6b and mao(HF)pETl6b 
(pMAO-N). 
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2.1.2. Expression from pET16b 
Expression of MAO-N from pET16b was carried out at 30°C and 37°C (7.2.2; ii). 
E. coli BL2 1 (DE3) transformed with pET 1 6b was used as a control reference. 
imi and lOmi aliquots of growing culture (7.2.2; iv) were used for further studies. 
The hydrogen peroxide (8. 1.1) and benzaldehyde (§8.1.2) formation assays were 
used to assay the specific activity of MAO-N. The frozen imi pellets were used for 
volumetric specific activity determination (7.2.4; i). The specific activity towards 
n-amylamine (CH3(CH2)4NH2) was determined as activity units produced per 1 ml of 
culture (Table 4). 
- 
- 




MAO-N specific activity 
(Unit1 ) 
1 pECME3 37 0.03 
T pECME3 30 0.02 
3 mao(taq)pET16b 37 0.0004 
4 mao(taq)pETl6b 30 0.01 
5 mao(HF)pETl6b 37 0.03 
6 mao(H1F)pET16b 30 0.1 
Table 4: MAO-N specific activity in whole cells, cultured at different temperature 
with amylamine as substrate in the hydrogen peroxide formation assay; pECME3-
supplied by Professor Schilling129 (mao-n cloned into pET3a); mao(taq)pET16b-
mao—n amplified by taq polymerase and cloned into pET16b; mao(HF)pET16b (also 
called pMAO-N). 
A further set of imi frozen pellets was used to analyse the level of expressed MAO-
N by SDS PAGE (7.2.5; Figure 44). 
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Figure 44: quantitative SDS PAGE analysis of MAO-N presence in E. coil 
BL21(DE3)/pMAO-N. The cells were cultured at 30°C and MAO-N express from 
the original construct pECME3129 and as pMAO-N. 
The frozen lOml pellets were used to prepare a CFE (cell free extract; §7.2.3; i). The 
specific activity towards benzylamine was determined in the CFE as expressed as 
activity produced per 1mg of protein (Table 5). BL21(DE3) transformed with 
pET 16b was used as a background reference. 
Construct MAO activity (Umg1 ) MAO activity (U mt') 
1 pECIv1E3 0.2 - 




Table 5: MAO-N specific activity in CFE (Umg') and whole cell culture 
(UmF') grown at 30°C incubation with benzylamine as a substrate in the 
benzaldehyde formation assay. 
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Two different substrates and assays were used to confirm the reproducibility of the 
obtained results. Additionally, two DNA polymerases with different levels of fidelity 
were used to amplify the mao-n gene. This was carried out to address the potential 
for error in the amplification. 
The activity of MAO-N was about 10 fold lower when expressed from mao-n clone 
amplified by taq polymerase (Table 4; entry 3&4) compared to the activity derived 
from a mao-n clone amplified by the high fidelity Hot start Herculase DNA 
polymerase (Table 4; entry 5&6). However, the SDS PAGE revealed the same level 
of expressed MAO-N protein in each case (result not shown) and thus the reduced 
activity of the enzyme was possibly caused by errors introduced by the lower fidelity 
taq DNA polymerase. 
The SDS PAGE also gave insight into the different levels of MAO-N protein 
expressed in cells cultured at 30°C or at 37°C (result not shown). However, the 
amount of active enzyme was found to be greatest when the gene amplified by high 
fidelity DNA polymerase (Table 4; entry 5&6) was expressed in cells cultured at 
30°C (Table 4; entry 4& 6). 
Intermolecular association of hydrophobic domains during folding is believed to play 
a role in the formation of inclusion bodies. The growth temperature often directly 
affects both expression levels and protein solubility. The lower temperature often 
reduces expression levels but yielding a higher amount of soluble protein.228 In this 
case the activity of the enzyme expressed from pECME3 was not significantly 
affected by the incubation temperature, because of the low overall expression level. 
Changing the codons specifying particular amino acids in MAO-N to ones more 
frequently used by E. coil, resulted in the production of higher levels of protein 
(Figure 44; lane 4) which was more active (Table 4; entry 6, Table 5; entry 3). Codon 
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usage affects translational efficiency since highly expressed E. coil genes use a 
characteristic set of codons that correspond to abundant tRNA molecules.229 
The cell cultures were inoculated with a single colony rather than an over-night 
culture. The reason for this was to avoid the destruction of ampicillin by f3-lactamase, 
secreted by an ampicillin resistant seed culture. Ampicillin is an unstable antibiotic 
and is rapidly depleted in growing cultures 
.228 Subculturing from over night cell 
cultures leads to the initial presence of 13-lactamase in the growth media, potentially 
resulting in the enrichment of a sub-population of cells without plasmid, thereby 
reducing the population of cells bearing the plasmid. 
The set of conditions applied to improve the level of active MAO-N expression was 
efficient to produce five times more active enzyme compared to the original 
pECMIE3 construct (Table 5; entry 1,2&3). 
2.2. Development of high-throughput screen 
The development of a high throughput screen to validate the mutant library was the 
next crucial step in the enzyme directed evolution experiment. Most of the existing 
screening methods rely either on time consuming picking of colonies or on the use 
expensive robotic equipment. The current project required the development of a 
cheap, effective and widely applicable method, which could potentially deal with 
libraries of clones in excess of a million. 
2.2.1 Detection of oxidase activity 
At the outset of this work a variety of assay protocols, which allowed quantification 
of amine oxidase activities had been described.222  The reaction catalysed by 
monoamine oxidase can summarised as follows: 
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RCH2NH2 + H20 +02 -* RCHO + NH3 + H202. 
The enzyme activity can be measured by either measuring oxygen consumption or 
formation of aldehyde, ammonia or hydrogen peroxide. It is apparent that the identity 
of the aldehyde formed is dependent upon the identity of the substrate and, while 
some aldehydes can be detected directly by spectrophotometry (e.g. benzaldehyde), 
the technique is often unsuitable for use with crude extracts. 
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production can be measured continuously with a coupled colorimetric assay 230' and 
with Nestler reagent.23°' A number of assays have been developed that allow 
measurement of enzymatic activities based upon hydrogen peroxide production.222' 
231,232 
2.2.2. Soluble dye production assays 
Most assays designed to detect hydrogen peroxide are based upon the formation of a 
coloured product. The production of a dye via an enzymatic reaction would allow 
quick and easy identification of active clones and could also be adapted to become a 
quantitative method using a spectrophotometer together with a kinetic-measuring 
program. A highly sensitive colorimetric assay for hydrogen peroxide was reported 
by Szutowitcz et al. 1 2.2'- azino-bis (3-ethylbenzthiazoline-6-sulfOflic acid, ABTS) 
was used as the chromogen although this causes inhibition of MAO at the 
concentrations used in the assay. Another hydrogen peroxide formation assay was 
described by Yamada et al.  232, In this reaction, 4-aminoantipurine acts as the proton 
donor in the peroxidase reaction and then condenses with 2,4-dichlorophenol to form 
a red quinineimine dye. This reaction was used to measure sheep blood plasma 
amine oxidase activities232b and to assay porcine kidney diamine oxidase.232' The 
drawback in this method is the toxicity of 2,4-dichlorophenol towards MAO. Thus it 
was modified by Halt and co-workers222  by replacing 2,4-dichiorophenol with vanilic 
acid. In this case the reaction was applicable for enzymatic activity measurement. In 
a modification of this approach, vanilic acid was replaced by 2,4,6-tribromo-3- 
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hydrobenzoic acid 233  to obtain a more intensely coloured dye. The mechanism of this 
reaction is presented on Figure 45. Hydrogen peroxide is reduced to water in the 
presence of horseradish peroxidase (HPR) and proton donor (e.g 4-aminoantipurine, 
AAP). The proton donor for this peroxidase reaction is oxidised in the process and 
subsequently reacts with an acid, in this case 2,4,6-tribromo-3-hydrobeflzOic acid, to 
form a soluble dye. The absorbance change at 51Onm can be measured and used to 
calculate the activity of the oxidase enzyme (8. 1.1). 
LAAO or MAO 
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Figure 45: peroxidase-coupled soluble dye formation assay. 
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2.2.3. Detection of oxidase activity in bacterial colonies on agar plates 
Initially a "solid phase assay" was developed to detect the enzyme activity directly in 
colonies grown on a nitrocellulose membrane placed on LB Amp agar. For optimal 
sensitivity it is necessary that the intracellular enzyme is released from the cell and 
available for detection. Another key point is to fix the dye produced by the colony to 
help identify the positive isolate for further analysis. In order to do that, the agarose 
was added to the assay mixture thereby fixing the dye corresponding a particular 
colony and making it available for further studies. The method is described in detail 
in §8.3.2; i and is featured in Figure 46. 
2.2.4. Use of soluble dye 
To demonstrate the practical application of the solid phase assay, two 
transformations were carried out in parallel using E. coli BL2 1 (DE3) transformed 
with pMAO-N and E. co/i BL21(DE3) transformed with pET 16b. The cells from 
both transformations were mixed together and plated onto one membrane placed on 
LB Amp plate to perform the solid phase colorimetric assay in situ using amylamine 
as substrate (8.3.2). 
The cells were plated directly onto a nitrocellulose membrane to avoid the 
preparation of replica filters. This was done because colonies, which heavily 
expressed MAO-N in situ (without IPTG), developed a texture which significantly 
impeded their transfer onto a membrane. Also, the cells plated directly onto the 
membrane were easy to disrupt by freezing/thawing. Another advantage of avoiding 
colony replicating is the more precise identification of positive colony. 
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Figure 46: diagram of solid phase screening.(I)The cells were plated directly onto a 
nitrocellulose membrane to avoid the preparation of replica filters. (II) Peeled off filter placed into a 
fresh Petri dish (III) and subjected to freezing (IV) and thawing (\'). (VI) Partially lyzed cells release 
the enzyme and the positive clone is picked (arrow pointing the positive clone). (VII) Recovery of the 
positive clone occurs via the partial lyzis of the cells. 
The colonies harbouring the vector with mao-n began to develop a pink colour after 
2 hours of incubation and the colonies with pET16b did not develop the colour at all 
(Figure 47). 
However, after 4 hours incubation the pink colour was found to have diffused and 
hence we concluded that this soluble dye formation assay would not be applicable as 
a high throughput assay for high-density colony screening. 
Plate lransfomants 
0 0 
20h,37°C 	 D, 
Tcdhish 
filter 
Place filter on fresh Petri 	11 
0 	 - 
Purify plasmid and go 
for second screen 
VII 
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B 
A 
Figure 47: soluble dye formation solid phase assay (arrows A show positive colonies, 
arrows B show the negative colonies). 
2.2.5. Use of insoluble dye 
The problem with diffusion of the dye was overcome by switching to 3,3'-
diaminobenzidin (DAB) as the substrate for HRP which gave rise to a dark pink 
insoluble product resulting in both very high definition and contrast of the active 
colonies. Oxidase activity was detected by incubation with HRP and DAB. The 
mechanism of this assay is shown in Figure 48. 
79 
Results and Discussion 
SUBSTRATE 	 PRODUCT 
HRP 
02 	H202 	 . 02 + 21-12O 
pH7.6 
02 	+ DAB 	











H202 HN=tJ(jNH  
n 
Figure 48: peroxidase-coupled insoluble dye formation assay. 
The transformation and cell plating procedure was the same as for the soluble dye 
formation solid phase assay described above. Amylamine was used as a substrate. A 
membrane containing the colonies was incubated with the chromogenic solution 
containing 1% agarose (§ 8.2) at room temperature for several time intervals (8.3.2; 
ii). On this occasion the coloured colonies began to develop significantly after 2 
hours and the colour did not diffuse after prolonged exposure (Figure 49). 
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4 2A 
Figure 49: insoluble dye formation with solid phase assay (arrows A show positive 
colonies, arrows B show the negative colonies). 
To further validate the screen, twenty positive colonies were picked from the 
membrane under the solid agarose gel with a yellow Gilson pipette tip. All of the 
colonies were recovered after 24 hours incubation at 30°C in lOmi LB Amp 100 in 
50m1 Falcon tubes and the enzymatic activity was determined in the liquid phase 
soluble dye formation assay. The picked positive colonies were able to be recovered 
because some cells in the colony were left intact by freezing/thawing treatment. 
Also, it was noticed that the colonies were able to be recovered under the agarose gel 
after several days of incubation at room temperature. This observation could be 
explained by a protective role of the agarose gel layer, which covers the colonies. In 
support of this protocol, we found that colonies grown on a membrane and not peeled 
from the LB agar plate prior to the freezing/thawing procedure, were subsequently 
not able to develop colour, presumably, because they were protected by the LB agar 
(Figure 50). 
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Figure 50: different approaches to screen the MAO-N activity towards L-AM1BA by 
the insoluble dye formation solid phase assay. The colonies on figure B were treated 
as shown on Figure 46. The figure A shows the result of assay if the nitrocellulose 
filter with the colonies was not peeled off from the LB agar prior to the 
freezing/thawing treatment. 
2.2.6. Application of high-throughput screening 
In the present work the two assays were applied to detect the activity of MAO-N, 
LAAO from snake venom (Sigma), DAAO from porcine kidney (Sigma) and LAAO 
from cyanobacterium Synechococcus PCC6301. 4  This demonstrates that both 
assays might be applied for other enzymes producing hydrogen peroxide in the 
catalytic reaction. 
It should be noted that a similar solid phase assay has been used by Bylina et a! 205 to 
detect the change of enzymatic properties of (3-glucosidase from Agrobacterium 
faecalis in directed evolution experiments. The reaction involved the enzymatic 
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hydrolysis of an indolyl derivative used in the colorimetric solid phase assay. 
However, there are some important differences between the two procedures as shown 
in Table 6. 
Reported protocol Present protocol 
Enzyme expression obtained in two steps Enzyme expression obtained in one step 
of growth (before IPTG induction and without IPTG induction. 
after)  
Cells lysed by chloroform vapour Cells partially lysed by freeze-thaw 
procedure 
Peroxidase solution was spread manually Peroxidase was mixed with warm (60°C) 
on the surface of assay mix and allowed agarose 
to diffuse into the gel over night at 4°C. 
Membrane placed on the top of solid Membrane placed under the solid phase 
phase assay mix. assay mix. 
Table 6: difference between the reported 20-5  and present solid phase assay conditions. 
We decided to compare the two procedures in practice to detect MAO-N activity 
towards amylamine. Freshly transformed E. coli BL21(DE3) cells were plated onto 
each of the two nitrocellulose membranes. The resulting colonies were treated by 
chloroform or by freezing/thawing according to either protocol. The chloroform 
treated membrane was placed on the top of the solid phase assay mixture and the 
latter was placed under the assay mixture. The rate of dye production in the 
published assay was faster, but the recovery of positive clones was a problem. Only 
one of three picked colonies was recovered after over night incubation in lOml LB 
Amp 100 at 30'C, whereas all three picked colonies were recoverable under the same 
conditions after incubation with the assay described in this thesis. This difference in 
recovery is probably due to the difference in cell lysis conditions i.e. freezing/thawing 
is milder then chloroform treatment. 
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Another experiment was set up to compare the two procedures. 10 month old E. co/i 
BL21(DE3) colonies transformed with MAO-N and kept on a membrane at —20°C 
were subjected to both the published and solid phase assay described herein. Only 
one of three picked colonies again was recoverable from the published assay 
(membrane is "on" the gel) and all three colonies recovered from the present assay. 
This result may be possibly due to lower dye toxicity or to the protective role of 
agarose gel layer as was discussed in §2.2.5 (Figure 50). 
2.3. Oxidation of D/L-a-methylbenzylamifle by MAO-N 
Initially the rate of oxidation of wild type MAO-N towards D/L-AMBA was 
investigated. pMAO-N was used to transform E. coil BL2I (DE3) and to express 
MAO-N. E. coil BL21(DE3) transformed with pET 16b was used as a reference. The 
oxidation reaction was carried out using whole cells grown in liquid media and by 
colonies grown on a plate. 
2.3.1. Oxidation of DL-AMBA by whole cells 
8 thawed whole cells pellets containing MAO-N and 8 reference pellets (7.2.4; ii) 
were incubated with the chromogenic solution (8. 1.1) containing D-AMBA or L-
AMBA at 22°C for 72 hours. At the end of the incubation period the cell suspension 
was centrifuged at 13,000 rpm for 5min and the absorption at 51 Onm was measured 
in both the reference samples (Table 7) and in the MAO-N samples (Table 8). The 
average Abs510  data for both the reference and for the MAO-N samples are in 
Table 9. 
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Sample L-AMBA (Abs 51 Onm) D-AMBA (Abs 51Onm) 
1 0.23 0.16 
2 0.23 0.18 
3 0.22 0.17 
4 0.20 0.19 
5 0.20 0.18 
6 0.20 0.17 
7 0.22 0.18 
Table 7: L-and D- AMBA oxidation by reference samples (E. coli BL21(DE3) 
transformed with pET 16b. 
Sample L-AMBA(Abs 510nm) D-AMBA (Abs 510nm) 
1 0.36 0.19 
2 0.34 0.18 
3 0.34 0.19 
4 0.35 0.18 
5 0.34 0.19 
6 0.33 0.18 
7 0.35 0.17 
8 0.38 10.19 
Table 8: L-and D- AMBA oxidation by MAO-N samples. 
Sample name Average Abs5lOnm Average Abs5lOnm LID oxidation ratio 
for L-AMBA for D-AMBA 
oxidation oxidation 
MAO-N 0.35±0.03 0.19± 1.90±0.3 
Reference 0.20 ±0.03 0.18 ± 1.20 ±0. 
Table 9: average data for L&D-AMBA oxidation activity and L- over D-AMBA 
oxidation ratio by MAO-N and by the reference samples. 
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The above data show that the whole cell culture can be used for initial activity 
studies as described in the present thesis. Even the small difference in activity 
between the sample culture and the reference culture can be detected. A 1.6 fold 
difference was detected towards L-AMBA oxidation and 1.6 fold difference towards 
the ratio of L-over D-AMBA oxidation. The initial 1.9 fold preference in activity of 
MAO-N towards L-AMBA was also established. The quality of this data was 
confirmed by solid phase assay (2.3.2; Figure 51) and by assay of purified enzyme 
(4.2.6.1; Table 18). 
The specific activity of whole cells expressing MAO-N towards L-AMBA was 
calculated as lo-6U/ml (U = jimol substrate oxidised per minute, ml - volume of 
whole cell culture). 
2.3.2. Oxidation of DL-AMBA by colonies growing on a plate 
The membranes containing the thawed E. coil BL21(DE3) colonies transformed 
with MAO-N, and the reference colonies lacking the mao-n gene, were subjected to 
insoluble dye formation using the solid phase assay (8.3.2; ii) in the presence of L-
AMBA or D-AMBA. The membranes were cut in half to evaluate colonies under 
identical conditions. The color development was visualised over 18 hours after which 
time it was clear that MAO-N preferentially oxidised the L-enantiomer of AMBA 
(Figure 51; entries 1&2). The reference samples showed only very small 
enantio selectivity. (Figure 51; entries 3&4) 
Both assays in whole cell culture (2.3. 1, Table 9) or using intact colonies of 
reference culture lacking mao-n gene (Figure 51, entries 3 &4) indicated the presence 
of endogenous amine oxidase enantioselectivity in E. coil towards AMBA. This was 
presumed to be to the presence of an endogenous Type I amine oxidase in E. coli. 
The Type I (copper-containing quinoprotein) enzyme expression was determined in 
E. coil K12 culture growing in presence of 2-phenylethylamine.235  
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The presence of the Cu(II) and TOPA was established by e.s.r. spectroscopy and by a 
characteristic peak at around 480nm in visible spectrum. The molecular weight of 
this enzyme was determined as 70kDa. 
I. 	D-AMBA; MAO-N 
	
It L-AMBA; MAO-N 
HI. 	D-AMBA; reference 
	IV. L-AMBA; reference 
Figure 51; application of the solid phase assay to assess the enantioselectivity of 
MAO-N towards L-and D-AMBA. 
There is the evidence in the literature that the E. coil copper-containing quinoprotein 
amine oxidase is able to catalyse the enantioselective oxidation of amphetamine with 
preference for the (R)- enantiomer (E '- 15). 111  The existence of copper and 3,4,6 
trihydroxyphenylalanine quinone (TPQ) cofactor containing amine oxidase in E. coil 
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K-12 was established by Cooper and co-workwers.72  The amine oxidase (AO) was 
found in the bacterial periplasm and the molecular weight of the enzyme was 
determined as 80kDa by SDS PAGE. The nucleotide sequence of the gene encoding 
AO from E. co/i (mao-A) and the amino acid sequence of the mature enzyme 
(MW=8 1,295) were determined by Azakami and co-workers.7' 
The novelty of the above data is the establishment of enantioselectivity of the 
reference culture towards AMBA with preference for the (L)-enantiomer (Tables 7 & 
9; Figure 51, entries 3 & 4) as well as of MAO-N towards L-enantiomer (Tables 8, 9 
&18; Figure 51, entries 1&2). 
The initial enantioselectivity of MAO-N towards L-AIMBA can be a good starting 
point to develop this property further by enzyme directed evolution in vitro. 
3. 	Results and Discussion: Random mutagenesis by 
E. coil XLI -Red 
Recently, many laboratories have begun using the polymerase chain reaction to 
generate random mutations in genes of interest. This is of particular value with genes 
that have no selectable phenotype. This method exploits the inherent infidelity of Taq 
DNA polymerase during this reaction. By varying the reaction conditions (MgCl2 
concentration, adding MnCl2, or unbalancing the concentration of the four dNTPs), 
the PCR process can yield random mutations at a rate up to seven base pairs per 1000 
during 30 PCR cycles.163,164  
A low error rate (2-3 base substitutions or 1 amino acid substitution per sequence 
per generation) accumulates beneficial mutations, whereas higher error rates often 
generate neutral and deleterious mutations more frequently than beneficial ones. But 
there is a problem associated with this procedure. The gene of interest must be 
recloned with high efficiency into a suitable vector after the PCR reaction to generate 
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a highly representative library. The serious problems in finding appropriate 
conditions for the PCR itself as well as for the efficient ligation of PCR products 
have been encounted by researchers during directed evolution experiments. 178 This 
makes the method very time-consuming and expensive. 
As an alternative, we used a commercially available mutator strain lacking DNA 
repair mechanism and called XL1-Red.'70"76  It has been demonstrated that if the 
clone of interest is propagated in XL1-Red in a high copy number plasmid (i.e., 
pBluescript, pUC-derived), over 30 generations of growth ( 2 hours needs to 
produce 1 generation), this will result in approximately one base change per 2000 
nucleotides. If the gene of interest is 2000bp in length, then on the average, every 
single isolate should have one point mutation. 
In addition, if the gene of interest is cloned in a lower copy number plasmid (i.g., 
pBR322, pACYC177), the XL1-Red strain can still be used in the manner described, 
except that the clone should be propagated in the mutator strain for additional 
generations to account for the lower relative gene dosage of the target sequence. The 
majority of obtained mutations were reported as transitions, but also some 
transversions and insertions occurred. 
The process of propagating a clone in the mutator strain makes it extremely easy and 
cost-effective to generate random mutations in a gene that does not have any 
selectable or screenable phenotype. Alternatively, if there is a genetic screen or 
colorimetric screen to monitor mutations, the mutator strain makes it very easy to 
isolate mutants of interest. 
A comparison of error-prone PCR and the mutator strain as mutagenesis tool is 
shown in §1.3.1.1; Table 1. 
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3.1. Production of libraries of plasmid mutants 
Two different approaches were used to produce a library of mutated plasmids. The 
first method involved producing a library of MAO-N mutants cloned in pMAO-N 
and 3-galactosidase mutants cloned into pUC18. The latter construct was used to 
establish the mutagenic efficiency of E. co/i XL1-Red mutator strain using this 
approach. This strain contains mutations in the mismatch repair pathway (mutS), in 
the oxo-dGTP repair pathway (mutT), and in the 3'-5' exonuclease subunit of DNA 
polymerase III (mutD). The mut D mutation is more relevant to genes cloned into a 
non-colE 1 derived vector which requires DNA polymerase III for replication. The 
PET 16b and pUCI8 vectors are colEl derivatives and require mostly DNA 
polymerase I for replication. To establish the rate of spontaneous mutagenesis by 
combined action of mutS, mutT and mutD deficiency, pUCI8 was used as a model. 
3.1.1. First method of making mutations 
Transformed cells were subjected to repeated over night growth with reinoculations. 
The published protocol200d was followed with some modifications (§9.1.2). The 
plasmid of interest (9. 1.1) was used to transform E. coil XL 1-Red competent cells 
(Stratagene, La Jolla, CA) using the manufacturer's protocol. The suspension of 
transformed cells was used to inoculate LB Amp 100 and the culture grown over 
night (18 hours) (Transformation 1). Approximately 12 generations of cells were 
produced (E. coil XL1-Red doubling time - 90 - 120 mm). 
After 12 generations of growth, the plasmid was purified (pMAO 1 and pUC 18.1 
libraries). 20p1 of this culture was then added to lOmi of fresh LB AmplOO media 
and subjected to another mutation cycle over 24 hours. From this sample a lml 
volume was centrifuged, the plasmids were isolated (pMA02 and pUC 18.2 
libraries). This mutation cycle was repeated to produce the library of mutants afierl2, 
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24, 36,48, 60, 72, 84 and 96 cells generations (pMAO1 - pMAO8 and pUC18. 1 - 
pUC 18.8 libraries). The detailed protocol of this method is described in §9.1.2. Some 
of the plasmid libraries were used to transform expression host and subjected to 
screening. 
3.1.2. Second method of making mutations 
The second method was developed to minimise the production of sibling mutants 
during amplification. Another reason was to avoid the rapid accumulation of 
mutations in the host genomic DNA which, can lead to the loss of genotype 
specificity and viability. 176,236 
The second method differed from the first method in that retransformation of the 
fresh mutator strain was undertaken every two cycles of growth. The detailed 
protocol of this method is described in §9.1.3. Plasmid pMA02 obtained in the first 
method was used to transform E. co/i XL 1-Red (Transformation II). The total 
transformed cell suspension was used to inoculate 20m1 LB Amp and grown for 24h. 
The plasmid was purified and named pMAOretrl. 1 library. The transformation II 
growing culture was used to inoculate LB Amp. The culture was grown for 24h, the 
plasmid purified (pMAOretrl .2 library) and used for Transformation III. The total 
transformed cell suspension was used to inoculate LB Amp, grown for 24h and the 
plasmid purified (pMAOretr2. 1 library). The transformation III growing culture was 
used to inoculate LB Amp, grown for 24h, the plasmid purified (pMAOretr2.2 
library) and used for Transformation IV. Total suspension of transformed cells was 
used to inoculate LB Amp, grown for 24h and the plasmid purified (pMAOretr3. 1 
library). The transformation IV growing culture was used to inoculate fresh 1 Oml LB 
Amp, grown for 24h and the plasmid purified (pMAOretr3.2 library). Each library 
was obtained after approximately 24 generations of growth of fresh cells. Some of 
the obtained plasmid DNA libraries (pMAOretr2 .2, pMAOretr3. 1, pMAOretr3 .2) 
were used to transform E. coil BL2 1 (DE3) cells to express mutated MAO genes and 
detect their activity towards the oxidation of L-ct-methylbenzylamine (L-AMBA). 
91 
Results and Discussion 
3.2. Determination of the mutagenic efficiency of the mutator strain 
Seven pUC18 plasmid libraries (pUC18. 1 - pUC18.7) obtained by the second 
mutagenesis method were subjected to white/blue colony screening (9.2. 1). The 
white colonies represented a lack of -galactosidase activity caused by mutation. 
Seven plasmid libraries (pUC18.1 - pUC18.7) were used to transform E. coil Top 10 
competent cells (Invitrogen) using the manufacturer's protocol with modification. 
As described in §9.2.1, the transformed cells were plated on LB Amp 100 agar 
supplemented with X-Gal (5-bromo-4-chloro-3 indolil3D-galactozide, substrate for 
3-galactosidase; §11.4). E. coil Top 10 cells do not require IPTG to induce 
expression from lac promoter. Using this method, approximately 2000 colonies per 
plate were obtained. 
The efficiency of the mutator strain to mutate pUC18 plasmid which has the same 
origin of replication as pETl6b, is clearly shown in Table 10. The frequency of 
inactivation of the 3-galactosidase a-fragment produced by pUC 18 was quantified 
by the number of white colonies per 1000 transformants. E. coil Top 10 cells 
transformed by non mutagenized pUC18 were used as a control. 
Generations number White colonies per 1000 colonies 
PUC18.1 	12 2 
PUC18.2 	24 8 
PUC18.3 	36 8 
PUCI8.4 	48 12 
PUC18.5 	60 10 
PUC18.6 	72 26 
PUC18.7 	96 26 
Table 10: the efficiency of E. coil XLI-Red mutator strain to inactivate 13-
galactosidase. 
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In conclusion, mutations in pUC 18 plasmid DNA, propagated for 96 generations in 
X1L1 -Red, were generated at a frequency of at least 2.6%. Given that the 3-gal a-
fragment is tolerant of significant structural perturbations, the actual mutation 
frequency, including conservative and silent mutations, could be much greater. This 
was not quantitated due to the other priorities of this work. 
3.3. 'Screening of the libraries of MAO-N mutants 
Two attempts were undertaken to screen libraries of the MAO-N mutants. The first 
attempt is referred to as "the scrubbed colonies screening". In this case the liquid 
phase whole cell biotransformation was performed on washed or scrubbed colonies 
from an entire plate prior to the solid phase assay. The second attempt is termed" the 
intact colonies screening". In this case the formation of solid phase insoluble product 
was performed directly on in situ colonies from an entire plate. 
3.3.1. The scrubbed colonies screening 
Schematically, this method can be presented as followed. The library of mutated 
plasmids is used to transform the expression host. The resulting colonies are washed 
or "scrubbed out" with LB medium and cultured in a shaking incubator. An aliquot 
of the pooled of whole cell cultures with expressed enzymes (some of them being 
amplified MAO-N mutants) is subjected for assay. If the pool contains amplified 
positive mutants, then the activity towards a substrate of interest can be detected. 
The plasmid DNA from this pooled positive whole cell culture is purified and used 
for retransformation and further screening either by solid phase colorimetric assay or 
by a moderate throughput assay as appropriate. Thus the "scrubbed colonies" assay 
can be applied as a high throughput screen even when a colonmetric assay is not 
available. 
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The diagram of this method is presented on figure 52. 
solid phase assay 
harvest colonies 	whole cell culture 	assay mix+ cell culture 
00 plasmid 
DNA 00 
00 	 mini prep, 
transformati7on 
GD 
Co 	 00 
3000 colonies per 	
00 00 	 OR 
plate 
*12x103 colonies for screening  
(GC/LC) MS. HPLC analysis 
Figure 52: "The scrubbed colonies screening". 
* also discussed in §4.1.2. 
pMAO1, pMA02, pMA03, MA08 (libraries produced by the first method) and 
pMAOretr3.1, pMAOretr3.2 (libraries produced by the second method) were 
subjected for the "scrubbed colonies screening" (8.4). Each library was used to 
transform the expression host E. coli BL21(DE3) using the manufacturer's protocol 
with some modification as described (8.4. 1). Each library was plated on either two 
or three plates with 2000-3000 colonies on each. Additionally two plates containing 
cells transformed with pMAO-N served as baseline activity and two plates with cells 
harbouring pET 16b served as the background activity reference or negative control. 
The colonies from each plate were washed out and subjected for assay as described 
in §8.4.2 in details. 
Fifteen library cultures, two MAO-N scrubbed colonies as positive control and two 
reference negative control cultures were cultured over night and the 0D600 was 
measured to confirm the identity of growth conditions. The 0D600 varied from 13 to 
7. The obtained cultures were assayed towards amylamine oxidation to confirm the 
enzyme expression. The average activity towards amylamine oxidation in the whole 
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cell cultures harbouring the mutated plasmid libraries and pMAO-N was 0.2 Uml' 
compared to "no activity" in the reference negative control. The whole pellet from 
1 ml aliquots of culture was used to detect enzyme activity towards D/L-AMBA 
oxidation (7.2.4; ii) and for plasmid purification. In order to do this, the frozen 
pellet was thawed and incubated with the chromogenic solution (8. 1.1) containing 
D-AMBA or L-AMBA. At the end of the incubation period the cell suspension was 















0 tail - ILI 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
plate number 
Figure 53: "Liquid phase" whole cell biotransformations performed on resuspended 
colonies from an entire plate. Blue line: L-AN'IBA as substrate, pink: D-AMBA. 
Plates number 8 and 14 are from wild type MAO-N. 
As shown in Figure 53, the oxidation of L-AMBA by the culture from plate 7 
(pMAOretr3 .2, plate 3, Abs5io = 0.80) was significantly different to the control 
platesl4 and 8 (Abs510  = 0.26 and 0.30 respectively). The OD600  value for culture 7 
was 7.0 and for the control cultures - 10.0 and 13.0. 
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The plasmid from culture 7 (pMA07a library) was purified and subjected to further 
screening using the "intact colonies solid phase assay". 
3.3.2. The intact colonies screening 
pMA07a (library from scrubbed colonies), pMAO1, pMA02 (libraries produced by 
first method), pMAOretr2.2, pMAOretr3.1, pMAOretr3 .2 (libraries produced by the 
second method) were subjected to solid phase screening using insoluble dye 
formation (8.3.1; §8.3.2; ii). Ten plates containing 2000-3000 colonies per plate 
were used to display the library(Figure 77,A). Positive clones were picked from the 
membrane and subjected to a second round of screening at low colony density (100-
200 colonies per plate; §3.3.4, §8.3.3, Figure 77,B) to confirm activity. Plasmid 
DNA from the positive clone was isolated and used to confirm the enantioselectivity 
(Figure 77, C&D) 
3.3.3. Identification of positive clones 








MA07a 25 11 1 
MAO1 2 2 0.08 
MA02 1 1 0.04 
pMAOretr2.2 11 3 0.44 
pMAOretr3. 1 26 11 1.04 
PMAOretr3.2 36 9 1.44 
Table 11: identification of positive clones from the libraries. 
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3.3.4. Second screening of the libraries 
The positive clones obtained from the first round screening were subjected to a 
second library screen (8.3.3). In order to do that, E. coli BL21(DE3) was 
transformed by plasmid purified from the positive clone, obtained after the first 
screen. The transformed cells were transferred onto a membrane using a sterile loop 
(Figure 54; A) or by a spreading cell suspension onto the plate (approximately 100 
colonies per plate) (Figure 54; B). 
IC 
Figure 54: two different approaches for second round screening. Transferring 
positive colonies via: (A)-a loop; (B)-plate spreading. ( *indicates a negative control 
(pMAO-N as the reference). 
The first approach (Figure 54; A) was more economical because it allowed plating of 
three samples and one control cell cultures onto one membrane (2 per membrane). 
Also, the presence of the control colonies together with sample ones on the same 
membrane allowed maintenance of the colonies under the same conditions during the 
assay. This was extremely beneficial to visualisation of the difference between the 
selected colonies. 
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Positive clones were picked from the membrane under the solid agarose using a 
yellow pipette tip and were subjected to a liquid phase whole cell assay with AA and 
D-,L-AMIBA (7.2.4; i,ii) using the chromogenic solution (8.1.1). 
4. 	Results and Discussion: Validation of positive clones 
4.1. Validation of positive clones obtained from the "scrubbed 
colonies" screening 
Six positive clones were selected after the second screening of the MA07a library by 
the solid phase assay. All of them were subjected to further studies. 
4.1.1. Validation of activity of positive clones in whole cell culture 
Plasmid DNA from the clones was purified and used to transform E. coil 
BL21(DE3). Protein expression was performed in small scale (lOml) cultures 
(§7.2.2; i). A MAO-N wild type culture and the reference culture (BL2 I (DE3) 
transformed with pET 1 6b) were grown at the same time. The reference culture was 
used to subtract the signal due to any background reaction. 
The whole frozen/thawed cell pellet from the 1 ml culture was used to perform a 
liquid phase assay with L-AMBA and D-AMBA as the substrates (7.2.4; ii) for 96 
hours, to confirm the positive nature of the clones. A 100 .tl aliquot of the 
frozen/thawed pellet suspension (7.2.4; i) was used to measure the initial rate of 
activity towards amylamine to detect the level of enzyme expression. 
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The activity of the mutants towards amylamine was comparable with the MAO-N 
wild type enzyme, although the activity towards L-AMBA was much higher. This 
observation supported the positive nature of the picked mutants (Figure 55). The 
activity towards D-AMBA also appeared to be higher, but the possibility of an 
artefactual result is high when measuring a low absorption reading. Moreover, the 
determination of enzyme activity in a whole cell is not a precise method at very low 












Figure 55: activity in whole cell culture of the six positive clones identified from 
MA07a library screening. Blue line: L-AIMBA as substrate; pink: D-AMBA; clone 7 
is the MAO-N wild type control sample. 
4.1.2. Validation of positive clones by sequencing 
The MWG-BIOTECH facilities were used to perform sequencing reactions. The 
plasmids were prepared according to the MWG-BIOTECH requirement and provided 
together with forward (pETFor), reverse (pETRev) and internal (Int2) 
oligonucleotide primers (§10-1; § 10.1.1; § 10.1.2) .The sequencing analysis revealed 
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the same mutation in all six clones. Glycine (G) at position 403 had been replaced by 
glutamic acid (E) by changing the codon from GQG to GAG. The sequencing result 
(4.2.4) also revealed the clone with this mutation (G403E) in the pMAOretr3.2 
library, which was screened by "intact colonies screening" (3.3.2). 
The fact that all six positive clones had the same mutation indicated that the original 
increase in activity detected in the whole cell assay of scrubbed colonies was not an 
artefact. The occurrence of positive clones was one per 1000 colonies due to the 
original mutant clone amplification. This result suggests that the scrubbed colonies 
assay might be an alternative approach to "intact colonies" assay when the 
colorimetric screen is not available (Figure 52). 
The "scrubbed colonies" method is more labour intensive compared to the 
colorimetric "intact colonies" assay, however it should be noted that this method 
required the manual screening of only 1000-2000 colonies to obtain a variant with 
desired property. 
4.1.3. Validation of positive clones by purification studies 
The protein of MAO-N mutant G403E was purified to homogeneity using metal 
chelating affinity chromatography (10.4.1). The mechanism of protein affinity to 
the nickel chelating resin is described in §4.2.6.2. MAO-N wild type protein was 
purified at the same time. 
The G403E MAO-N mutant was purified at a concentration of 0.14 mg/ml and 
MAO-N wild type at 0.10 mg/ml. 10 jil and 100 p.1 samples of the purified oxidases 
were subjected to the liquid phase soluble dye formation assay (§ 8.1.1) with 
amylamine (AA) and with L-AMBA respectively (Table 12). 
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Measured parameters 
AA; L-AMBA; L-AMBA; D-AMBA; Activity ratio 
Purified Purified Purified Purified (L -AMBA over 
protein; protein; protein; protein; D-AIvIBA) 
Sample Specific 5580mm Specific Specific 
activity incubation activity activity 
((J/m)g (A U510, (U/mg) (U/mg) 
reading) 
MAO-Nwild 4.5 1.3 7.2xl004  4.4x10 5  16 
type 
thMA07a 4.0 3.6 1.6 x 10 1.5 x i0 106 
Table 12: activity studies on partially purified mMA07a mutant. 
The activity towards amylamine was found to be unaffected, but the specific activity 
towards L-AMBA was increased approximately in 2.2 fold and was in agreement 
with the data obtained on whole cell culture (4. 1.1). Interestingly, the selectivity for 
L-versus D-AMBA was increased from Ca. 16 to 106. The increase was due both to 
an increase in activity for the L-enantiomer and a decrease for the D-enantiomer. 
The data in Table 12 allow assignment of this mutation as a "hot spot" and one 
which might affect the active site of the enzyme. 
4.2. Validation of positive clones obtained by intact colonies 
screening 
18 positive clones were selected after the second screening of pMAO 1, pMA02, 
pMAOretr2. 2, pMAOretr3. 1, pMAOretr3 .2 libraries and subjected to the liquid 
phase soluble dye formation assay to confirm the positive nature of clones. 
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4.2.1 Validation of the activity of the positive clones in the whole cell 
culture 
The small scale expression of the enzyme from each positive colony was performed 
(7.2.2; i). The expression host transformed by MAO-N was cultured at the same 
time and served as a control. The activity assay towards amylamine (8.1 .1) was 
performed in whole cell culture (7.2.4; i) to confirm the efficiency of protein 
expression. 
The assay towards L-AMBA and D-AMBA (8. 1.1) in whole cell culture (7.2.4; ii) 
was performed to confirm the positive activity of the isolated clones. The initial rate 
of reaction with amylamine was measured over 3 minutes and the OD510 was read 
after 96 hours incubation to find the activity towards L- and D-AMBA. 
The results from the whole cell culture assay led to the identification of clones with 
improved activity towards L-AMBA compared to the wild type enzyme (Figure 56). 
Some clones also possessed increased activity towards amylamine. However two 
(identical) clones were clearly superior in terms of their selectivity and activity 
towards L-versus D-AIMBA. 
The activity of this "best" mutant against amylamine was significantly lower ('-10 
fold) compared to the wild type clone. This observation suggested that this mutant 
might possess interesting properties in terms of substrate specificity and improved 
enantioselectivity. 
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E 20 	 D-AMBA 
15 - 	 []AA rate/sec 
<10- 	 DUD 
Mutant number (number 9 & 18 are MAO-N 
wild type) 
Figure 56: whole cell activity of the mutant clones identified by screening of intact 
(in situ) colonies. Blue line: L-AMBA as substrate, pink; D-AMBA, yellow, AA, 
light blue, ratio of activity towards L-versus D-AMBA. The data for L&D-AMBA 
oxidation was obtained by static absorption data measurement. The data for 
amylamine (AA) was measured as initial rate of oxidation reaction (v (AA) 
10-3S-1), 
4.2.2. Determination of protein expression 
Examination of the polyacrylamide gels (7.2.5) showed that several of 24 positive 
clones appeared to be "expression" mutants: mutant 1 (clone 11 of pMA07a library), 
mutant 4 (clone 6 of pMAOretr3. 1 library), mutant 6 (clone 1 of pMAO 1 library), 
mutant 14 (clone 2 of pMAOretr2.2 library), mutant 22 (clone 7 of pMAOretr3.2 
library), mutant 23 (clone 7 from library pMAOretr3. 1), mutant 24 (clone 11 from 
pMAOretr3. 1) and mutant 25 (clone 9 from library pMAOretr3. 1). The "expression" 
nature of these mutants was evidenced as increased levels of MAO-N protein 
expression (Figure 57). All of the "expression" mutants possessed increased level of 
activity towards AA when examined in whole cell culture. However, mutant 19 (the 
"best" mutant) (clone 10 from library pMAOretr3. 1; Figure 57, entries 5&6 on a gel 
A and 3,4&10 on a gel B; Figure 56,entry 19) appeared not to have an increased 
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level of protein expression, suggesting that the mutation had affected the specific 
activity of the enzyme. 
The high levels of protein expression in "expression" mutant clones could be due to a 
number of reasons: 
(i) 	plasmid copy number mutants that have a higher gene dosage of the MAO-N 
wild type; 
structural gene mutants which increase transcription/translation efficiency; 
mutants in the gene regulatory signals for MAO-N activity that result in a 
greater quantity of the wild type MAO-N. 
Gel A order 
1 	2 	3-IS 	67 	89 Ili 11l213I4l6 	1118 	 1 -protein marker 
2 -131,2I pETI6b 
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Gel B order 
Wa 
1 	2 3 	4 	5 6 	7 5 	9 	lit 	Il 12 	13 	14 	15 16 	17 
1_BL21(DE3)pETl6b 
2-MAO-N wild type 
175 	\ 3-MAO mut best small scale 
83 4 -MAO mut best large scale 
62 .. 
5 protein marker 
6pMAOretr2.2.2 mut 14 - 	... 
7 pM.AOretr2 2 3 mut 15 
47 8 -pMAOI.2 rout 16 
. 9-pMAO7a.2 mut l7 
l0pMAOretr3.1.10 rout l9 
11-pMAOretr3.1.8 rout 20 
25 12MAOretr3.2.2 mut 21 
13-pMAOretr3.2.1 mut 22 





B 17-pMAOretr 2.2.lmut 26 
Fugure 57: SDS PAGE examination of the obtained mutants. Arrows point the band 












4-MAO-N wild type 
5 - MAO mut best small prep 
6 - MAO mut best large prep 
7-pMA07a.1 1 mut 1 
8 - pMA07a. 7 mut 2 
9-pMA07a.5 rout  
10pMAOretr3.1.6 rout 4 
11 -pMAOretr 3.1.5 mut 5 
l2pMAO1.1 mut 6 
pMAOretx3.1.1 mutl 
pMA02 mut 8 
15 -pMAOretr 3.1.2 mut 10 
16 -pMAOretr 3.2.6 mut II 
17 -pMA07a.10 mut 12 
18 -pMA07a. 6 mut 13 
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To distinguish among these possibilities, the DNA of these "expression" mutants was 
either analysed by agarose gel electrophoresis, stained with ethidium bromide, or 
subjected to the subcloning procedure described below (4.2.3). 
4.2.3 Validation of "expression mutants" by DNA manipulation 
Some of the "expression" mutant clones (Figure 57) were chosen for further DNA 
examination by restriction digests: mutant 1, entry 7, gel A; mutant 4, entry 10, gel 
A; mutant 6, entry 12, gel A; mutant 14, entry 6, gel B; mutant 22, entry 13, gel B; 
mutant 24, entry 15, gel B; mutant 25, entry 16, gel B. 
Plasmid DNAs harbouring the MAO-N "expression" mutant genes were isolated and 
treated by restriction digest with restriction enzymes NdeI and BamHl (10.2. 1) 
which are the restriction sites flanking MAO-N pETl6b (7.2. 1). 
The digested samples were examined by agarose gel electrophoresis. Mutant 1 
(MA07a library, clone 11; Figure 58, entries 6&7 ) was found to have the same 
quantity of plasmid DNA compared to the wild type (Figure 58, entries 2-5). 
This observation suggests that the increased level of protein expression was due to a 
mutation either within the structural gene or the genetic control region that results in 
the over expression of the native protein. The other mutants possessed more intense 
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Sample order 
1-1kb DNA ladder 
2-5-mao-n wild type 
6,7-mut 1 
8,9-mut4 
10,11- mut 6 
12,13-mut 14 
14,15-mut22 
16- 1kb DNA ladder 
17,18-mut24 
19,20inut 25 
Figure 58: plasmid DNA analysis of "expression" mutants. (5.7kb-pET16b)-
1.5kb-mao-n). 
To identify which parts of the plasmid might contribute to the increased MAO-N 
expression level, a further subcloning procedure was undertaken. The vector portion 
of the mutated plasmids (Figure 58) was purified from the agarose gel. Wild type 
mao-n served as the insert to clone into the vector part of the mutants. If the increase 
in the mutant activity was due to the plasmid copy number, the total activity of 
MAO-N in whole cell culture should also increase. 
Plasmid pMAO-N was purified to yield 1 15p.g (OD2601.0 corresponds to 
approximately 50pgmr1 of DNA)237  and the purity of the plasmid was determined 
by measuring the ratio of absorption reading at 260 nm versus 280 nm. These data 
provide an estimate of the purity of DNA. Pure preparation of DNA has an 
0D260/0D280  value of 1.8. If there is contamination with protein or phenol, the ratio 
will be reduced and an accurate quantification of the amount of DNA is not 
possible 7. The purified pMAO-N had an OD260/OD280 value of 1.7. 
pMAO-N was digested by Nde 1 and BamHl to separate the wild type mao-n gene 
from the vector and clone it into the vectors derived from the" expression" mutants 
(§ 10.2.2). 
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The following recombinants were obtained: pMAOrecl (MAO-N wild type cloned in 
vector of mutant 1), pMAOrec4 (MAO-N wild type cloned into the vector of mutant 
4), pMAOrec6, pMAOrecl4, pMAOrec22, pMAOrec24, pMAOrec25 were obtained 
on the same manner. In each case, a single recombinant colony was used to perform 
the small scale expression of the enzyme (7.2.2; i). At the end of induction the 
enzyme activity in whole cell culture towards AA was measured (7.2.4; 1). Two 
cultures of each recombinant and each "expression" mutant were grown at the same 
time to minimize results due to artifact. Two cultures of MAO-N wild type served as 







Figure 59: MAO-N activity in whole cell towards AA. Blue bars: MAO-N wild type 
cloned in "expression" mutant vector, red bars: "expression" mutants. C- MAO-N 
wild type. 
The activity of the MAO-N cloned into the vectors derived from "expression 
mutants" was close to MAO-N wild type. This result suggested that the "expression" 
mutant's vectors were not affected by the mutator strain and that increasing level of 
the protein expression was due to mutations in the structural gene. This was 
supported by SDS PAGE examination of MAO-N cloned into "expression mutant" 
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vectors (7.2.5) which showed no increase in the level of protein expression 
compared to MAO-N wild type (Figure 60). 













5. 6 -pMAOrecl 




15, 16- pMAOrec24 
17, 18- pMAOrec25 
Figure 60: SDS PAGE examination of MAO-N expression level driven by vectors 
obtained from "expression" mutants. The arrow points to the band of interest. pMAOrecl - 
MAO-N wild type cloned in vector of mutant 1, pMAOrec4 - MAO-N wild type cloned in vector of 
mutant 4; pMAOrec6 - MAO-N wild type cloned in vector of mutant 6, pMAOrecl4 - MAO-N wild 
type cloned in vector of mutant 14, pMAOrec22 - MAO-N wild type cloned in vector of mutant 22; 
pMAOrec24 - MAO-N wild type cloned in vector of mutant 24; pMAOrec25 - MAO-N wild type 
cloned in vector of mutant 25. 
The overall strategy used to study the "expression" mutants is schematically 
represented on Figure 61. 
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Figure 61: cloning, SDS PAGE examination and activity studies on MAO-N 
"expression" mutants. 
The described DNA manipulation studies revealed that the plasmid bearing mao-n in 
the vectors chosen "expression" mutants were not involved in the over expression of 
protein and are not a subject for further studies. 
4.2.4. Identification of positive clones by DNA sequencing 
The mao-n gene DNA from the l 5 isolated mutants was subjected for sequencing 
studies. The MWG-BIOTECH facilities were used to perform the sequencing 
reactions. The plasmids were prepared according to the MWG-BIOTECH 
requirement and provided together with forward (pETFor), reverse (pETRev) and 
internal (Int2) primers (10.1; §10.1.1; §10.1.2). The results of the sequencing 
analysis are in Table 13. 
The sequencing results revealed that all of the "expression" mutants (4, 6, 22, 24 and 
25) had the same mutation at position 260 wherein arginine was replaced by lysine. 
The MAO-N amino acid sequence has two arginines at positions 259 and 260. They 
are both encoded by codon (AGO) which has a low occurrence in E. coil genes (4%) 
The introduction of lysine instead of arginine in the MAO-N sequence does not 
change the charge of the protein but results in replacementof the low frequency 
codon for Arg AGO to the codon for Lys AAG (22 %). We concluded that this codon 
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change is preferential for higher protein expression in E. co/i and decided to apply 
this mutation to achieve greater expression of the MAO-N wild type enzyme (5. 1). 
The sequencing results also revealed the clone with a G403E mutation in 
pMAOretr3.2 library (mutant 11). This mutation is the same as that found in the 
pMAOretr3.2 library by sequencing of the "scrubbed colonies" (4.1.2) lending 
further support to the efficiency of the latter method. 
Library name Mutant name Number 
of mutant 
Genotype of the 
mutant 
pMAOI MAOI.2 16 
pMAOI MAO!.! 6 ROK(agg/aag) 
pMAO2 MA02 
8 19V(gcg/g(g) 
pMAOretr2.2 MAO2.2.1 26 ()5Aga1/gct) 
pMAOretr3. I MA03. 1.6 4 
)Kagg/aig) 
pMAOretr3.1 MAOS.l.l 7 NP37R(atg/aggh 
pMAOretr3 I MA03.1.2 10 D5Ggaii 	
t 
pMAOretr3.1 A03. 1.5 5 45 I 	(ggt/agl) 
pMAOretr3. I A03. 1.8 20 6451 S(ggl/agt) 
k494C(cgt/1t) 
pMAOretrS.I MAO' .1.9 25 R2(1)K( agg/aag) 
pMAOretr3.! MAO3. 1.11 24 R2601cuigg!aag) 
pM.AOretr3.I 'IAOimitbest 19 NoS(aat/agt) 
pMAOretr3.2 MA03.2.6 11 (4-IOSE(ggg/gag). 
pMAOretr3.2 M.A03.2.7 22 R2(Ok(agg/Ia} 
pMA0retr3 2 MA03.2.2 21 Li-5K(gag/aa) 
Table 13: the mutations identified by sequencing studies. 
Among the 15 sequenced clones, five mutants had the same mutation (R260K) and 
two had mutation D385G. These two mutations were introduced by the mutator 
strain after the first 18 generations (mutant 16, clone 2 from library pMAO 1 and 
mutant 6, clone I from library pMA01; Table 13) and then were amplified after 
110 
Results and Discussion 
sequential transformations (mutants 4, 25, 24, 22 -R260K and mutant 10 - D385G). 
The other 8 sequenced mutants were produced throughout retransformations and 
revealed a great diversity of mutations (Table 14). 
Wucleolkic changed Mzitatwn name 
D3 85G((:Fat/gt) Transition 
R260K(agIa g) Transition 
A289V(gcg/gi g) Transition 
D3 85A((Yat/gct) Transversion 
M33 7R( atgla g), Transversion 




E 145K(gag/aag) Transition 
Table 14: nature of mutations produced by the mutator strain 
The frequency and quality of mutations produced by the mutator strain is in 
agreement with published results. 
176,238 Approximately 1.2 mutations were produced 
per lSOObp gene after 12-24 generations of the mutator strain. Among 10 point 
mutations, transitions (80%) predominated over transversions (20%). The frequency 
of individual transitions was 30% for A - G, 40%, G —A. 201/6  C —*T. There was 
one A —C and T —*G transversion and no G —>T, C— G or G —C transversions. 
There were no insertions and deletions (Table 14). 
Mutant 19, which produced the most intensely coloured colony in the solid phase 
assay screening and exhibited the highest activity in whole cell culture (Figure 56), 
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was named the MAOmut"best". This clone possessed a mutation at position 336 
wherein asparagine had been replaced by serine. 
4.2.5. Validation of MAOmut"best" 
4.2.5.1. Validation of MAOmut"best" by site directed mutagenesis at position 336 
To confirm the importance of the of Asn336Ser mutation, a site directed mutagenesis 
experiment was undertaken. The genes encoding for MAO-N wild type and 
MAOmut"best" were amplified by PCR using the external MAO For and MAO Rev 
primers (7.2.1.1). 
The internal primers MAOSer For and MAOSer Rev were designed to introduce 
serine at position 336 in the MAO-N wild type sequence. MAOmutAsn For and 
MAOmutAsn Rev were designed to introduce asparagine at position 336 in the 
MAOmut"best" sequence (§ 10.3.1.1). 
1\lAOInnrhesl"ASfl336 
A 	 B 
MAO-N 	MAO-N wild type 
chimei 
C 	 D 
Figure 62: solid phase assay screening of MAO-N wild type (N336), 
MAOmut"best"(S336) and their chimeras towards L-AMBA oxidation. 
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The introduction of the mutation was undertaken by serial PCR reactions 
(10.3. 1.2). Recombined genes were NdeIlBamHI digested, ligated into pETl6b 
(10.3.1.3) and transformed into E. coil Top 10. 4 colonies from each ligation were 
chosen for plasmid DNA purification followed by transformation into K coil 
BL2 1 (DE3). The cells were plated on nitrocellulose membranes and subjected to 
solid phase screening to evaluate the resulting chimeras (Figure 62). The positive 
clones were sequenced to confirm the results of the site directed mutagenesis 
(1O.1). 
The clone with the replacement of asparagine at position 336 to aspartate was 
produced accidentally and possessed lower activity towards AA compared to MAO-
N wild type, and no activity towards L-AMBA. This clone (N336D) was also 
sequenced. Sequencing analysis revealed aspartic acid at position 336 in this clone, 
further confirming that position 336 is essential for the catalytic properties of MAO- 
10 
4.2.5.2. Confirmation of significance of N336S mutation by subcloning 
To establish that the vector part of the plasmid pMAOmut"best" was not mutated by 
the mutator strain, the following additional subcloning procedure was undertaken. 
The c-DNA sequence encoding the amino acid at position 336 is located between 
Nod and MunI restriction endonuclease sites. These restriction sites are unique in the 
mao-n sequence and not present in the pET 16b sequence. Plasmid DNAs encoding 
MAO-N wild type and MAOmut"best" were therefore treated with MunJINotI 
restriction enzymes and crossover religated (§ 10.3.3). Ligation mixtures were used to 
transform E. coil BL21(DE3). The cells were plated onto nitrocellulose membrane 
and the desired constructs were obtained by solid phase screening. Positive clones 
were subjected to further study for determination of enzyme activity. 
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4.25.3. Activity studies on the site-directed MAO mutants and cloning chimeras 
at position 336 
The site-directed mutants and cloning chimeras were subjected to small scale 
expression (7.2.2; i) and assayed towards amylamine (7.2.4; i) and L-Av1BA 
(7.2.4; ii) oxidation (Table 15). The activity against AA and L-AMBA was 
measured as an initial rate reading at ?=5 1 Onm. The data confirmed that the vector 
did not affect the activity of the MAOmut"best" towards L-AMBA but rather that the 
Asn336Ser mutation was the important one. 
The presence of Asp at position 336 resulted in approximately a 10 fold decrease in 
activity towards amylamine and also the total absence of activity towards L-AMBA 
(Figure 63). The latter data confirmed the significance of the specific amino acid 
position 336 to the MAO-N phenotype. 
MAO-N wild d type 	 MAO N336D mutant 
A 	 B 
Figure 63: solid phase assay screening of MAO-N wild type (A) and MAO N336D 
mutant (B) towards L-AMBA oxidation. 
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Enzyme Amylamine (AA sec' 	510,,) L-AMBA 
(LL4 ,sec' .a 510n,g) 
MAO-N wild type (N336) 2.8 x lO as MAO-N wild type 
MAOmut"best" (S336) 7 x 4,8 x 10 
MAOmut"best" per chimera 20 	I0 a 	MAO-N \\ld 
t\pc 
(S336 replaced to N) 
MAO WT per chimera(N336 H 7 	lft 
replaced to S336) 
Muni/NotI MAOmut"best" 2. I 	I (Y as MAO-N wild type 
chimera (S336 replaced to 
N336) 
Muni/NotI MAO-N WT I 7 	I 
chimera (N336 replaced to 
S336)) 
MAO-N WT per 1.4 x 10 No activity 
chimera(N336 replaced to 
D336) I 
Table 15: characterisation of MAOmut"best" by measurement of enzyme activity in 
whole cell culture. The data in blue denotes that the activity corresponds to the level 
of wild type activity; in red the activity corresponds to the level of MAOmut"best" 
activity; in black the activity which differs form both MAO wild type and 
MAOmut"best"; 
4.2.5.4. 	Mutagenesis at position 348 
DNA sequencing of all the mutants, randomly obtained by using the mutator strain, 
revealed four differences in the amino acid sequence compared to the published 
sequence (e.g.. Schilling et al. 
129 reported alanine at position 300 but valine was 
observed; L304 - published, V304 - observed; K348 - published, M 348 - observed 
and R450 - published, G 450 - observed). Two of these differences (K348M and 
R450G) had previously been noted by Sablin et al.57, but had been missed by the 
author of the present thesis, so that K348M was initially considered as a "mutation" 
produced by the mutator strain. To investigate the significance of this change a 
mutant was constructed in which methionine at position 348 in the MAOmut"best" 
was reverted back to lysine. The gene encoding MAOmut"best" was amplified by 
PCR using the external MAOFor and MAORev primers (7.2. 1.1). 
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The internal primers MAOmutLys348FOR and MAOmutLy5348REV were designed 
to introduce lysine at position 348 in the MAOmut"best" sequence (10.3.2. 1). The 
introduction of this mutation was undertaken as described in § 10.3.2.2. The 
recombined gene was NdeI/BamHI digested, ligated into pET 16b (10.3.1.3) and 
used to transform E. coil Top 10. 4 colonies were chosen for plasmid DNA 
purification followed by transformation in E. coil BL21(DE3). The cells were plated 
on nitrocellulose membrane and subjected to solid phase screening. The resulting 
chimeras were identified by solid phase assay as described in §4.2.5.1 
(MAOmut"best" and MAO-N wild type were used as the controls). The presence of 
the double mutation (N336S and K348M) was confirmed by sequencing (10.1). 
The activity of one clone towards L-AMBA was clearly greater than 
MAOmut"best". A single colony of that clone was used to express the protein in 
medium scale culture (7.2.2; ii) to determine the specific activity of a cell-free 
extract (7.2.3; i) towards AA and L-AMBA by using the chromagenic solution 
(8.1. 1).  MAOmut"best" and MAO-N WT were grown and purified under identical 
conditions (Table 16). 
Enzyme (CFE) 
Protein Specific activity (U/mg)11 
(Mg/ml) Amylamine L-iEA 
MAO-N WT 5.0 0.30o ND 
MAOmut"best" 5.0 0.06 3.0 x 
LAOmutN336S, 
M348K 
7.0 0.05 4.0 x 10 
Table 16: specific activities of MAO-N WT and mutants at position 336 and 348. 
(ND* not determined) 
The data in Table 16 show that the double mutant produced higher specific activity 
(1.3 fold) towards LAIMBA then MAOmut"best". 
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4.2.6. Purification and characterisation of mutant enzymes 
4.2.6.1. 	Purification of MAOmut"best" 
Both the wild type and MAOmut"best" enzymes were purified from E. coil 
BL2I(DE3) harbouring pMAON or pMAOmut"best plasmid. E. coil is a known 
producer of Type I monoamine oxidase which was reviewed in §2.3.2. In order to 
eliminate possible interference from this endogenous enzyme, the CFE of a reference 
culture (E. coil BL21(DE3) harbouring pET 16b was subjected to liquid 
chromatography purification at the same time. The reported protocol57 was used for 
purification, but a ResourceQ column was used instead of a DEAE-sepharose 
(10.4.2). Using this method the E. co/i monoamine oxidase can be removed at the 
first stage of purification. 57  Purification of three CFE' s was performed on the same 
day. The efficiency of purification of the two MAO enzymes was determined by 
measuring the specific activity of eluted samples towards amylamine (§ 10.4.4.1; 
Table 17). The highest activity was found in fractions 15 and 16 with MAO-N and 
MAOmut"best". There was no activity detected in fraction 15 and 16 with protein 
from the reference culture (Figure 64). 
Stage Protein AA Yield 
b Fold a 
(mg/mi) (Umg') (%) purification 
MAO-N CFE 7.0 0.40 100 1 
L Resource Q 0.4 7.0 45 16 
MAOmut"bes CFE 9.0 0.02 100 1 
t" Resource Q 0.60 0.90 90 47 
Reference CFE 2.0 0 - - 
Resource Q 0.03 0 - - 
Tablel7: efficiency of purification of MAO enzymes using anion exchange 
chromatography. U = p.mol of amylamine oxidised per minute (8. 1.1). 
aData corresponds to the most active fraction.' Data corresponds to the two most 
active fractions. 
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Figure 64: elution profiles of MAO-N from Resource Q column. 
(\)-MAO-N wild type, (B) protein pool of reference culture (E. co/i BL2 1 (DE3) 
transformed by pET 16b) and (( )_MAOmut"best"(N336S). Arrows point the elution 
peak of MAO-N and MAOmut"best". 
The active fractions (15 & 16) were also analysed by SDS PAGE. SDS PAGE 
analysis showed a high concentration of MAO-N and MAOmut"best" in the purified 
active fractions at about 10% purity and the absence of a 70 kDa endogenous AO in 
any of preparations (Figure 65). Neither MAO-N protein nor endogenous AO were 
observed in the reference culture. 
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1234567 
kDa 1) MAOmut"best" fraction 16 
-175 
2 MAOmut"best" fraction 15 
-93 MAO-N wild type fraction 16 
—62 MAO-N wild type fraction 15 
IlP1 -47.5 
BL2I(DE3) [pET16b] fraction 16 
-32.5 
BL21(DE3) [pET16b] fraction 15 
-25  
- 16.5 molecular weight marker 
MW(MAO-N) = 55.5kDa 
Figure 65: SDS PAGE analysis of purified extracts (fractions 15&16) on Q-
sepharose column. 
Values of turnover numbers, kcat, were measured per mol of flavoprotein subunit 
(10.4.4.2; Table 18). The molar concentration of protein appeared to be 5 .tM 
(50nM applied for assay) for MAO wild type and 7.2 tM (72nM applied for assay.) 
for MAOmut"best". 
Values for KM were measured for AA and L-AMBA as substrates. To determine 
KM 
for MAOmut"best", activities were measured by determination of formation of H202 
(8.1.1) at different substrate concentrations (from lSnMto 10mM; §10.4.4.2). 
The activity studies data is presented in Table 18. 
Substrate MAO-N Wild type MAOmut"best" 
kcat(min') Km(MM) kcat(min'Y 
L-AA ND 0.171  0.4 
L DAA ND 0.0 ND 0.081 
benzylamine 
Ø•3** 
370 ND 196 
0.25 * 1000 0.4 116 L__AA 
Table 18: KM kcat values for MAO-N wild type and MAOmut"best" using different 
substrates. * ND--not determined; "Published result57 . k was obtained by measuring the initial 
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rate of oxidation to calculate the value for V, and protein concentration was obtained from molar 
extinction coefficient of FAD. k was obtained from V.ax  calculated from measuring Abs 510m at 
the end point of 24h oxidation assuming linearity of reaction, protein concentration was obtained from 
molar extinction coefficient of FAD. 
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Figure 66: measurement of KM and k 1  for MAOmut"best". 
k,,t is the catalytic constant of an enzyme and reflects the number of enzymatic 
reactions (turnovers) that each active site catalyses per unit time: kcat = Vmax / [EI1Z] 
Vmax 
is the maximum velocity of a reaction, which occurs at high substrate 
concentration when the enzyme is saturated and [Enz]- molar enzyme concentration. 
The Michaelis constant KM is the substrate concentration at which the reaction 
velocity is half maximum. 
The eluted protein fraction from the reference culture did not show any activity 
towards the range of studied substrates. The data revealed that the activity of the 
MAOmut"best'towards L-AMBA (k 0t 8.0 min) was 47-fold higher than the wild 
type enzyme (k 0 0. 17 min-'). Moreover, the selectivity of the mutant for the L 
enantiomer versus D-AMBA (100:1) had also increased (5.8-fold) relative to the 
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wild-type enzyme (17:1). Thus, the outcome of the directed evolution experiments 
had been to simultaneously improve both the enantioselectivity and catalytic activity 
of the enzyme. For comparison, the activity towards the best substrate for the wild 
type, namely amylamine, and also benzylamine, is also presented. 
4.2.6.2. 	Purification  and characterisation of other mutants 
The following mutant enzymes, presented in Table 13: number 4(R260K), 5 
(G45 1 S), 7(M337R), 8(A289V), 1 O(D385G), 11 (G403E), 1 9(N336S; 
MAOmut"best"), 20(G45 1 S;R494C), 21(E145K), 26(D385A), were subjected to 
purification by metal affinity chromatography as well as double mutant 
MAOmutN336S/ M348K, and MAO-N WT (1O.4. 1). The procedure exploits the 
fact that many transition metal ions, e.g. zinc, nickel and copper, can coordinate to 
the amino acids histidine, cysteine, and tryptophan via Lewis basic groups on their 
respective amino acid side chains. In order to do so, the metal ion is first immobilised 
onto the chromatographic matrix and protein binding occurs at ph>7.0 to ensure that 
the amino groups are not protonated. 
The high concentration of salt in the loading buffer prevents any ion-exchange effect. 
Elution of the protein can then be achieved by a decreasing pH gradient, which 
results in protonation of the metal binding group. An alternative elution protocol, 
which was employed here, involves the use of a competitive ligand (e.g. elution with 
an increasing concentration of imidazole). 
The first attempt to express protein in medium scale culture (7.2.2; ii) failed and we 
turned to the protocol for protein expression in large-scale culture (7.2.2; iii). The 
protein expression was detected (7.2.4; i, §8.1.1) and the bio-mass obtained 
(§ 7.2.2, iv) was subjected to purification (10.4.1.1). 
Such a difference in expression level was due to the procedure of inoculation of the 
(Ca. OD600nm=1 .0) rather then by a single colony in the case of the medium scale. 
The protein expression also suffered when the starting culture was used at stationary 
phase. This dependence of protein expression level on the age of a starting culture 
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could be explained by the presence of 13-1actamase at the late stage of growth. The 
absence of antibiotic selection could lead to the large population of cells which are 
not able to express the protein of interest. 
The eluted samples were diluted with 25mM Tris HCl pH 7.8 to lower the imidazole 
concentration to 75mM, in order to reduce the effect on enzyme activity. The diluted 
samples were concentrated using a 50K Vivaspin (2m1) filtration unit, stored over 
night on ice at 4°C, and then subjected to SDS PAGE analysis (Figure 67) and 
activity studies. 
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13- mut 26 (D385A) 
Figure 67: SDS PAGE of MAO and MAO variants purified by Ni affinity 
chromatography. All protein samples were purified at the same day to maintain the similarity of 
enzymes condition prior obtaining the activity data. 
Protein concentration was determined by Bradford assay (10.4.3) and the molar 
concentration of the enzyme was calculated from the flavin extinction coefficient and 
absorption measured at 458nm (10.4.4.2). The activity towards AA was measured 
under standard conditions (8. 1.1) to establish the starting level of enzyme activity. 
The kcat towards AA was calculated as described in § 10.4.4.2. Specific activity was 
calculated as the amount of .imol (U) of substrate oxidised per minute and per 
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milligram of protein (10.4.4.1). The volumetric activity (Umt1) was measured to 
reflect the amount of protein contributing to the activity (Table 19). 
Enzyme Protein Protein k Volumetric Specific 
(mg/m1) (1umois) (min 1) activity activity 
(U/Ml) (U/mg) 
Wild type 0.11 2 250 0.5 4.5 
Mutant 20 0.14 2.5 208 0.5 3.7 
G541 S, 
R494C ______ 
Mutant 10 0.04 0.7 150 0.1 2.7 
D385G  
Mutant 5 0.13 2.4 208 0.5 3.8 
G451  _______ 
Mutant  0.17 
______ 
3.1 325 1.0 5.9 
M337R _____ _____ 
Mutant 26 
_____ 




0.14 2.5 245 0.6 4.0 
G403E _____  
Mutant 8 
_ 
0.50 91 128 1.2 2.3 
A289V ____  
Mutant 
______ 
 1.0 18.0 156 1.1 1.0 
R260K 
Mutant 21 0.5 9.6 105 1.0 1.9 
E145K  _____  
MAOmut"best 0.15 2.7 74 0.2 1.3 
N3 3 6S ________ 
MAOmut 0.20 3.6 89 0.2 1.2 
N3 3 6S/ 
M348K  
Table 19: preliminary activity studies on MAO-N enzyme mutants towards AA 
The specific activities of MAO WT and MAOmut"best" towards AA were lower 
than after previous purification on the Resource Q column (4.2.6. 1 ;Table 17). This 
is presumably due to the loss of activity during the purification procedure and protein 
handling (protease inhibitors were not used at this time). Nevertheless, the data can 
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be used to compare the relative activity of the mutants since they were all purified at 
the same time, and under the same conditions as the MAO-N wild type. 
The activity of the mutants 5,10,11,20 and the MAO-N wild type towards L-AMIBA 
was calculated from the absorption reading at SlOnm after incubation for 5580 
minute (7.2.4; ii, §8.1.1). The activity of all enzymes towards D-AMBA was 
measured on the same way. This reading was taken to calculate the Vm and kcai 
(10.4.4.2). A sample without enzyme was incubated in parallel and used as the 
reference. 
The mutants 4,7,8, 21,26,19(MAOmut"best") and mut N336S/ M348K gave 
measurable initial rates using L-AMBA as a substrate and these values were used to 
determine the kcat towards the latter substrate. The data obtained are shown in 
Table 20. 
The final column in Table 20 gives the relative activity of the mutant enzymes 
towards L-AMBA compared to wild type. The data is in agreement with the previous 
studies using whole cell culture (4.2. 1; Figure 56), partially purified (§4.1.3; Table 
12) and SDS PAGE analysis (4.2.2; Figure 57). 
The mutants 20, 5, 26, 8, 4 and 21 were initially detected (3.3.2) due to increased 
level of protein expression and were designated as" expression mutants" by SDS 
PAGE (Figure 57). These mutants appear to have the same kcat value as MAO wild 
type. 
The mutants with higher turnover numbers (k )  than WT (10, 7, 19 (MAO 
mut"best") and double mutant N336S1 M348K), clearly possessed mutations, which 
affect the catalytic properties of MAO. These mutations allow the identification of 
"hot spots" within the enzyme, which appear to be important for activity. The data in 
the last two rows in Table 20 confirm that the MAOmutN3 36Sf M348K corresponds 
to an "expression" mutant of MAOmut"best". 
124 
Results and Discussion 
- L-AMBA D-AMBA L-AMBA Data Data in Data in I 
(kcat min 1) (kcat min ') (U/mi) in I IV 
relative to 
versus relative data for 
Enzyme data in to data MAO 
II for MAO wild type 
wild type in I 
in IV 
I II III IV V 
IV 
Wild type 3.0 x 10 2 2.0 x i0 8.0 x 10-5 15 1.0 
10 
Mutant20 4.0x10 2 LOx 10 
LOx 10-4 40 2.7 1.3 
6541S, 
R494C  
Mutant 10 0.10 2.0x 10 lOx 10 50 * 
D3 8 5G 









5.0 x 10 2 1.0 x 10 4.0 x iO4 50 
1.7 
D385A ____ 









2.Ox 10 2 
_________
tMutajit4 x 10 4.0 x iO4 50 3.3 0.6 
R260K __  
'Mutant 11 3.5x102 7.0x104 4.0x104 50 
3.3 1.0 
E145K ___ ___ 
"Best" 4.5 lOx 10 2 lOx 10
2 450 
N336S  
tMut 4.0 1,0x10 2 	1.0x10 2 400 
N336S/ 
M348K  
Table 20: Activity of MAO mutants towards L- and D-AMBA. 
. k was obtained by 
measuring the initial rate of oxidation to calculate the value for 	and protein coflcefltnItlOfl was 
obtained from molar extinction coefficient of FAD. k, was obtained from V calculated from 
measuring Abs 510. at the end point of 24h oxidation assuming linearity of reaction, protein 
concentration was obtained from molar extinction coefficient of FAD. 
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4.3 Conclusion 
The data obtained in this chapter clearly confirmed that the amine oxidase enzymatic 
activity could be detected by different approaches. The activity can be determined in 
situ by solid phase assay, by SDS PAGE, in whole cell culture and from purified 
enzyme. The determination of activity in situ was able to speed up the cloning 
procedure by eliminating the step of individual colony analysis. The activity in whole 
cell culture allowed analysis of a large number of samples in a short period of time. 
The importance of this multiple approach is that data obtained by one method can be 
supported by other approaches. 
5. 	Results and Discussion: Application of MAO mutants 
obtained by directed evolution in vitro 
5.1. Improvement of MAO-N WT expression 
It has been shown in §4.2.4 (Table 13) that some of the higher expressing MAO 
mutants (6, 4, 24, 25, 22) contained a mutation at amino acid position 260, in which 
arginine has been replaced by lysine. The wild type MAO-N amino acid sequence 
has two arginines at position 259 and 260 both encoded by the codon (AGG), which 
has a low occurrence in E. coli genes (4%). Lysine and arginine are both basic amino 
acids and hence replacement of one by the other should not affect the charge of the 
protein, however the replacement of a low frequency codon for Arg AGG (4%) by a 
high frequency codon for Lys AAG (22 %) results in improved protein expression in 
E. coli. Thus we decided to replace the codons of both Arg 259 and Arg 260 with the 
codon CGT (38%) by site directed mutagenesis to evaluate the effect upon the 
expression level of MAO-N. 
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The genes encoding for MAO-N wild type were amplified by PCR by using the 
external MAO For and MAO Rev primers (7.2. 1.1). The internal primers 
MAOArg259/260 For and MAOArg259/260Rev (10.5. 1) were designed to 
introduce CGT codons at position 259 and 260 in the MAO-N wild type sequence. 
The site-specific mutations were introduced by the cloning protocol described in 
§10.5.1. 
Four of the resulting colonies were analysed by the solid phase screening assay as 
described in (4.2.5.l). One clone appeared to be significantly more active than 
MAO WT. This positive clone was named pMAOArg259/260 and subjected to 
further analysis. DNA sequencing of this clone revealed that the desired codon 
replacements had been achieved. 
MAO WT and MAOArg259/260 were partially purified from recombinant 
E. co/i BL21(DE3) harbouring a pET 16b carrying the corresponding mao-n 
gene and 
subjected to small scale growth (7.2.2.1; i). CFE's were prepared by sonication 
(7.2.3; i). Protein concentration was determined by Bradford assay (10.4.3) and the 
specific activities of MAO WT and MAOArg259/260 towards AA were measured 
for both the soluble and insoluble fractions (10.5.2; Table 21). 
[iEnzyme Protein Soluble Insoluble 
Total activity 
concentration fraction fraction ('U) 
(mg.mL') (Umg) ((J.mg') 
MAOWT 1.20 0.20 0.30 
0.60 
fMAOArg259/260 1.30 0.50 0.60 1.20 
Table 21: specific activities of partially purified MAO WT and MAOArg259/260 
(MAO wild type with replaced codons for Arg at positions 259 and 260) towards 
amylamine. 
The total protein extracts from whole cell cultures of recombinant E. co/i BL2 1 (DE3) 
harbouring pECME3, pMAO-N and pMAOArg259/260 were analysed by SDS 
PAGE as well as soluble and insoluble fractions of MAO-N and MAOArg259/260 
(Figure 69). 
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I - Protein MWmarkers 
2 - 131-2 I (DE3) [pET16b] reference 
(whole cells) 
3 - pECME3 (whole cells) 
4 - pMAO-N(wliole cells) 
5 - pMAOArg2S9/26() (whole cells) 
6 - Soluble fraction from lane 5 
7 - Insoluble fraction from lane 5 
8 - Soluble fraction from lane 4 
9 - Insoluble fraction from lane 4. 
Figure 69: SDS PAGE analysis of protein expression in soluble and insoluble 
fractions. Protein expression was driven from different expression constructs: pECME3 (original 
plasmid from B.Shcilling), pMAO-N (mao-n geen with replaced codons at the beginning of the 
sequence (Table3, page 70) and MAO-N with replaced codons for Mg at position 259 and 260. 
To confirm the increased level of the R260K mutant expression, CFEs of MAO WT, 
mutant 4 (R260K) and MAOArg259/260 were obtained (7.2.3; iii) and assayed 
towards L-AMBA. This was achieved by incubating 50.i1 of each sample for 240 
minutes and specific activities were determined (§ 10.4.4.1; Table 22). 
Enzyme ZjAbS5iOnm Soluble fractionT1 
(Umg') 
MAO WT 0.06 3.6 x 10-3  
MAOArg259/260 0.12 7.0x i0 
MAO mutant 4 
L 
0.16 5.7 xl 0 
Table 22: specific activities towards L-AMBA of partially purified MAO WT, MAO 
mutant 4 (R260L) and MAOArg259/260. 
The data in Tables 21 & 22 and in Figure 69 confirm the previous results obtained 
with whole cell cultures and by SDS PAGE analysis, namely that the activity 
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MAOArg259/260 was purified from a 4 litre culture inoculated with starting culture 
(7.2.2, iii). A total 30g of biomass was used to obtain a CFE (7.2.3, ii) and the 
latter was subjected to chelate affinity chromatography (§10.4.1.2; Figure 70). The 
concentration of pure protein was measured by Bradford assay and appeared to be 30 
mg U' (3U.mg 1) compared to a published result of 10 mg.L 1.57 
kDa 1 2 3 
I - protein MWmarkers 
175 	
2- after Ni column fraction I 






Figure 70: purification of MAO Arg 259/260 by Ni chelating chromatography. The 
favorite codons for Arg 259 and Arg260 were introduced in MAO-N wild type gene to obtain larger 
level of protein expression. 
Such an improvement in enzyme activity supported all the previous data regarding 
the "expression" mutant R260K obtained throughout the present directed evolution 
in vivo experiment. 
5.2. DeracemisatiOfl of D,L-AMBA 
The deracemisation of D/L-AMIBA was achieved using MAOmut"best" enzyme. 
This experiment was performed by Dr. Alexis Enright. The substantial improvement 
in oxidase activity and selectivity of the mutant was confirmed by chiral HPLC 
(Chiralcel CrownPak CR+) in which the complete oxidation of the L-enantiomer of 
AMBA was achieved after 24 hours, whereas there was no detectable conversion of 
the D-enantiomer. This result facilitated the application of the mutant enzyme to the 
deracemisation of D/L-AMBA. A 77% yield of D-AMBA with an ee value of 93% 
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was obtained after deracemisation of 1 miVi D/L-AMBA in the presence of 
MAOmut"best" and an ammonia-borane complex as a reducing agent. The 
stereoinversion of L- to D-AMBA was also achieved in 18% yield and 99% ee but 
under identical conditions there was no conversion of D- into L-AMBA.239 
5.3. Studies on the active site of MAO-N 
To assess the effects of the amino acid replacements in the mutant enzymes, a WU-
Blast2 sequence alignment (EMBL-EBI) between MAO-N and MAO-B, the closely 
related enzyme with a published three-dimensional structure,' was performed. The 
amino acid sequence alignment revealed 24% sequence identity and 43% sequence 
similarity between the two proteins. 
Figure 71 shows that L171, C172, F168, Y326 of the MAO-B active site correspond 
respectively to the identical amino acids in MAO-N (L213, C214, F210, Y365). 
Other similar amino acids possessing aromatic side chains include: 
Y398 (MAO-B)/W430 (MAO-N); Y188 (MAO-B)!W230 (MAO-N); Y435 (MAO-
B)1F466 (MAO-N); Y60 (MAO-B)1W94 (MAO-N). 
The residue numbers on Figure 71 for MAO-B show one number difference 
compared to the numeration used in Figures 72 and 74. 
Significant differences between MAO-B and MAO-N lie in residues that line the 
substrate cavity including F343 (MAO-B)! T384 (MAO-N), Q206 (MAO-B)! 1246 
(MAO-N) and two MAO-B isoleucines at positions 199 and 198 which do not have 
any corresponding residues in MAO-N sequence (Figure 72). 
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Query: 	41 DVIVIGGGYCGLTATRDLTVAGFKTLLLE RIGGRSWSSNIDGYPYEMGGT1Q 99 
DV+V+GGG G+ A + L +G ++LE1RDR+GGR+++ 	Y ++GG+-V Q 
Sbjct: 	5 DVVVVGGGISGMAAKLLHDSGLNVVVLEDRVRTYT 14QKVIYVDLGGSVGPTQ 64 
Query: 100 SHVWR ----- EXTRYI4NALSPSFNFSRGVNFQI 	S- -TYMTREAEDELLP.S 151 
++R 	+ YK+N+ + +G++F+ P + TY+H 
Sbjct: 	65 	
114 
Query: 152 ALHKTNVDGTNGRTVLPFPHDM_FYVPEFRKYDEHSYSERIDQXELSLNERSSL 	210 
+ F 	GR + P D + P 4+0 M+ E +04+ 	S + ++L 
F 
Sbjct: 115 --NUFWRTMDDMGREI - - - PSDAP APLAEEWDNHTb8(ELLDKLcWTESQITL -F 167 
Query: 211 ILIF: -SGGTLENSSFGEFLH .WAMSGYTYQ-  -GCMDCLI SYKFKDGQSAFARRFWEEAAG 267 
+LC+ TES+ FL: 	G T + 	+ 	KF G 	+R + 
Sbjct: 168 WLTAETHEVSALW_FLWKQCTTR STTNGGOERKFVGGSGQVSERIMDLLGD 226 
Query: 268 TGRLGY FGCP SVVNERDARVTARDGRE 	LVCTI PLNVLSTIQFSPALSTER
- 326 
PV + R+ V + +N(++ IP + IF+PL R 
Sbjct: 227 RVKLER ---- PVIYIDQTR LVETLNBEMEKYVI SAl PPTLGMKIBFNPPLPRN 282 
Query: 327 --I S1NQAGHVNMCTKVHAEV _DN1 RSWTGIAYPFLCJAIGDGTT 	THLVCF 382 
I++ G  C +E 	KID 	I 	++DTPGN+ 
Sbjct: 283 QHITRVPLGSVIKCIVYYKEPFWRKKDYCGTMI IDGEEAPVAiTLDD-TKPEGN-1M 340 
Query: 383 GTDHIQPDKDVR ---- ETLKAVGQLAPGTFGVKRLV- -FH-- - -NWVKDEFAKGA F- 431 
G H+ + R ELK++L 	G + H l4W+++++G-- 
Sbjct: 341 GFILAH_KBKLRLTKEEPi LCELY GSL ALE 	
SEQ SGGCTT 399 
Query: 432 FSRPGMVSECLQGLREKHRG FANSDWALGWRSFIDGAI EEGTRAARVVLEELG 486 
+ PG++++ + LR+ 	+ FA ++ A W +++GA+E G RAAR +L +G 
Sbjct: 400 YFPPGILTQYGRVLRQPVDRIYFAGTETATSG EGAVEAGSR2AREILH14G 454 
Figure 71: sequence alignment of MAO-N and MAO-B from human liver (WU-
Blast2). "Query" sequence corresponds to MAO-N, "Sbjct" sequence corresponds to MAO-B. 
Identical and similar residues belong to active site of MAO-B are in red and the residues from active 
site without similarity are in blue. 
Figure 72(b), shows the position of an inhibitor bound at the active site of MAO-B 
together with most of the corresponding MAO-N amino acids that have aromatic side 
chains. The differences are mostly in the rear region where the substrate cavity is in 
van der Waals contact with the benzene ring of the inhibitor pargyline. 
One of the mutations found in MAO-N that led to greater activity against L-AMBA 
(D385G) is next to Thr 384 which corresponds to Phe 343 in MAO-B and plays a 
role in separating the two cavities of the active site. 
Phenylalanine at position 343 in MAO-B sequence corresponds to threonine at 
position 384 in MAO-N sequence. These amino acids clearly have different chemical 
structures. However, Thr 384 in MAO-N is next to aspartic acid, which was mutated 
twice to glycine and to alanine by the mutator strain. One of the mutations (D385G) 
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brought significant changes in the catalytic properties of MAO-N and another one 
(D385A) although lesser, also had some effect on the activity of enzyme (4.2.6.2; 
Table 20). This observation can identify Asp385 as an important residue in MAO-N 
active site. The position of Asp385 next to Thr384 (corresponding to Phe343, active 
site residue in MAO-B) can also be considered as evidence of the importance of 
Asp385 in MAO-N active site architecture. 
The recent determination of the crystal structures of plant PAO"' and human MAO- 
B1 	have revealed valuable insights into the structure-function of the flavin 
dependent amine oxidases. PAO is involved in catabolism of polyamines by 
catalyzing the oxidation of secondary amino groups of spermine or spermidine and 
their acetyl derivatives. It is a soluble enzyme with a non-covalently bound FAD 
cofactor. MAO-B oxidises the primary amino group of arylalkylamines. MAO-B has 
a C-terminal segment for membrane attachment, which is absent in PAO. PAO (472 
residues) and MAO-B (520 residues) share about 20% amino acid sequence identity. 
Despite their overall structural folding similarity, PAO and MAO-B differ in overall 
topology of their substrate binding-sites (Figure 73)160 
The PAO U-shaped tunnel and the MAO-13 cavities follow entirely different 
pathways and are lined by residues that are not homologous in sequence. The only 
conserved features can be found in the sites for binding of the flavin and for 
recognition of the substrate amino group that undergoes oxidation. 
In particular, Lys 300 of PAO is bridged to the N5 atom of the flavin through a water 
molecule and participates in addition of a hydrogen atom to the N5-position, which 
occurs during the cofactor reduction. This interaction is strictly conserved also in 
MAO B where Lys296 occupies a position identical to that ofLys300 in PAO 
(Figure 74, A& B). X-ray diffraction data on MAO-B have shown a water molecule 
acting as a bridge between Lys 296 and the flavin N5 atom. This structural feature is 
not unique to these amino acid oxidases and also been found in other flavoenzyme 
oxidases (e.g. L-amino acid oxidase). 
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Figure 72 :148   the substrate binding site of human MAO-B. 
a) Stereo view of pargyline inhibitor and the residues lining the binding site at the re side of the flavin. 
Carbon atoms are in black, nitrogen in blue, oxygen in red and sulphur in yellow. The inhibitor is 
outlined by shaded bonds. The corresponding MAO-N amino acids are in red. b) Schematic 
representation of the pargyline binding site. MAO-B residues that are conserved in human MAO-A 
are indicated by an asterisk. For non-conserved amino acids, the replacement side chains of MAO-A 
are in parentheses. Aromatic side chains are enclosed in ellipsoidal frames. Other residues are in 
rectangular boxes. The atoms of the flavin ring are numbered. The corresponding MAO-N amino 
acids are in red. c) A model for the binding of the substrate, benzylamine, to human MAO-B. For 
illustrative purposes, the atoms and bonds of the modeled substrate are shown in an increased size. 
The surface of the solvent inaccessible substrate-binding cavity is semitransparent. For clarity, only 
some of the residues lining the cavity are depicted. Carbon atoms are in cyan, nitrogen -in blue and 
oxygen -in red. The reactive N5 site on the twisted flavin is labelled. The corresponded MAO-N 
amino acids are in red. 
Figure 73 :160 structures of PAO and of MAO-B. 
A. Overall structure of maize PAO (Protein Data Bank entry IB5Q). Labels N and C indicate the N 
terminus and C terminus, respectively. The FAD cofactor is shown in yellow, and the U-shaped 
catalytic tunnel is highlighted in red. B. Overall structure of human MAO-B (Protein Data Bank entry 
IGOS) in the same orientation used for PAO inA. Labels N and C indicate the N terminus and C 
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terminus, respectively. The C-terminal membrane-binding region is in green, and the FAD cofactor is 
in yellow. The active site cavity is colored in red, whereas the entrance cavity is in blue. 
Because MAO-N has 24% identity and 47% similarity to total MAO-B sequence 
(Figure 71) and 22% identity and 39% similarity to PAO (region of 279 to 483 amino 
acid, Figure 78) we decided to apply the structural information available for MAO-B 
and PAO to explore the MAO-N active site and thereby provide a partial 
rationalization of the mutations found through the directed evolution experiment. 
Thus, Lys 340 in MAO-N occupies a position identical to that of Lys 300 in PAO 
(Figure 74, A). However, Lys 296 in MAO-B corresponds to Met337 in MAO-N 
(Figure 74,B) which is the location of the mutation found in mutant 7 (M337R, 
§4.2.4, Table 13). According to the preliminary activity studies (4.2.6.2, Table 20), 
this mutation M337R was featured as a "hot spot" mutation. The position of 
methionine 337 next to asparagine 336, which was mutated to serine to produce 
MAOmut"best", can be used as evidence of the importance of both Met337 and 
Asn3 36 in MAO-N active site structure. 
The PAO and MAO substrate-binding sites, where the flavin-dependent amine 
oxidation takes place, display several conserved features. In both proteins, two 
aromatic amino acids form an "aromatic sandwich" by facing each other in 
perpendicular orientation to the flavin. In PAO, residues Phe403 (Phe43 un MAO-N) 
and Tyr439 (Phe466 in MAO-N) are positioned parallel to each other and 
perpendicular to the flavin plane (Figure 74,A). Likewise, in MAO-B, there is an 
aromatic pair formed Tyr 398 (Trp430 in MAO-N) and Tyr435 (Phe 466 in MAO-N) 
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Figure 74:160 catalytic sites of PAO and MAO B. A. Structure of the catalytic site of PAO 
with the substrate spenrnne modelled into it. Carbon atoms are in black, oxygen are 
in red, and 
nitrogen atoms are in blue. B. Structure of the catalytic site of MAO-B with the substrate 
benzylamine 
modeled into it. Atom color codes are as in A. C. Structure of the superposed PAO and MAO-B 
catalytic sites. PAO and MAO-B residues are outlined in green and magenta, respectively. Atom color 
codes are as in A. Residues are labeled as PAO/MAO B numbering. The larger blue spheres indicate 
the positions of spermine and benzylamme amino groups undergoing oxidation. The corresponding 
MAO-N amino acids are in red. 
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Furthermore, in both PAO and MAO-B the aromatic pairs are sheltered by additional 
aromatic residues. Trp60 in PAO (Trp 94 in MAO-N) and Tyr60 in MAO-B (Trp94 
in MAO-N) are positioned at the top of the flavin ring, being coplanar to the 
respective pyrimidine rings of the flavin coenzymes. This aromatic residue was 
found to be conserved in almost all amine oxidases published in the data bank (WU-
Blast2 alignment to MAO-N query). Tyr298 of PAO (Cys338 in MAO-N) and 
Phe343 of MAOB (Thr 384 in MAO-N) are both located on the same side of the 
flavin, in proximity of the lysine that is hydrogen bonded to the FAD. 
The combination of the flavin and aromatic sandwich generates an "aromatic cage" 
that is suggested to recognize the deprotonated amine group of the substrate. The 
"aromatic sandwich" active site organization in MAO-N could be proposed as based 
on the aromatic side chain of the corresponding amino acids. This observation could 
account for the effects obtained after the amino acid replacements at position 336, 
337 and 385 in MAO-N. 
The origin of G403E "hot spot" mutation (4.2.6.2; Table 20) is obscure due to the 
absence of a three-dimensional structure of MAO-N. 
An overview of MAO-N amino acids which correspond to MAO-B and PAO active 
site residue and which were affected by random mutagenesis is given in Figure 75. 
The amino acid highlited in the second-row position is the corresponding residue in 
MAO-B (in red) and in PAO (in blue) sequences. 
>MAOcDNA 
1 	atg acc tcc cga gac gga tac cag tgg aca ccc gag aca ggg ctc 45 
1 Met Thr Ser Arg Asp Gly Tyr Gin Trp Thr Pro Giu Thr Gly Leu 15 
46 	acg cag ggc gtc ccc tct cta gga gtc atc tcc ccg ccc act aat 90 
16 Thr Gin Gly Val Pro Ser Leu Gly Val lie Ser Pro Pro Thr Asn 30 
91 	atc gaa gac acg gac aaa gat ggt cca tgg gac gtg att gtc att 135 
31 lie Giu Asp Thr Asp Lys Asp Gly Pro Trp Asp Val lie Val lie 45 
136 	ggt gga ggg tac tgc ggg ttg act gcc act agg gac ttg act gta 180 
46 Gly Gly Gly Tyr Cys Gly Leu Thr Ala Thr Arg Asp Leu Thr Val 60 
181 	gca ggc ttc aaa acc ctt ctc ctc gaa gcc cga gac cgc ata ggc 225 
61 Ala Gly Phe Lys Thr Leu Leu Leu Giu Ala Arg Asp Pig lie Gly 75 
226 	ggc cgc tcc tgg tcc tct aac atc gac ggc tat cct tac gag atg 270 
76 Gly Arg Ser Trp Ser Ser Asn lie Asp Gly Tyr Pro Tyr Giu Met 90 
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271 ggc ggc aca tgg gtc cac tgg cac caa tcg cac gta tgg cgc gaa 
315 
91 Gly Gly Thr 	Val His Trp His Gin Ser His 
Val Trp Arg Glu 105 
316 atc acg cgc tac aag atg cac aac gcc cta tca ccc tcc ttc aac 
360 
106 lie Thr Arg Tyr Lys Met His Asn Ala Leu Ser Pro Ser Phe Asn 
120 
361 ttc tcc cgc ggc gtg aat cac ttc cag cta cgg acc aac ccc acc 
405 
121 Phe Ser Arg Gly Val Asn His Phe Gin Leu Arg Thr Asn Pro Thr 
135 
406 aca tca acc tac atg act cac gaa gcc gag 	
gac gag ctc ctc cgc 450 
150 
136 Thr Set Thr Tyr Met Thr His Glu Ala ./I.:: 
Asp Glu Leu Leu Arg 
451 tcc gca ttg cac aag ttc acc aac gtg gat ggc acc aac ggc cgt 
495 
151 Ser Ala Leu His Lys Phe Thr Asn Val Asp Gly Thr Asn Gly Arg 
165 
496 act gtc ctg ccc ttc ccg cat gac atg ttc tat gtt cct gag ttc 
540 
166 Thr Val Leu Pro Phe Pro His Asp Met Phe Tyr Val Pro Glu Phe 
180 
541 agg aag tat gat gag atg tca tac tcg gag cgg att gat caa atc 
585 
181 Arg Lys Tyr Asp Glu Met Ser Tyr Ser Glu Arg lie Asp Gin lie 
195 
586 cgg gat gag ttg agc ctt aat gaa cgg agt tct ctg gaa gcg ttt 
630 
196 Arg Asp Glu Leu Set Leu Asn Glu Arg Set Set Leu Glu Ala 
Phe 210 
F 
631 ata ttg ctt tgc tct ggc gga acg ctg gag aat agc tca ttt gga 
675 
211 Ile Leu Leu Cys Ser Gly Gly Thr Leu Glu Asn Ser Ser Phe Gly 
225 
LLT 
676 gaa ttc ctg cat tgg tgg gcg atg agc gga tat acg tat cag gga 
720 
226 Glu Phe Leu His Trp Trp Ala Met Set Gly Tyr Thr Tyr Gin Gly 
240 
721 tgc atg gac tgc ttg ata agt tat aag ttc aag gat ggg cag tct 
765 
241 Cys Met Asp Cys Leu lie Set Tyr Lys Phe Lys Asp Gly Gin Set 
255 
766 gca ttt gcg agg agg 	ttt tgg gag gag gcg gcc ggg acg ggg 
agg 810 
270 
256 Ala Phe Ala Arg Arg/Lys 
Phe Trp Glu Glu Ala Ala Gly Thr Gly Arg 
811 ttg ggg tat gtg ttt ggg tgt ccg gtt agg agt gtt gtt aat gag 
855 
271 Leu Gly Tyr Val Phe Gly Cys Pro Val Arg Ser Val Val Asn Glu 
285 
856 aga gat gcg gcg 	aga gtg acg gcg agg gat ggc agg gag ttc 
gct 900 
300 
Asp Ala 	Arg Val Thr Ala Arg Asp Gly Arg Glu Phe 
Ala 
286 Arg 
901 gcg aag cgg ctg gtt tgc act att ccc ctc aat gtc ttg tcc acg 
945 
301 Ala Lys Arg Leu Val Cys Thr lie Pro Leu Asn Val Leu Ser Thr 
315 
946 atc cag ttc tca cct gcg ctg tcg acg gag agg atc tct gct atg 
990 
316 lie Gin Phe Set Pro Ala Leu Set Thr Glu Arg lie Ser Ala Met 
330 
991 	cag gca ggt cat gtg aat 	
atg tgc acg aag gtg cat gcc gaa gtg 	1035 
331 Gin Ala Gly His Val Asn/Ser Met Cys Thr Lys Val 
His Ala Glu Val 345 
]e Met/ArgY:: 	CIH1I 
Lv s 
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1036 gac aat aag gat atg cgg tcg tgg acg ggc att gcg tac cct ttc 1080 
346 Asp Asn Lys Asp Met Arg Ser Trp Thr Gly lie Ala Tyr Pro Phe 360 
1081 aat aaa ctg tgc tat gct att ggt gat ggg acg act ccc gcg gga 	1125 
361 Asn Lys Leu Cys Tyr Ala lie Gly Asp Gly Thr Thr Pro Ala Gly 375 
1126 aac acg cat ctg gtg tgt ttc ggg acg gat 	gcg aat cat atc cag 
376 	Asn Thr His Leu Val Cys Phe Gly Thr Asp/Gly/ Ala Asn His lie Gin 390 
1171 ccg gat gag gac gtg cgg gag acg ttg aag gcg gtt ggg 	cag tta 	
1215 
391 	Pro Asp Glu Asp Val Arg Glu Thr Leu Lys Ala Val Gly/Glu Gin Leu 405 
1216 gcg cct ggg aca ttt gga gtg aag cgg ttg gtg ttt cac aat tgg 1260 
406 	Ala Pro Gly Thr Phe Gly Val Lys Arg Leu Val Phe His Asn Trp 420 
1261 gtg aag gat gag ttt gcg aag ggc gcg tgg ttc ttc tct agg cct 	1305 
421 	Val Lys Asp Glu Phe Ala Lys Gly Ala TLp 
Phe Phe Ser Arg Pro 435 
4 H 
1306 ggg atg gtg agt gag tgt ttg cag ggg ttg agg gag aag cat cgc 1350 
436 	Gly Met Val Ser Glu Cys Leu Gin Gly Leu Arg Glu Lys His Arg 450 




Val Val Phe Ala Asn Ser Asp Trp Ala Leu Gly Trp Arg 	. 465 
H 
H 
1396 ttt att gat ggg gcg att gag gag ggg acg aga gct gct agg gtg 	1440 
466 	Th lie Asp Gly Ala lie Glu Glu Gly Thr Arg Ala Ala Arg Val 
480 
1441 gtg ttg gag gaa ttg gga acg aag agg gag gtg aag gct cgt 	ttg 1485 
481 	Val Leu Glu Glu Leu Gly Thr Lys Arg Glu Val Lys Ala Arg/CysLeu 495 
1486 tga end 
Figure 75: cDNA of MAO-N. 
"expression "  mutation 
Dark purple- "hot spot" mutation 
Red - amino acid corresponded to amino acid in MAO B active site 
Blue- amino acid corresponded to amino acid in PAO active site 
amino acid corresponded to amino acid in both PAO and MAO B active sites. 
Bold black- no change 
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6. 	Conclusions and Future work 
In conclusion, the "directed evolution" of an amine oxidase has been achieved to 
meet the specific requirement of a novel biotransformation. The decision to select the 
A. niger MAO-N gene for in vitro evolution was based upon the observation that the 
wild-type MAO-N enzyme showed inherent selectivity for L-over D-AMBA (Ca. 
17:1), although the overall rate was very low. An interesting aspect of the present 
work was the identification of a mutant with enhanced enantioselectivity by using a 
single enantiomer substrate in the screen (L-AMBA). There is currently much effort 
directed towards the development of truly enantioselective screens using both 
racemates, because the two enantiomers must compete for the enzyme in 
nature. ,0,11,242a,1) However, the high throughput screen developed in the present 
work, allowed us to screen large library of variants and identify a MAO-N variant 
with improved enantioselectivity. The properties of obtained mutants are summarised 
below: 
G403E 	No significant changes on the native substrate (amylamine). Minor 
activity increase on L-a-methylbenzylamine (L-AMIBA) combined with major 
activity drop towards D-AMBA. 
M337R No significant change on the native substrate. Minor improvement on 
L-AMBA, significant improvement in enantioselectivity 
D385G No significant change on native substrate and minor improvement on 
L-AMBA, some improvement in enantioselectivity. 
D385A No significant change on native substrate and minor improvement on L- 
AIMBA, some improvement in enantioselectivity 
5.N336S Strong improvement on L-AMBA and reduced activity towards native 
substrates (amylamine and benzylamine), dramatic improvement in 
enantioselectivity. 
According to homology modelling, all sites are located close together in space and in 
close proximity to the putative active site. Though it is still possible that each 
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individual mutation affects reaction specificity from the distance as a result of 
conformational changes, it seems more likely that the mutated residues are involved 
directly. First, two mutations (G403E, M337R) bring moderate activity improvement 
towards L-AMBA which might probably be associated with the increase in 
polarizability of the active site by each of the first two mutations. Additional charges 
introduced by either of the two mutations might help to protonate the substrate amino 
group, but only in case of L-AMBA. It is not inconceivable to imagine that the 
neutral G403 and M337 are located at the opposite sides of the substrate binding 
pocket and the addition of a negative charge from one side (G403E) would have 
similar effect as the addition of a positive charge (M337R) to the other side of the 
binding pocket. Interestingly, these mutations affect only L-AMBA, but not the 
native substrate amylamine. The presence of the methyl group might drive the 
substrate towards G403 and M337 in the pocket. 
Negative charge elimination of D385 by the next two mutations (D385G and 
D3 85A) did not affect the native substrate and resulted in a small improvement 
towards the methylated substrate. If compared to the first two cases, these mutations 
decrease the active site polarizability but improve the activity towards AMIBA 
anyway. 
The third mutation has the replacement of asparagine to serine at position 336. Both 
asparagine and serine are from the same group of amino acids with uncharged polar 
side chains. This mutation has much more interesting affect - it greatly improves the 
enzyme activity towards L-AMBA and reduces the activity towards the native 
substrate. The activity enhancement is stereo-selective improvement is much smaller 
for D-AIMBA. It is plausible that the N336S shortening of the side chain (the amide 
group in Asti and hydroxyl group in Ser) introduces a spatial misfit between the 
enzyme and the native substrates amylamine and benzylamine (table 18, page 119) in 
the binding pocket but create more room for binding L-AMBA (Figure 75a) 
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Figure 75a. the presumable model of MAO-N and MAOmut"best" active site. 
The 
size of the arrows corresponds to the size of the binding pocket in active site of the enzyme 
It would be interesting to further investigate the mechanisms by which the mutations 
described, effect the function of MAO-N by X-ray structural studies of MAO-N wild 
type. Such studies may also shed light on the effect upon the altered substrate 
specificity of MAOmut"best". 
The current activity of MAOmut"best" towards L-AMBA could potentially be 
improved further by either saturation mutagenesis at the specific residues identified 
in this work or by subjecting the MAOmut"best" variant to further rounds of random 
mutagenesiS. 
The application of MAOmut"best" for deracemisation of a range of chiral amines 
can be optimised further. In this case, the broadness of substrate specificity of 
MAOmut"best" would have to be investigated. The improved expression level of 
MAOmut"best" (as achieved for MAO-N wild type) will also be an advantage to 
provide suitable quantities of enzyme for further studies. 
142 
Experimental 
7. 	Experimental: Cloning and Expression 
7.1. 	General Techniques 
Plasmid (pECME3) carrying the full length of A.niger MAO-N gene was provided as 
a gift by Boris Schilling (Givaudan-Roure Research Ltd., Switzerland). Synthetic 
oligonucleotides were purchased from Interactiva Biotechnologie GmbH or Sigma-
Genosys (Biotechnologies (Europe), Cambridge, UK). Restriction enzymes and T4 
DNA ligase were purchased from New England Biolabs. PCR reaction 'Ready to go' 
beads containing taq DNA polymerase was purchased from Amersham Pharmacia 
Biotech and Herculase Hoistart DNA Polymerase was purchased from Stratagene. 
PCR reactions were performed in Mastercycler personal (Eppendorf). 
Plasmid DNA was analysed by agarose gel electrophoresis (0.8% in TAE buffer) 
using equipment purchased from Anachem, Luton, UK. Agarose was obtained from 
Bio-Rad Laborarories, UK and DNA was extracted from agarose gels using the 
Qiaquick Gel Extraction Kit (Qiagen,UK, #28704). Plasmid DNA preparations were 
performed using the QlAprep Spin Miniprep Kit (Qiagen #27104) and GenElute 
Plasmid Midiprep Kit (Sigma-Aldrich, # PLD-35). 
The expression vector pET 16b was obtained from Novagen (CN Biosciences Ltd, 
Nottingham, UK) and E.coli competent cells of Top 10, BL21(DE3) cell lines were 
obtained from Invitrogen ( Paisley,UK). Expression media components were obtained 
from Becton Dickinson Microbiology Systems, USA. 1PTG was purchased from 
Europa Bioproducts. Ampicillin was purchased from Boehringer Mannheim. 
Reagents for buffers, assay mixtures and cultures media were of standard laboratory 
grade and were used as supplied from commercial sources. Bacterial growth in liquid 
culture was performed in an orbital shaker (Innova 4430 or Innova 4000), set at the 
desired temperature. For static incubation a dry block heater (Machem HBS- 130) or 
a water bath set at the desired temperature were used. 
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Centrifugation of culture media and lysed cells was carried out in a Sorval RC5C plus 
centrifuge. Speed and rotor size follow in parentheses. Small-scale (<1 Sm!) 
centrifugation was performed in either an Eppendorf 5G1 5C microfuge or a Hareaeus 
Biofuge p/co. 
Sterile procedures were performed either on the bench under flame, or in a SterilGard 
Class II Type A/B3 biological safety cabinet. Equipment and media were sterilised 
using a Monarch 745rh autoclave (121°C, 20mm) or an Astell Scientific autoclave 
(121°C, 15mm). 
Optical density measurements and Bradford assay measurements were performed on a 
Cecil CE 1020s spectrophotometer (D2 lamp). Kinetic measurements were carried out 
on a Hewlett Packard 8453 spectrophotometer (D2 lamp), using HP 845xU V-visible 
system software for analysis. 
SDS- PAGE equipment was purchased from Bio-Rad. Three different gels were used 
for SDS-PAGE analysis; I) Biorad Ready gels 10-20% acrylamide gradient, Tris/HCI, 
19 wells, 30p1; ii) Biorad Criterion precast gel 10-20% acrylamide gradient 
TrisIHCl, 18 wells, 30p.l; iii) self-poured 15% acrylamide gels (11.9). 
7.2. 	mao-n wild type cloning and expression in pET16b 
72.1. 	Construction of the plasmid pMA 0-N 




Z 2.1.1. 	Gene amplification by PCR 
A full-length maoN DNA (1502bp) was recovered by selective amplification (PCR) 
from the original plasmid pECME3. Two oligonucleotides were utilised in the 
reaction (both 5'-3') corresponding to the termini of the coding region. They were 
designed to contain unique restriction sites for subcloning into the expression vector 
pET 16b. 
MAOForNde primer (GCTCTAGACATATGACCTCCCGTGACGGTTACCAGT 
GGACCCCGGAG) contained a unique NdeI site (in bold, N-terminal methionine 
underlined). 
MAORev-BamHI primer (ATAGGATCCATCAATCACAAACGAGCCT) 
contained the unique BamHI site (in bold) and a stop codon (underlined). Nucleotide 
substitution from the native gene sequence included according to E. co/i codon usage 
(2.1.2, Table 3). 
The PCR reaction was performed by using 'Ready to go' PCR beads with taq DNA 
polymerase or Hot start Herculase DNA polymerase. Template DNA (1ng) and 
primers ( 1 Opmol) were added to the reaction. 
i). 	Amplification by taq DNA polymerase 
One PCR bead was mixed with the solution containing 1 p.1 DNA template (usually 
from 1:10 dilution of plasmid DNA purified by Qiagen Plasmid Miniprep, unless 
otherwise stated), 0. 5p1 of each primer (from 0.1 p.g/ml primer solution) and 23 1.il of 
water to perform the PCR reaction. 
Amplification by Hot start Hercu/ase DNA polymerase 
ljil DNA template (made up as above), 0.5t.il 1 of each primer (made up as above), 
1 p.1 of 10mM dNTPs, 51.11 DNA polymerase buffer (supplied with kit), 0,51.11 DNA 
polymerase and 41.51A of water was mixed to perform the PCR reaction. 
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PCR reaction was performed using optimised cycling conditions: 
Denaturing and polymerase activating - 940 C 2min 30sec 
Denaturing - 94oC 40sec 
Annealing - 50°C 45sec 
Extension - 72°C 1 min 20sec 
Go to 2) and repeat for 29 cycles 
Final extension - 72°C 2mm 
The presence of a PCR product of the correct molecular weight was determined by 
UV visualisation of ehidium bromide stain by agarose gel electrophoresis. The 
fragment was purified (approximately lp.g), eluted in 3011,1 of water and subjected to 
restriction digest. 
7.2.1.2. 	Restriction digest of PCR product and construction of the plasmid 
pMAO-N 
The amplified DNA fragment and the vector pET 16b were each double digested with 
the restriction enzymes NdeI and BamHI (37'C, 4h) as followed: 




4.tl BamHl buffer 
21.il H20 
The digested product was agarose gel purified in a total volume of 30il, ligated into 
pET 16b (vector/insert--1/10) by incubation with T4 DNA ligase in the buffer supplied 
(22°C-room temperature, 16 h). The ligated product was transformed into E. coil TOP 
10 competent cells and colonies were screened for an Amp 100 resistance. Plasmid 
DNA was purified by using the QlAprep Spin Miniprep Kit (Quiagen), digested by 
NdeI /Bam HI, mixed with loading buffer (§ 11.13) and analysed by agarose gel 
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electrophoresis at constant current of 80 mamp, in TAE buffer (11. 5).  The DNA in 
agarose gel was stained with ethidium bromide (§ 11.15) and visualised in ultraviolet 
light. 
i1 	k I (7 190)  
Bsp HI (7137) 	fluid III (30) 
Bsp I 
P 
Bsp HI (6024) 
Nco 1(1356) 
I 	I i I 	I 
.\co 1(1873) 
I I I 	2 
Bsp HI (2098) 
Figure 76: mao-n gene cloning into pET 16b vector 
7.21. 	Expression of maoN gene in pET system 
Expression of mao-n gene in E. colE BL21(DE3) was performed with reference to the 
Novagen pET System Manual.225  
E. coli  BL21(DE3) transformed with vector pET l6b without maoN gene was used as 
a background reference culture. 
Transformation of E.coli BL21(DE3) (Invitrogen) by pMAON or by pET 16b was 
performed according to the manufacturer's protocol. 
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Small scale expression 
A freshly transformed colony was used to inoculated in lOmi LB Amp 100 and 
cultured in 50m1 falcon tube by agitation for 24 hours at 30°C until cells density 
reached 0D600=4.0-5 .0. 
Medium scale expression 
A freshly transformed colony was used to inoculate into lOOmi of LB Amp 100 and 
grown in 500m1 baffled conical flasks by agitation for 23 hours at 30°C until an 
0D600=4. 0-5.0. 
Large scale expression 
A freshly transformed colony was inoculated in lOOml LB Amp 100 and cultured in 
500ml conical flack by agitation either at 30°C over night or at 37°C during the day 
until cells density reached 0D600=0. 8-1.0. This culture was spun at 4000 rpm, 
5 minutes at room temperature, and the pellet resuspended in fresh the LB Amp 100 
media. 0.3m1 of this suspension was then used to inoculate a total of 300m1 LB 
ArnplOO media, which was aliquated into 1L conical buffled flasks. 
The culture was cultivated in a shaking incubator at 26°C for 24 hours until 
013600=4.0-5.0. 
iv). 	Biomass recovery 
1 ml, 1 Oral aliquots or the entire volume of growing culture were spun down (1 ml 
aliquots - at 13000rpm, 3min in microfuge; lOmi aliquots- at 4000rpm, 20min in 
bench top Sorvall Legend RT centrifuge; whole volume of culture in large scale 
expression—at 6000 rpm for 10min in Sorval RC5C plus) and the pellets were stored at 
- 20°C until required. 
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I ml frozen pellets were used for whole cell activity determination and for SDS PAGE 
analysis, 1 Omi frozen pellets were used for small scale CFE preparation and large 
scale culture pellets was used for large scale CFE preparation and purification. 
7.2.3. 	Cell free extract preparation 
1) 	Small scale 
Lysis was performed as close to 4°C as possible. The frozen lOml pellet 
( 	.2.2; iv) was thawed and resuspended in 5 ml of 25mM potassium phosphate buffer 
pH 7.6. The cell suspension was sonicated (Soniprep 150) on ice following an on-off 
protocol: (10 sec "on" lOsec "off") for 2mm. The resulting mixture was centrifuged 
at 4000 rpm, (Sorwal Legend RT, Kendro Ltd, USA) at 4°C for about 40 minute or 
until a clear supernatant was obtained. Cell free extracts were stored at —80°C. 
ii) 	Large scale 
The cell pellet obtained from large scale protein expression (7.2.2; iv) was 
resuspended in buffer (lml/lg cells) in the presence of lyzozyme at a final 
concentration of 1mg/mI. The cell suspension was incubated at 30°C for 30 minutes 
and was subjected to sonication. The sonication was performed on ice and in culture 
volume not greater then 15m1. The sonication conditions were: 30 sec "on", 1mm 
"off' or until the culture viscosity disappeared. The resulting mixture was centrifuged 
at 20000rpm, Sorval SS-34 rotor (Kendro Ltd, USA) at 4°C until a clear supernatant 
was obtained. Cell free extracts were stored at —80°C. 
iii). Medium scale 
The cell pellet obtained from medium scale protein expression (7.2.2; ii) was 
resuspended in 2ml buffer. The resulting culture was subjected to sonication 
performed on ice. The sonication conditions were: 10 sec "on", 20 sec "off' for 3 
repeats. The resulting mixture was centrifuged at 20,000rpm using a Sorwal SS-34 
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rotor for 20min or until a clear supernatant was obtained. Cell free extracts were 
stored at —80°C. 
7.2.4. 	Whole cell activity determination 
I). 	Determination of the initial rate of enzymatic activity 
The frozen pellets from imi culture were thawed and resuspended in imi of 25mM 
potassium phosphate buffer pH 7.6. A 0. 1 m aliquot of this suspension was mixed 
with colorimetric solutions (8. 1.1 or §8.1.2) and used for the assays. 
ii). 	Static measurement of enzymatic activity. 
The whole frozen pellet from 1 ml culture was resuspended in 1 ml of assay mixture 
(8. 1.1 or §8.1.2) and subjected to static incubation at room temperature. E. coli BL21 
(DE3) transformed with pET 1 6b was used as a reference culture. At the end of 
incubation, the assayed samples were centrifuged at 13,000rpm, 5mm. The 
spectrophotometer (Cecil CE 1020s ) was zeroed using a reference culture supernatant 
and the absorption at 51Onm in experimental supernatants was measured. 
7.2.5. 	Protein analysis by SDS-PAGE 
7.2.5.1. 	Protein in whole culture 
The frozen pellet from imi culture was resuspended in 300p.l of SDS-reducing 
loading buffer (§ 11.10), boiled for 5min and debris were removed by centrifugation 
on microfhge for 2 min at maximum speed. Prepared samples were loaded on 
acrylamide gel and run at a constant voltage on of 200V (Powerpac 200, Bio-Rad 
Laboratories Ltd, UK). The gel was placed in staining solution (11. 3)  and agitated on 
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a rocking platform until the gel was dark blue in colour. The gel was de-stained in the 
same way using fresh de-stain solution (§11.4) until protein bands were visible and 
the \background gel was clear. 
7.2.5.2. 	Pu rifled protein 
1Oil of protein sample was mixed with lOi.tl of loading buffer, boiled for 5minutes 
and loaded on the acrylamide gel. The subsequent procedure was as described in 
§7.2.5.1 
8. 	Experimental: Development of high-throughput 
screen 
8.1. 	Assay methods: soluble dye production assays 
Commercially available L-amino acid oxidase (LAAO) purified from snake venom 
(Sigma # A8390, 1.0 Um1) was used as the standard to develop reproducibility 
necessary for assay validation. L- Phenylalanine at 5mM was used as a substrate 
8.1.1. 	Hydrogen peroxide coupled assay, using 2.4. 6-tribromo-3- 
hydrobenzoic acid ('TBHBA) 
The standard chromogenic solution contained the following ingredients at final 
concentration: 
0. 1M potassium phosphate buffer pH7.6 for monoamine oxidase or pH 7.0 for 
amino acid oxidase. 
5mM substrate 




v). 	25U (50 .ig/ml) HRP (horseradish peroxidase, Sigma # P-6782) 
The dye produced by HRP from H202, 4-AAP, and TBHBA was detected at 51 Onm 
(65,o= 29400M1cm1).243 
The spectrophotometer was blanked against the chromogenic solution: 
Potassium phosphate buffer (1M) 	5m1 
TBHIBA (2% in DMSO) 	500 
4-AAP (1M) 	 37.5 j.il 
Substrate from commercial flask 
amylamine (8.6M) 	 30pJ 
or 
D,L-AMBA (7.7M) 	 40p1 
or 
Benzylamine (9.2M) 	 28i.ii 
or 
L-Phenyiaianine lOOniM 	2.5 p1 
HR.P (Sigma # P-6782) 
5mg/mi, 987U/mg solid 	 25O.il 
vi) 	Water 	 up to 50m1 
Purified enzyme (10 p1) or CFE (10 p1) or cell suspension (7.2.4; i, ii) was then 
added to make the total volume of assay mixture up to 1 ml. The dye produced by 
HRP from H202, 4-AAP, and TBHBA was detected at SlOnm 
(6510 29400M 1 cm 1).243  
The initial rate or standard reading was measured and the activity unit was defined as 




(Um1')= (Aus') x (1/c) x60 x (t.VIs.v) x lx 106.  
Where c = molar extinction coefficient (M 'cm) 
t.v. = total reaction volume 
s.v. = sample volume 
8.1.2. 	Product formation assay 
The spectrophotometric assay was based on the difference between the molar 
extinction coefficients of benzylamine and benzaldehyde at 250nm. A quartz cuvette 
was used throughout this assay experiment. The spectrophotometer (Hewlett Packard 
8453) was zeroed against 990.tl of benzylamine solution: (20mM potassium 
phosphate buffer pH 7.2, 2mM benzylamine). lOp.l of enzyme was mixed in 
benzylamine solution and the absorbance at 250nm was measured at 3 seconds 
interval at room temperature. The initial rate was measured and the activity was 
calculated as for method in §8.1.1 (c (PhCHO) 250n 	12500 M'cm 1). 
8.2. 	Hydrogen peroxide coupled assay, using 3,3- 
diaminobenzidifle 
One tablet of DAB from SIGMA FAST kit (Sigma l D4418) was dissolved in lOml 
of chromogenic solution (it takes approximately 20min to dissolve the pellet). The 
chromogenic solution contained the following ingredients at final concentration: 
100mM Potassium phosphate buffer pH 7.6. 
10mM L-AMBA (or other required substrate) 
50p.g/ml of horseradish peroxidase HRP (Sigma # P-6782) 
Water up to lOmi 
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2% agarose (Bio-Rad # 161-3102) was melted in water, cooled down to 60°C and 
kept in water bath at 60°C until required. lOmI of 2% agarose solution was mixed 
with lOml of chromogenic solution contained DAB immediately and poured over the 
membrane. 
8.3. 	Detection of oxidase activity in bacterial colonies on agar 
plate (intact colonies screening) 
8.3.1. 	Preparation the colonies for screening 
A 5p.l aliquot of each DNA library was used to transform a 45 j.tl cell suspention of 
expression host BL21(DE3) according to manufactures protocol with the following 
modifications. The transformed cells were incubated in 1 ml of SOC medium in a 
shaking incubator for ihour at 37°C to induce t3-lactamase expression. 100 p.1 of cell 
suspension was then plated out directly onto nitro-cellulose HiBond-C Extra 
(Amersham Pharmacia # RPN82E) membranes placed on a LB Amp 100 agar plate. 
Ten plates, containing 2000-3000 colonies per plate, were used to display the library. 
The plates were incubated for 24h at 37°C after which time the membranes containing 
the colonies were lifted from the plate, kept at —20°C for 24 hours and then incubated 
with the assay mixture (8. 1.1 or §8.2) at room temperature. Positive clones were 
picked from the membrane by using the yellow tip and subjected to a second round of 
screening as described below (§8.3.3). 
0.5 p.1 of pMAO-N was used to transform into 5 p.1 of E. coli BL21(DE3) and 
incubated as described above but with 100 p.! of SOC. The total volume (105.5p.I) of 
cell suspension was plated onto nitro-cellulose HiBond-C Extra filter and used as a 
control in solid phase colony screening as described above. 
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8.3.2. 	Screening protocol 
Each filter was transferred on a fresh petri-dish and stored at —20°C for 24-72 hours in 
order to partially lyse the cells. Thereafter, each plate was treated with a cocktail 
containing both the assay mixture (§ 8. 1.1 or § 8.2) and also 2% agarose as described 
in §8.2. 
Use of soluble dye 
1 Oml of chromogenic solution (8. 1.1) was mixed with 1 Omi of melted 2% agarose 
which was kept at 60°C in a water bath until required. Resulting mixture was then 
immediately poured onto the membrane carrying the colonies. The agarose mixture 
was allowed to polymerise on the membrane within 1-2 mm. The plates were then left 
at room temperature for sufficient time to allow the assay to be developed. 
ii,). 	Use of insoluble dye 
A DAB tablet was dissolved in lOml of phosphate buffer, substrate and HPR mixture. 
Melted 2% agarose was kept at 60°C in a water bath until required. lOmi of 2% 
melted agarose was added to the 1 Oral of dissolved pellet. The resulting mixture was 
subjected to colonies screening as described above (§8.3.2; i). 
8.3.3. 	Second screening of the libraries 
51.11  of E. coli BL21(DE3) was transformed using 1 p.1 of plasmid DNA purified from 
a positive clone, obtained from the initial screening of the library(8.3 .2). 
Transformed cells were incubated with 200 j.il of SOC medium at 37°C and 
transferred onto a membrane using a sterile loop or by spreading 50p.1 of cell 
suspension per plate to obtain a low plating density of colonies. 
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8.4. 	Detection of oxidase activity in scrubbed bacterial 
colonies from the agar plate (scrubbed colonies screening.) 
	
8.4.1. 	Transformation into expression host E. Coli BL2I(DE3) 
A 2 p.1 DNA aliquot from each library was used to transform a 20p.l aliquot of 
expression host E. co/i BL21(DE3) (Invitrogen) using the manufacturers protocol 
with the following modification. 150 p.1 of SOC medium was added to induce - 
lactamase expression and 50 p.1 of cell suspension was plated on each LB Amp 100 
agarose plate. Two or three plates with 2000-3000 colonies on each plate represented 
each library. pMAO-N was used as a control (8.3.l). 
8.4.2. 	Scrubbing the colonies and whole cell culture assay 
A lOml volume of LB Amp 100 was added to each plate to pool the colonies. The 
pooled colonies were incubated in shaking incubator in 50 ml Falcon tubes at 30°C for 
16 hours. Two MAO-N two reference control cultures were prepared on the same 
way. At the end of incubation, the 10p.1 aliquots were used to measure the initial rate 
(3mm) of amylamine oxidation to confirm expression of the enzyme (7.2.4; i). 
Pellets obtained from centrifugation of lml aliquots (7.2.2; iv) were collected and 
kept frozen until needed to assay oxidase activity opon D, L-AMBA (7.2.4; ii) or for 
plasmid purification. The thawed pellets were incubated with chromogenic solution 
(8.1.1) containing D-AMBA or L-AMBA at 22°C for 18 hours. At the end of this 
incubation the cell suspension was centrifuged at 13,000 rpm for 5min and absorption 
at SlOnm in supernatant was measured. Plasmid DNA was purified from positive 
isolate and subjected to intact colony solid phase screening. 
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9. 	Experimental: Random mutagenesis by E.coIi XLI - 
Red 
9.1. 	Preparing libraries of mutated plasmids 
9.1.1. 	Plasmids applied for mutagenesis 
Plasmid DNA of pMAO-N was isolated using a QlAprep Miniprep kit (Quiagen, 
Hilden, Germany) from 2m1 over-night cultures in LB Amp 100 media. pUCI8 was 
supplied with the "Epicurian coli XL1 -Red competent cells" kit. 
9.1.2. 	First method of making mutations 
The plasmid of interest (5 td (50 ng) of pMAO-N and 1 .tl (0.1 ng) of pUC 18) was 
used to transform cells of the Epicurian coli XL 1-Red (Stratagene, La Jolla, CA) 
using the manufacturers protocol. A 0.7ml aliquot of transformed cell suspension was 
used to inoculate 20nil of LB Amp 100 and grown over-night (18 hours) in a 50m1 
Falcon tube in shaking incubator at 37T. These culture conditions were used 
throughout the experiment. Approximately 12 generations of cells were produced 
(E.coli XL 1-Red doubling time is 90— 120 mi. Plasmid DNA was purified 
(QlAprep Miniprep kit) from lml of culture. A 201.1.1 aliquot of this culture was then 
added to lOml of fresh LB Amp 100 media and subjected to another mutation cycle 
over 24 hours. From this sample a imi volume was centrifuged (13,000rpm, 5mm) 
and the plasmid DNA isolated. Repetition of this mutation cycle produced libraries of 
mutants from 12, 24, 36,48, 60, 72, 84 and 96 generations of cells. Selected plasmid 
libraries were used to transform into the expression host (§8.3. 1) and subjected to the 
solid phase screening assay (8.3.2; ii). 
157 
Experimental 
9.1.3. 	Second method of making mutations 
A 5p.l (.-50 ng) aliquot of pMAO-N plasmid DNA was used to transform EpicurEan 
co/i XL 1-Red using the manufacturers protocol. 0.7m1 aliquot of transformed cell 
suspension (Transformation 1) was used to inoculate 20m1 of LB Amp 100 and grown 
over-night (18 hours) in a 50m1 Falcon tube in a shaking incubator at 37'C. These 
culture conditions were used throughout the experiment. About 12 generations of cells 
were produced. Plasmid was purified from lml of culture. A 20p. aliquot of this 
culture was added to lOml of fresh LB Amp100 media and subjected to another 
mutation cycle over 24 hours. I ml of this culture was centrifuged (13,000rpm, 5mm) 
and the plasmid DNA isolated. 
Isolated plasmid was used to transform E. co/i XL 1-Red (Transformation II). The 
total transformed cell suspension was used to inoculate lOml of LB Amp and grown 
for 24h. Plasmid was purified from lml of culture. 100 .il aliquot of Transformation II 
culture was used to inoculate IlOmi of LB Amp. The culture was grown for 24h and 
the plasmid DNA purified. 
Isolated plasmid was used for Transformation M. Total transformed cell suspension 
(I ml) was used to inoculate lOmI of LB Amp, grown for 24h and plasmid purified. A 
100 .d aliquot of Transformation ifi culture was used to inoculate the next lOml of 
LB Amp. The culture was grown for 24h and the plasmid DNA purified. 
Isolated plasmid was used for Transformation W. Total suspension of transformed 
cells (I ml) was used to inoculate lOml of LB Amp, grown for 24h and the plasmid 
DNA purified from imi culture. A 100 p.1 aliquot of Transformation IV culture was 
used to inoculate fresh lOml LB Amp. The culture was grown for 24h and the plasmid 
purified. 
Resulting plasmid libraries were used to transforme expression host (§8.3. 1) and 
subjected to the solid phase screening assay (8.3.2; ii). 
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9.2. 	Determination of the mutagenic efficiency of mutator strain 
9.2.1. 	Screening for /1- galactosidase activity (white/blue colonies 
screening) 
A 241 sample pUCI8 plasmid DNA mutated by the first method of mutagenesis 
(§9.1.2) was used to transform 251.11 of E. coli Top 10 competent cells (Invitrogen) 
using the manufacturers protocol with the following modifications. 1251.11 volume of 
Soc medium was used to induce 13-lactamase expression and 50 p1 was plated onto 
LB Amp 100 agar supplemented with X-Gal (11. 14).  After over night incubation at 
37'C, the colonies producing active 3-galactosidase are blue in colour. 
10. 	Experimental: Validation and application of 
mutated clones. 
10.1. 	Validation by sequencing 
The MWG-BIOTECH facilities were used to perform DNA sequencing reactions. 
Plasmid DNA for sequence analysis was purified using GenElute Plasmid Midiprep 
Kit (Sigma # PLD-35). The plasmids and primers were provided in quantities 
according to the MWG-BIOTECH requirement (1-2p.g of dry pellet of plasmid DNA 
(10. 1.1) and lOpmolIpi of each primer). 
10.1.1. 	Preparation of plasmid DNA 
Plasmids were purified from 15 ml of over-night E. co/i Top 10 culture. The purity of 
plasmid DNA was determined by the ratio of 0D260/0D280 (10.2.2). 
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A dry DNA pellet was obtained by ethanol precipitation as follows. 500pJ of DNA 
solution was mixed with imi of ethanol (molecular biology grade, Aldrich # E702-3) 
and 50tl of 3M sodium acetate pH5.2. The solution was kept on ice for ihour and 
precipitated DNA was then collected by centrifugation using a microflige (13,000rpm, 
30mm, room temperature). The ethanol was discarded and pellet was washed with 
70% ethanol (500p3). The ethanol was removed and the pellet was then dried out on 
air at 37°C. 
10.1.2. Primers used for sequencing reaction 
T7 promoter primer (pETFor) was obtained from Novagen # 69348-1 
5' TAA TAC GAC TCA CTA TAG GG 3' 
T7 terminator primer (pETRev) was obtained from Novagen # 69337-1 
5' GGC GAC TCGTTATTGATC G3' 
The internal primer (Int2) sequence consisted of 20 nucleotides of MAO-N 
wild type coding sequence beginning from nucleotide 510. 
5' CCC GCATGACAT GAC ATGTTC TAT G3' 
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10.2. 	Restriction analysis of mutated genes 
	
10.2.1. 	Analysis of plasmid DNA of "expression" mutants by 
agarose gel electrophoresis. 
Plasmids were used to transform E. coil XLI -blue (Stratogene) according to 
manufacturer's protocol and purified from imi of over-night culture. 
A 20p.l aliquot of plasmid DNA was mixed with 30p.l of restriction enzyme digest 
cocktail stock (20p1 NdeI, 20..tl BamHI, 50t.tl BumHl buffer, 205i.ii H20, 5 il BSA) 
and was incubated forihour at 37°C. The products of digestion were visualised by UV 
illumination of ethidium bromide stained agarose gels following electrophoresis 
(§7.2.1.2). 
10.2.2. 	Subcloning of mao-n wild type gene into mutant vectors. 
Plasmid pMAO-N was used to transformed into E. coil JM1O9 (Promega) according 
to manufacturers protocol and purified from a 50m1 of LB Amp 100 culture (GenElute 
Plasmid Midiprep Kit, (Sigma # PLD-35). The yield of plasmid was determined by 
0D260 measurement (OD260  =1.0 corresponds to approximately 50p.gmIT1 of DNA). 
The quality of the plasmid was determined by measuring the ratio of absorption 
reading at 260 nm versus 280 nm. Pure preparation of DNA has 0D260/OD280 value of 
1.8. 
A 140p.1 aliquot of plasmid DNA (50 .ig) was mixed with a restriction digest cocktail 
(16p.l Mel, 16il Bamh'I, 32.d BamHI buffer, 3.2p1 BSA 96 j.tl H20) and the reaction 
was carried out at 37°C for 3 hours. The 1.5Kb mao-n band was purified from a 
preparative agarose gel. The mass ratio of vector/mao-n insert was determined by UV 
visualation after agarose gel electrophoresis to be 1:10. The ligation reaction was 
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performed with a quick ligation kit (Roche # 1 635 379) and was composed of 0.5 !.t1 
mutant vector DNA, 7.5 p.l of mao-n insert DNA, 2 p.! DNA dilution buffer, 10 p.1 
ligation buffer and 1 p.! T4 ligase. The reaction was incubated at room temperature for 
20mm. A 5 p.1 aliquot of ligation mix was used to transform BL21(DE3) in the 
presence of 3-mercaptoethanol (2 p.1 from 0.5M stock). 
10.3 	Characterisation of MAOmut"best" 
10.3.1. 	Validation by site directed mutagenesiS at position 336 
10.3.1.1. 	Primers used to introduce the mutations 
The genes encoding MAO-N wild type and MAOmut"best" were amplified by PCR, 
using the external MAO For and MAO Rev primers (7.2. 1.1). The internal primers 
MAOSer For and MAOSer Rev were designed to introduce serine at position 336 in 
MAO-N wild type sequence (codon for serine is in bold). 
MAOSer For 
5' GGT CAT GTG AGT ATG TGC ACG AAG 3' 
MAOSer Rev 
5' CGT GCA CAT ACT CAC ATG ACC TGC 3' 
The internal primers MAOmutAsn For and MAOmutAsn Rev were designed to 
introduce asparagine at position 336 in MAOmut"best" sequence. 
MAOmutAsn336 For 
5' GGT CAT GTG AAT ATG TGC ACG AAG 3' 
MAOmutAsn336 Rev 




10.3.1.2. 	Introduction of the mutations 
Six PCR reactions (7.2. 1.1) were performed to introduce the desired mutation in 
mao-n wild type or in mao-rn Ut "best" genes. 
First PCR: mao-n as a DNA template, MAOSerFor and MAORev as the primers. 
Second PCR: mao-n as a DNA template, MAOSerRev and MAOFor as the primers. 
Third PCR (gene recombination): 1.tl from solution (I pd of first PCR product, ll.tl of 
second PCR product and 8..tl water) as a DNA template, MAOFor and MAORev as 
the primers. 
Fourth PCR: mao-rnut"best" as DNA template, MAOmutAsn3 3 6For and MAORev 
as the primers. 
Fifth PCR: mao-mut"best" as DNA template MAOmutAsn3 3 6Rev and MAOFor as 
the primers. 
Sixth PCR (gene recombination): ipi from solution (li.tl of fourth PCR product, ipi 
of fifth PCR product and 8pi water) as a DNA template, MAOFor and MAORev as 
the primers. 
First, second, fourth and fifth PCR products were gel purified and recovered into 30p.l 
of H20 prior to subsequent PCR reactions. 
10.3.1.2 	Cloning protocol 
Final PCR products (third and sixth) were gel purified and recovered in 301l of H20 
and digested with NdeI and BamHI (1.5 p.1 each) in presence of BamHI buffer, in a 
volume of 40 p.1 for 4 hours. The digested PCR products were agarose gel purified in 
a total volume of 30p.l of H20, ligated to pET 16b digested with NdeI and BamHl 
(vector/insert 1/10) by incubation with T4 DNA ligase at room temperature, 16 h. 
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10.3.2. 	Mutagenesis at position 348 
	
10.3.2.1. 	Primers used to introduce the mutations 
The gene encoding MAOmut"best" was amplified by PCR, using the external 
MAOFor and MAORev primers (7.2. 1.1). The internal primersMAOmutLys348FOR 
and MAOmutLys348REV were designed to introduce lysine at the position 348 in 
MAOmut"best sequence (cogon for lysine is in bold). 
MAOmutLys348FOR 
5' GTG GAC AAT AAG GAT ATG CGG TCG 3' 
MAOmutLy5348REV 
5' CCG CAT ATC CIT All GTC CAC TIC 3' 
10.3.2.2. 	Introduction of the mutations 
Three PCR reactions were performed as described in § 10.3.1.2 but using 
MAOmutLys348FOR and MAOmutLy5348REV as internal primers. 
10.3.3. 	Validation of MAOmut"best" by subcloning 
A lOpd aliquot of plasmid DNA of MAO-N wild type (4 p.g) and the same amount of 
MAOmut"best" were separately mixed with a restriction digest cocktail (2p.l Noll, 2p.l 
MunI, 2p.l buffer U (Stratagene) and 4p.l H20) and the reaction carried out at 37
°C for 
2 hours. Upon agarose gel electrophoresis the resulting sizes of the bands were 
6184bp and 1029bp. Band 1029bp contained the sequence encoding the amino acid at 
position 336 and the 6184bp band contained the sequence encoding pET 16b and the 
remainder of the MAO gene. 4 bands were purified from the gel slices and the cross 
over ligation was undertaken. The 6184bp fragment of DNA of mao-n wild type in 
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pET 16b was ligated with the 1029bp DNA of mao-mut"best" and in addition the 
6184bp fragment of DNA of mao- mut "best " in pETl6b was ligated with 1029bp 
DNA of mao-n wild type. The mass ratio of vector/ insert was determined by 
visualization after agarose gel electrophoresis to be 1:10. The ligation reaction 
consisted of 1 .tl of the vector part of the plasmid, 7 tl of MunL1NotI insert DNA, 1 p.l 
ligase buffer and 1 p.1 T4 ligase. The reaction was incubated at room temperature for 
18 hours. Thereafter 5 p.l of the ligation mix was used to transformed into BL2 1 (DE3) 
in the presence of -mercaptoethanol (2 p.1 from 0.5M stock). 
10.4. 	Validation of positive clones by purification studies 
10.4.1. 	Purification by metal chelate affinity chromatography 
10.4.1.1. 	Purification on BoiCAD FPLC 
i). 	Purification procedure 
The protein was purified by employing the BioCAD 700E FPLC system (PerSpective 
Biosystems) with "Scout Column Select". The column (POROS MC, 4.6mm width, 
100mm width, 1. 66ml  volume) was self-packed with "Self Pack POROS 20 MC 
Media". 
The whole procedure was performed as close to 4°C as possible. A cell pellet from a 
300m1 culture (7.2.2; iii) was resuspended in starting buffer and CFE was obtained 
by sonication (72.3; i.). A 5m1 sample of CFE was filtered through a 0.45p.m sterile 
membrane prior to loading on the column using the loop. 
The purification was performed at lOml!min flow rate. The eluted samples were 
diluted with 25mM Tris HCI pH 7.8 to decrease imidasol concentration to 75mM, 
because of the negative effect of imidazole on enzyme activity. 
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The diluted samples were concentrated on a 50K Vivaspin (2m1) filtration unit, and 
kept over-night on ice at 4°C, until they were subjected to SDS PAGE analysis and 
activity studies. Imidasol needs to be removed completely from protein samples by 
dialysis (25mM Tris HC1 pH7.8) for long term storage of purified protein at 80°C. 
ii). 	Buffers. 
Charging buffer 	0. IM NiCl2 pH4.5-5.0. 
Starting buffer 	25mM Potassium phosphate, 300mM NaCl, 10mM Imidasole, 
pH 7.8. 
Elution buffer 	25mM Potassium phosphate, 0.3M NaCl, 1M Imidasole, pH 
7.8. 
Strip buffer 	0. 1M EDTA, IM NaCl 
H20 
NaCl 	 0.5M NaCl 
The NaCl and Strip buffers were prepared from standard stock solutions of 4M NaCl 
and 0.5M EDTA blended in the appropriate concentrations. 
All buffers were degassed and filtered (0.2p.m). 
The protein was eluted by a step gradient of imidasole in 3 ml fractions. 
iii). 	Basic method. 
Strip Buffer 5CV 
H20 1OCV 
Charge buffer 30CV 
H20 1OCV 
NaCl 1OCV 
Starting buffer 1 OCV 
Load loop 5m1 
Flush loop + Wash unbound lOmi 
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25mM Imidasole 	25CV 
Elution: 300mM Imidasole 1 5CV 
H20 	 10Cv 
10.4.1.2. 	Purification by metal chelating affinity chromatography on ACTA 
FPLC 
The protein was purified on "ACTA" FPLC protein purification system 
(AmershamPharmacia Biotech). The "HiTrap Chelating HP" (5m1 CV) column was 
obtained pre-packed from AmershamPharmaCia Biotech. 
Purification procedure 
The purification procedure was performed as close to 4°C as possible. A 30g quantity 
of cell pellet obtained from 4 liters culture (7.2.2; iii, iv) was resuspended in buffer 
A and CFE was obtained by sonication (7.2.3; ii). A 30m1 sample of CFE was then 
filtered through a 0.45p.m sterile membrane prior to loading on the column using the 
super loop. The eluted samples were diluted with 25mM Tns HC1 pH 7.8 to decrease 
imidasol concentration to 75mM and active fractions were stored at +40C over night 
without loss of activity. The residual imidasole was removed by dialysis against 
25mM TrisfHCl pH7.8; 0.1mM PMSF; ImM1DTT and sample stored at —80°C. 
Buffers 
Charging buffer 	0. IM NiC12 pH4. 5-5.0. 
Buffer A 	25mM TrisHCl, NaCl 300mM, 1mM PMSF20mM Imidasole, 
pH 7.8 
Buffer B 	Buffer A+ 1M Imidasole 
Strip buffer 	0. 1M EDTA. IM NaCl 
All buffers were degassed and filtered (0.2j.im). 
The protein was eluted by step gradient of Imidasole in 3m! fractions. 
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iii). 	Basic method. 
Strip Buffer 5CV 
H20 1OCV 
Charge buffer 1OCV 
H20 1OCV 
NaCl 1OCV 
Buffer A IOCV 
Load loop 30m1 
Fraction collected 5m1 
Wash unbound sample: 100% buffer A 2CV 
First step of elution: 90% buffer A and 10% buffer B 1OCV 
Second step of elution: 67% buffer A and 33% buffer B 1OCV 
Column clean: 100% buffer B 4CV 
Strip buffer 5CV 
H20 5CV 
10.4.2. 	Purification by anion exchange chromatography 
The protein was purified on "ACTA" FPLC protein purification system 
(AmershamPharmacia Biotech). The "ResourceQ" (6m1 CV) column was obtained 
pre-packed from AmershamPharmacia Biotech. 
i) 	Purification procedure 
The purifcation procedure was performed as close to 4°C as possible. The cell pellet 
obtained from 300ml culture (§ 7.2.2; iii, iv) was resuspended in buffer A and CFE 
was obtained by sonication (7.2.3; i.). A 5m1 sample of CFE was filtered through a 
0.45p.m sterile membrane prior to loading on the column using the loop. Fractions 
Experimental 
were assayed using a colorimetric solution (8. 1.1) and active fractions were stored at 
—80°C. 
ii). 	Buffers and basic method 
All buffers were degassed and filtered (0.2.tm). 
Buffer A 	 25rnMTris/HCL, pH 7.8 
Buffer B 	 Buffer A+ 1M NaCl 
Increasing gradient of NaCl was used to elute the protein. 
Flow rate 	 3m1min1 
Fraction to collect 	 2m1 
Wash unbound sample: 100% buffer A 	2CV 
Elution: 100% buffer A to 100% buffer B 20CV 
Column clean: 100% buffer B 	 4CV 
10.4.3. 	Bradford assay 
Protein concentrations were measured by mixing Bradford reagent (5m1, (11. 6)  with 
enzyme solution (lOOt.il) and standing for 2 minutes. The spectrophotometer was 
zeroed against Bradford reagent (5ml) and water (100tl), and then the absorbance of 
the protein sample at 595nm was measured. If the absorbance exceeded the 
calibration range then the enzyme was diluted accordingly and the assay repeated. 
The protein concentration was obtained by comparison with a pre-determined 
calibration curve derived from known dilutions of BSA. 
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10.4.4. 	Characterisation of mutant enzymes 
Activities towards amylamine (8. 1.1) and benzylamine (§8.1.2) were taken as an 
initial rate measurement over 3 minutes. Slow rates of activities were measured after 
17 hours incubation at 22°C. The spectrophotometer was blanked with chromogenic 
solution (8. 1.1). 
10.4.4.1. 	Specific activity 
The enzymatic activity units produced per I ml of enzyme sample, were calculated as 
described in (8. 1.1). The protein concentration in mg/ml was determined by 
Bradford assay (§ 10.4.3). Values for specific activity were calculated per one 
milligram of protein in solution. 
10. 4.4.2. 	Michaelis coefficient (Ku) and turnover number (kca). 
The rates of oxidation of various concentrations of L-AMBA and AA by enzyme 
were measured (8. 1.1) to determine KM and Vm for these substrates. 
The listed concentrations are in mM: 0.015; 0.03; 0.06; 0.08; 0.1; 0.12; 0.15; 0.2; 
0.24; 0.3; 0.6; 1.0; 5.0. Values for KM and Vmax were determined using the program 
"KaleidaGraph for Windows, Version 309; Synergy Software". 
Values of turnover numbers (k) were calculated per mol of flavoprotein subunit and 
per minute. Protein concentration in sample was determined by ratio AbS458r= over 
flavin extinction coefficient (6= 11 .0/mMlcm) 221. kcat min' was calculated as the ratio 
of Vmax over c =29400 (extinction coefficient of dye) over protein concentration, 
multiply by 60. 
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10.5. 	Application of the obtained mutations. 
10.5.1. 	Improvement of MAO-N wild type expression. 
The gene encoding MAO-N wild type was amplified by PCR, using the external 
MAO-For and MAO-Rev primers (7.2. 1.1). The internal primers MAOArg259/260 
For and MAOArg259/260Rev were designed to introduce CGT codon at position 259 
and 260 into mao-n wild type sequence (cogon for arginine 259&260 is in bold). 
Arg259Arg26OFor 
5' CAG TCT GCA TTT GCG CGT CGT TTT TGG GAG GAG GC 3' 
Arg259Arg26ORev 
5' GC CTC CTC CCA AAA ACG ACG CGC AAA TGC AGA CTG 3' 
The introduction of mutations and cloning protocol were the same as in § 10.3.1 & 
§10.3.2. 
10.5.2. 	Validation of protein activity in soluble and insoluble 
fractions 
The cell pellet was resuspended in detail buffer. The sonication was performed as 
described in §7.2.3. The supernatant was separated from the pellet and the latter was 
resuspended in the same volume of buffer as supernatant. The presence of active 
protein in supernatant and in pellet was analysed by liquid phase assay (8. 1.1) and by 
SDS PAGE (7.2.5.2). 
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11 	Stock recipes 
11.1. 	LB medium 
Per litre: 	Triptone peptone lOg 
Sodium Chloride lOg 
Yeast extract 5g 
	
11.2. 	LB agar medium 
LB medium 	 1 OOml 
Agar 	 1.5g 
11.3. 	Coomassie blue staining solution 
Methanol 450m1 
Acetic acid lOOmi 
Water 450m1 
Coomassie blueR-250 500mg 
11.4. 	Coomassie Blue de-staining solution 
Methanol 400m1 





11.5. 	5OxTris-acetate buffer (TAE) 
Tris base 	 242g 
Acetic acid 	 57.1ml 
0.5M EDTA (pH8.0) 	lOOmi 
11.6. 	Bradford reagent 
Coomassie Brilliant Blue G-250 	100mg 
Ethanol 	 50m1 
Phosphoric acid (85%) 	 lOOml 
Water 	 up toll, 
Comassie Blue was dissolved in ethanol and phosphoric acid added to this solution. 
Water was added last. 
11.7. 	Acrylamide solution 
30% (w/v) acrylamide/bis-acrylamide (Anachem) 
11.8. 	SDS stacking gel (4% acrylamide) 
Per lOml: 	Acrylamide solution 1.3m1 
0.5M Tris HCI, pH6.8 2.5m1 
10% (w/v) SDS 0.lml 
TEMED 20p.l 




TEMED and 10% APS (freshly made up) added immediately before pouring the gel. 
11.9. SDS separating gel (15% acrylamide) 
Per lOmi: 	Acrylamide solution 	5.Oml 
1.5M TrisHCl, pH8.8 	2.5m1 
10% (w/v) SDS 	 0. lml 
TEMED 	 101.1.1 
10%(w/v)APS 	 1001.1.1 
Water 	 2.35m1 
TEMED and 10% APS (freshly made up) added immediately before pouring the gel. 
11.10. 4xSDS reducing buffer 
0.5M TrisHCl, pH6.8 	 2.Oml 
Glycerol 	 1 .6-2.Oml 
10% (w/v) SDS 	 3.2m1 
2-3-Mercaptoethanol 	 0. 8m1 
0.05%(v/v) Bromophenol Blue 	0.4m1 
11.11. 	0.05(w/v) Bromophenol blue 




11.12. 	lOx SDS running buffer 
Per litre 	Tris base 	30g 
Glycine 	 144g 
SDS 	 lOg 
11.13. 	5 x DNA loading buffer 
0.05% bromophenol blue in 4% glycerol 
11.14. 	X-Gal solution 
Stock solution - 20mg/ml in dimethylformamide. 
80ig/ml final concentaration 
11.15. 	Ethidium bromide 
Stock solution 	10mg/mi 
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Pure clone assayed against D-enantiomer 
B 
First dilution of active clone 
Fol 
Pure clone assayed againsr L-enant!omer 
Figure 77: Strategy for solid phase assay. A. Colonies growing directly on nitrocellulose 
membrane at density 2000-3000 per plate. B. Active clone must be separated from the neighbour ones 
by subsequent dilution. C&D. Active clone plasmid DNA transformed into expression host and 
segmented membrane subjected to detect the enantioselectivity by solid phase assay. 
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>SWLL:PO_MAIZE 064411 Polyamifle oxidase precursor (EC 1.5.3.11). 
Length = 500 
Score = 121 (47.7 bits), Expect = 2.le-07, Sum P(2) = 2.1e-07 
Identities = 28/59 (47%) , Positives = 35/59 (59%) 
Query: 	38 	
95 
GP VIV+G G G++A + L+ AG LL LEA D IGGR +N G E+G WV 
Sbjct: 	32 GPRVIVVGAGMsG1s 	SEAGITLLEATDHI 
	 NVEIWWV 89 
Score = 79 (32.9 bits), Expect = 2.le-07, Sum P(2) = 2.1e-07 
Identities = 50/221 (22%) , Positives = 87/221 (39%) 
Query: 279 VRS NERDAARTARDGREF 	VCTIPLNVLST - IQFSPALSTERI SAMQAGHVN 336 
V t) ++A +++ LVL+ IQFPLT++A+ 	
+ 
Sbjct: 265 VREIKYSPGGVTVKTEDNSVYSADYVMVsASLGVLQSDLIQFKpKLpTWKVRAIyQFDMA 324 
Query: 337 MCTKH EVDNRSWTG --- IAYPFCYAIGTTPAGHLVCF 
	387 
+TI<+ + K 	G 	Y ++ Y+ 	+ 
p N IV TD + 
Sbjct: 325 	
383 
Query: 	388 HI 	
441 
I QDE +E+++++PG 	++ W DFKG F+P V+ 
Sbjct: 	384 RIEQQSDEQTAEIHQVL4FPGKDVPDATDILVPRSDIYKGTFSP 
	442 
Query: 442 LQGLREKHRG FANSDWAL RSFIDGAIEEGTA'J 482 
LR 	V F 	+ + ++ GA G +A+++ 
Sbjct: 443 YDQLRAPVGRVYFGEHTSENGHGAYLSGIDSILI 483 
DV+V+GGG G+ A + L +G ++LFJRDR+GGR+++ 	
Y ++GG++V Q 
Figure 78: sequence alignment of MAO-N and PAO from maize (WU-Blast2). "Query" 
sequence corresponds to MAO-N, "Sbjct" sequence corresponds to MAO-B. Identical and similar 
residues belong to active site of MAO-B are in blue and the residues from active site without similarity 
are in yellow. The only amino acids belonging to the mature protein participe in sequences alignment 
(the mature PAO protein sequence starts with amino acid number 29). 
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Figure 79: the map and the sequence of cloning/expression region of vector pET16b. 
The map obtained from the web site 	-- 	 -. 
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Appendices 
pETl6b restriction map 
BioEdit version 5.0.9 Restriction Mapping Utility 






81 CGTGTATGAAATCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGCATAGGCTTGGTTATG 160 












321 ATCCTCGAGCATATGACGACCTTCGATATGGCCGCTGCTG36ITGATGATGATGATGATGATGATGATGATGGCCCATGG 400 
321 TAGGAGCTCGTATACTGCTGGPLAGCTATACCGGCGACGAC361ACTACTACTACTACTACTACTACTACTACCGGGTACC 400 
NcoI 










BglII 	 Ng0AIV 	
Nan 
561 	
TGCGGTTGCTGCGCCTATATCGCCGACATCACCGATGAGATCGG6O1 GCTCGCCACTTCGGGTCTGATT 640 














































































































































2801 ATCTCGGGCAGCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGG 2880 

































































































Dral 	 Dral 
4641 TAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATT 4720 
4641 ATTTCATATATACTCATTTGAACCAGACTGTCAATGGTTACGAATTAGTCACTCCGTGGATAGAGTCGCTAGACAGATAA 4720 
4721 TCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTG4800 
4721 AGCAAGTAGGTATCAACGGACTGAGGGGCAGCACATCTATTGATGCTATGCCCTCCCGAATGGTAGACCGGGGTCACGAC 4800 
Pf111081 	 BmrI 




EciI 	 VapI 
4961 TAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCG5040 
4961 ATCAAACGCGTTGCAACAACGGTAACGACGTCCGTAGCACCACAGTGCGAGCAGCAPLACCATACCGPLAGTAAGTCGAGGC5040 








BtsI 	 BtI 
5201 AAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCC5280 

























5681 TATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAA 5741 
5681 ATAATAGTACTGTAATTGGATATTTTTATCCGCATAGTGCTCCGGGAAAGCAGAAGTTCTT5741 
RcaI 	 BssSI 
Appendices 
Restriction table: 
Enzyme Recognition 	Frequency 	Positions 
AatII GACGT'C - 	 1 
5 
5669 
900, 	2280, 	3179, 	4973, 	5346 AclI AA'CGTT 
Apal GGGCC'C 1 
1461 
ApaLI G'TGCAC 3 
3668, 	4168, 	5414 
BamHI G'GATCC 1 320 
BclI T'GATCA 1 
1263 
BglII AGATCT 1 
6 
504 
756, 	1163, 	1405, 	2059, 	3599, 	4793 
BmrI ACTGGG 
BsbI CAACAC 2 
3569, 5290 
BapEl T'CCGGA 2 
190, 	3043 
BspGI CTGGAC 3 
2437, 2515, 	3380 
BspLU11I A'CATG_T 1 
3 
3854 
456, 	3786, 	5507 
BsrBI CCG'CTC 
BssHII G'CGCGC 1 
3 
1661 
4030, 	5414, 	5718 
BssSI C'ACGAG 
BstZ17I GTA'TAC 1 
4 
3625 
1617, 	1978, 	5142, 	5169 
BtsI GCAGTG 
daT AT'CGAT 1 
3 
25 
4613, 	4632, 	5324 
Dral TTT'AAA 
DrdII GAACCA 1 
964 
EagI C'GGCC_G 1 
5 
2318 
1017, 	2774, 	3928, 	4074, 	4902 
EctI TCCGCC 
3 637, 2156, 3108 Eco47111 AGC'GCT 
2 188, 	1700 Ec0RV GAT'ATC 
3 2737, 2835, 	4969 FspI TGC'GCA 
Hindlil A'AGCTT 1 
30 
HpaI GTT'NkC 1 
1756 
Miul A'CGCGT 1 
1249 
MscI TGGCCA 1 
5 
2825 
552, 	573, 	690, 	1890, 	2585 
Marl GG'CGCC 
NcoI C'CATG_G 1 
396 
NdeI CA'TATG 1 
4 
332 
536, 	2148, 	2308, 	2662 
Ng0AIV G'CCGGC 
NruI TCG'CGA 1 
2353 
Pf111081 TCGTAG 2 
2137, 	4764 
PstI CTGCA'G 1 
4992 
PvuI CG AT'CG 1 
3 
5117 
1850, 	1943, 	3445 
PvuII CAG'CTG 
4 630, 4574, 5582, 	5687 RcaI T'CATGA 
ScaT AGT'ACT 1 
5227 
SphI GCATG'C 1 
707 
SspI AAT'ATT 1 
3 
5551 
1935, 	1994, 	4919 
VspI AT'TAAT 
1 435 XbaI T'CTAGA 
XhoI C'TCGAG 1 
325 
Table of unique sites: 
Enzyme Recognition Frequency Position 
AatIIGACGT,C 15669 
Apal GGGCC'C 1 
1461 
BamHI G'GATC C 1 
320 
BclT T'GATCA 1 
1263 
BglII A'GATC_T 1 
504 
BspLU11I A'CATGT 1 
3854 
BssHII G'CGCGC 1 
1661 
BstZ17I GTA'TAC 1 
3625 
Clal AT'CGAT 1 
25 
DrdII GAACCA 1 
964 
EagI C'GGCC_G 1 
2318 
Hindill A'AGCTT 1 
30 
HpaI GTT'AAC 1 
1756 
MluI A'CGCG_T 1 
1249 
MscI TGG'CCA 1 
2825 
NcoI C'CATGG 1 
396 




NruI TCGCGA 1 
2353 
PstI CTGCA'G 1 
4992 
PvuI CGAT'CG 1 
5117 
Scal AGT'ACT 1 
5227 
SphI GCATG'C 1 
707 
SspI AAT'ATT 1 
5551 
XbaI T'CTAGA 1 
435 
XhoI C'TCGAG 1 
325 
Enzymes that cut five or fewer times 
Enzyme Recognition Frequency Positions 
AatII GACG ,C 
15669 
5 900, 	2280, 	3179, 	4973, 	5346 AclI AA'CG_TT 
Apal GGGCC'C 1 
3 
1461 
3668, 	4168, 	5414 
ApaLI G'TGCAC 
BamHI G'GATCC 1 
320 
BclI T'GATC_A 1 
1263 





2 190, 3043 BapEl T'CCGGA 
3 2437, 	2515, 	3380  BspGI CTGGAC 
1 3854  BapLU11I A'CATG_T 
3 456, 	3786, 	5587  BarBI CCG'CTC 
BssHII GCGCGC 1 
3 
1661 
4030, 	5414, 	5718 
BssSI C'ACGA G 
1 3625  BstZ17I GTA'TAC 
4 1617, 	1978, 	5142, 	5169 BtsI GCAGTG 
Clal AT'CGAT 1 
3 
25 
4613, 	4632, 	5324 
DraT TTT'AAA 
DrdII GAACCA 1 
964 
2318 
EagI C'GGCCG 1 
5 1017, 	2774, 	3928, 	4074, 	4902 Ecu TCCGCC 
3 637, 2156, 3108 Eco47111 AGC'GCT 
2 188, 	1700 EcoRV GAT'ATC 
3 2737, 2835, 	4969 FapI TGC'GCA 30 
Hindlil A'AGCTT 1 
1 1756 Upal GTT'AAC 
1 1249 Miul A'CGCGT 
1 2825 MscI TGG'CCI\ 
5 552, 	573, 	690, 	1890, 	2585 Narl GG'CGCC 
1 396 NcoI C'CATG_G 
1 332 NdeI CA'TATG 
4 536, 	2148, 	2308, 	2662 N90AIV G'CCGGC 
1 2353 NruI TCG'CGA 
2 2137, 	4764 pfl1108I TCGTAG 4992 
PstI CTGCA'G 1 
1 5117  PvuI CGAT'CG 
3 1850, 	1943, 	3445 PvuII CAG'CTG 
4 630, 4574, 5582, 	5687  RcaI T'CATG_A 
1 5227 Scal AGT'ACT 
1 707 SphI GCATG'C 
1 5551 SapI AAT'ATT 
3 1935, 	1994, 	4919  VspI AT'TAAT 
1 435 XbaI T'CTAG_A 
1 325 XhoI C'TCGAG 
Enzymes that do not cut: 
AarI, Afill, AscI, Avrll, BbvCI, BsrGI, BtrI., EcoRl, FseI, KpnI, MunI, NheI, Nod 
NsiI, NspV, Pad, PinAll, PmeI, PmlI, Psil, Sad, SacH, Sail, SbfI, Sgfl, Smal 
SnaBI, Spel, Srff, Stul, Sun]I, SwaT 
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MA 0-N Restriction Map 
BioEdit version 5.0.9 Restriction Mapping Utility 




81 GCCCACTAATATCGAAGACACGGACAAAGATGGTCCATGGGACGTGATTGTCATTGGTGGAGGGTACTGCGGGTTGACTG 160 









241 TCTAACATCGACGGCTATCCTTACGAGATGGGCGGCACATGGGTCCACTGGCACCAATCGCACGTATGGCGCGAAATCAC 320 
241 	
AGATTGTAGCTGCCGATAGGAATGCTCTACCCGCCGTGTACCCAGGTGACCGTGGTTAGCGTGCATACCGCGCTTTAGTG320 
321 GCGCTACAAGATGCACAACGCCCTATCACCCTCCTTCAACTTCTCCCGCGGCGTGAATCACTTCCAGCTACGGACCAACC 400 






481 GGCACCAACGGCCGTACTGTCCTGCCCTTCCCGCATGACATGTTCTATGTTCCTGAGTTCAGGAAGTATGATGAGATGTC 560 
481 	
CCGTGGTTGCCGGCATGACAGGACGGGAAGGGCGTACTGTACAAGATACAAGGACTCAAGTCCTTCATACTACTCTACAG560 
















NsiI 	 Pail 	
EagI 









































GTGTTGAGGATTGGGAACGAAGGAGGTGGTCGTTTGTGA 	1488 1441 /CACT 1488 CACAACCTCCTTAACCCTTGCTTCTCTCCACTT 1441 
EsbI 
Restriction table: 
Enzyme 	Recognition 	Frequency 	Positions 
ApaLI G'TGCA_C 	 1 	
1012 
BciI T'GATCA 1 
577 
3 	 844, 	1354, 	1443 
BsbI CAPCAC 
1 519 BapLUllI A'CATGT 
4 	 231, 	450, 	570, 	701 BsrBI CCGCTC 
2 123, 1182 BtrI CAC'GTC 
1 	 1290 DrdII GAACCA 
3 226, 	490, 	795 EagI C'GGCCG 
1 	 648 EciI TCCGCC 
2 677, 	1366 EcoRI G'AATT_C 
1 	 1255 MunI C'AATTG 116 
NcoI CCATGG 	 1 
NotI GC'GGCC_GC 1 	
226 
NsiI ATGCA'T 	 1 
725 




2 	 370, 1122 Sacli CCGCGG 
1 967 Sail G'TCGA_C 
1 	 711 SnaBI TAC'GTP. 
1 1028 SphI GCATG'C 
1 	 1303 Stul AGG'CCT 
Table of unique sites: 
Enzyme Recognition Frequency Position 
ApaLI G'TGCA_C 1 
1012 
BciI T'GATC_A 1 
577 
BspLU11I A'CATGT 1 
519 
1 1290 DrdII GAACCA 
1 648 EciI TCCGCC i 1255 MunI C'AATTG 116 
NcoI C'CATGG 1 226 
NotI GC'GGCC_GC 1 725 













Stul 	AGGCCT 	 1 	 1303 
Enzymes that cut five or fewer times 
Enzyme Recognition 	Frequency 	Positions 
AarI CACCTGC - 	 1 959 
ApaLI G'TGCAC 1 1012 
BciI T'GATCA 1 577 
BsbI CAACAC 3 
844, 1354, 	1443 
BspLU11I A'CATG_T 1 519 
BarBI CCG'CTC 4 231, 
450, 	570, 	701 
BtrI CAC'GTC 2 
123, 1182 
DrdII GAACCA 1 
1290 
EagI C'GGCCG 3 226, 
490, 	795 
ECiI TCCGCC 1 
648 
EcoRI G'AATTC 2 
677, 1366 
MunI C'AATTG 1 
125.5 
NcoI C'CATGG 1 
116 
NotI GC'GGCCGC 1 
226 
NslI ATGCA'T 1 
725 
Psil TTA'TAPS 1 
744 
Sacl GAGCT'C 1 
444 
Sacil CCGC'GG 2 
370, 1122 
Sail G'TCGAC 1 
967 
SnaBI TAC'GTA 1 
711 
SphI GCATG'C 1 
1028 
Stul AGG'CCT 1 
1303 
Enzymes that do not cut: 
AatII,AclI,AflhI,ApaI,ASCI,AVrIT, BaniHi, BbvCI, BglII, BmrI, BspEI, BspGI 
BsrGI, BssHII, BssSI, BstZ 171, BtsI, Clal, Dral, Eco47111, EcoRV, FseI, FspI 
Hindu, HpaI, KpnT, Miul, MscI, Nan, NdeI, NgoAIV, NheI, NnuI, NspV, Pad 
Pfll 1081, PinAl, PmeI, PmlI, PstI, PvuI, PvuII, Real, Sbfl, Seal, Sgfl, Smal, Spel 
Srfl, SspI, Suni, Swal, VspI, XbaI, XhoI 
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